,Group1,res,method,operation,output,label,pattern,Group2,Group3,analysis,name,dec,rnd,disp
1,Placebo,86,Mth01_CatVar_Count_ByGrp,Mth01_CatVar_Count_ByGrp_1_n,Out14-1-1,n,(N=XX),,,An01_05_SAF_Summ_ByTrt,Summary of Subjects by Treatment,0,86,(N=86)
2,Xanomeline High Dose,84,Mth01_CatVar_Count_ByGrp,Mth01_CatVar_Count_ByGrp_1_n,Out14-1-1,n,(N=XX),,,An01_05_SAF_Summ_ByTrt,Summary of Subjects by Treatment,0,84,(N=84)
3,Xanomeline Low Dose,84,Mth01_CatVar_Count_ByGrp,Mth01_CatVar_Count_ByGrp_1_n,Out14-1-1,n,(N=XX),,,An01_05_SAF_Summ_ByTrt,Summary of Subjects by Treatment,0,84,(N=84)
4,Placebo,86,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-1-1,n,XX,,,An03_01_Age_Summ_ByTrt,Summary of Age by Treatment,0,86,86
5,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-1-1,n,XX,,,An03_01_Age_Summ_ByTrt,Summary of Age by Treatment,0,84,84
6,Xanomeline Low Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-1-1,n,XX,,,An03_01_Age_Summ_ByTrt,Summary of Age by Treatment,0,84,84
7,Placebo,75.20930233,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-1-1,Mean,XX.X,,,An03_01_Age_Summ_ByTrt,Summary of Age by Treatment,1,75.2,75.2
8,Xanomeline High Dose,74.38095238,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-1-1,Mean,XX.X,,,An03_01_Age_Summ_ByTrt,Summary of Age by Treatment,1,74.4,74.4
9,Xanomeline Low Dose,75.66666667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-1-1,Mean,XX.X,,,An03_01_Age_Summ_ByTrt,Summary of Age by Treatment,1,75.7,75.7
10,Placebo,8.590167127,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-1-1,SD,(XX.XX),,,An03_01_Age_Summ_ByTrt,Summary of Age by Treatment,2,8.59,-8.59
11,Xanomeline High Dose,7.886093849,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-1-1,SD,(XX.XX),,,An03_01_Age_Summ_ByTrt,Summary of Age by Treatment,2,7.89,-7.89
12,Xanomeline Low Dose,8.2860506,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-1-1,SD,(XX.XX),,,An03_01_Age_Summ_ByTrt,Summary of Age by Treatment,2,8.29,-8.29
13,Placebo,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-1-1,Median,XX.X,,,An03_01_Age_Summ_ByTrt,Summary of Age by Treatment,1,76,76
14,Xanomeline High Dose,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-1-1,Median,XX.X,,,An03_01_Age_Summ_ByTrt,Summary of Age by Treatment,1,76,76
15,Xanomeline Low Dose,77.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-1-1,Median,XX.X,,,An03_01_Age_Summ_ByTrt,Summary of Age by Treatment,1,77.5,77.5
16,Placebo,69.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-1-1,Q1,XX.X,,,An03_01_Age_Summ_ByTrt,Summary of Age by Treatment,1,69.2,69.2
17,Xanomeline High Dose,70.75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-1-1,Q1,XX.X,,,An03_01_Age_Summ_ByTrt,Summary of Age by Treatment,1,70.8,70.8
18,Xanomeline Low Dose,71,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-1-1,Q1,XX.X,,,An03_01_Age_Summ_ByTrt,Summary of Age by Treatment,1,71,71
19,Placebo,81.75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-1-1,Q3,XX.X,,,An03_01_Age_Summ_ByTrt,Summary of Age by Treatment,1,81.8,81.8
20,Xanomeline High Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-1-1,Q3,XX.X,,,An03_01_Age_Summ_ByTrt,Summary of Age by Treatment,1,80,80
21,Xanomeline Low Dose,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-1-1,Q3,XX.X,,,An03_01_Age_Summ_ByTrt,Summary of Age by Treatment,1,82,82
22,Placebo,52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-1-1,Min,XX,,,An03_01_Age_Summ_ByTrt,Summary of Age by Treatment,0,52,52
23,Xanomeline High Dose,56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-1-1,Min,XX,,,An03_01_Age_Summ_ByTrt,Summary of Age by Treatment,0,56,56
24,Xanomeline Low Dose,51,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-1-1,Min,XX,,,An03_01_Age_Summ_ByTrt,Summary of Age by Treatment,0,51,51
25,Placebo,89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-1-1,Max,XX,,,An03_01_Age_Summ_ByTrt,Summary of Age by Treatment,0,89,89
26,Xanomeline High Dose,88,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-1-1,Max,XX,,,An03_01_Age_Summ_ByTrt,Summary of Age by Treatment,0,88,88
27,Xanomeline Low Dose,88,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-1-1,Max,XX,,,An03_01_Age_Summ_ByTrt,Summary of Age by Treatment,0,88,88
28,,0.593435775,Mth04_ContVar_Comp_Anova,Mth04_ContVar_Comp_Anova_1_pval,Out14-1-1,p-value,X.XXXX,,,An03_01_Age_Comp_ByTrt,Comparison of Age by Treatment,4,0.5934,0.5934
29,Placebo,42,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,65-80,,An03_02_AgeGrp_Summ_ByTrt,Summary of Subjects by Treatment and Age Group,1,42,42
30,Placebo,14,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,<65,,An03_02_AgeGrp_Summ_ByTrt,Summary of Subjects by Treatment and Age Group,1,14,14
31,Placebo,30,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,>80,,An03_02_AgeGrp_Summ_ByTrt,Summary of Subjects by Treatment and Age Group,1,30,30
32,Xanomeline High Dose,55,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,65-80,,An03_02_AgeGrp_Summ_ByTrt,Summary of Subjects by Treatment and Age Group,1,55,55
33,Xanomeline High Dose,11,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,<65,,An03_02_AgeGrp_Summ_ByTrt,Summary of Subjects by Treatment and Age Group,1,11,11
34,Xanomeline High Dose,18,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,>80,,An03_02_AgeGrp_Summ_ByTrt,Summary of Subjects by Treatment and Age Group,1,18,18
35,Xanomeline Low Dose,47,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,65-80,,An03_02_AgeGrp_Summ_ByTrt,Summary of Subjects by Treatment and Age Group,1,47,47
36,Xanomeline Low Dose,8,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,<65,,An03_02_AgeGrp_Summ_ByTrt,Summary of Subjects by Treatment and Age Group,1,8,8
37,Xanomeline Low Dose,29,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,>80,,An03_02_AgeGrp_Summ_ByTrt,Summary of Subjects by Treatment and Age Group,1,29,29
38,Placebo,48.8372093,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),65-80,,An03_02_AgeGrp_Summ_ByTrt,Summary of Subjects by Treatment and Age Group,1,48.8,-48.8
39,Placebo,16.27906977,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),<65,,An03_02_AgeGrp_Summ_ByTrt,Summary of Subjects by Treatment and Age Group,1,16.3,-16.3
40,Placebo,34.88372093,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),>80,,An03_02_AgeGrp_Summ_ByTrt,Summary of Subjects by Treatment and Age Group,1,34.9,-34.9
41,Xanomeline High Dose,65.47619048,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),65-80,,An03_02_AgeGrp_Summ_ByTrt,Summary of Subjects by Treatment and Age Group,1,65.5,-65.5
42,Xanomeline High Dose,13.0952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),<65,,An03_02_AgeGrp_Summ_ByTrt,Summary of Subjects by Treatment and Age Group,1,13.1,-13.1
43,Xanomeline High Dose,21.42857143,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),>80,,An03_02_AgeGrp_Summ_ByTrt,Summary of Subjects by Treatment and Age Group,1,21.4,-21.4
44,Xanomeline Low Dose,55.95238095,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),65-80,,An03_02_AgeGrp_Summ_ByTrt,Summary of Subjects by Treatment and Age Group,1,56,-56
45,Xanomeline Low Dose,9.523809524,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),<65,,An03_02_AgeGrp_Summ_ByTrt,Summary of Subjects by Treatment and Age Group,1,9.5,-9.5
46,Xanomeline Low Dose,34.52380952,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),>80,,An03_02_AgeGrp_Summ_ByTrt,Summary of Subjects by Treatment and Age Group,1,34.5,-34.5
47,,0.143917026,Mth03_CatVar_Comp_PChiSq,Mth03_CatVar_Comp_PChiSq_1_pval,Out14-1-1,p-value,X.XXXX,,,An03_02_AgeGrp_Comp_ByTrt,Comparison of Age Group by Treatment,4,0.1439,0.1439
48,Placebo,53,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,F,,An03_03_Sex_Summ_ByTrt,Summary of Subjects by Treatment and Sex,1,53,53
49,Placebo,33,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,M,,An03_03_Sex_Summ_ByTrt,Summary of Subjects by Treatment and Sex,1,33,33
50,Xanomeline High Dose,40,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,F,,An03_03_Sex_Summ_ByTrt,Summary of Subjects by Treatment and Sex,1,40,40
51,Xanomeline High Dose,44,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,M,,An03_03_Sex_Summ_ByTrt,Summary of Subjects by Treatment and Sex,1,44,44
52,Xanomeline Low Dose,50,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,F,,An03_03_Sex_Summ_ByTrt,Summary of Subjects by Treatment and Sex,1,50,50
53,Xanomeline Low Dose,34,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,M,,An03_03_Sex_Summ_ByTrt,Summary of Subjects by Treatment and Sex,1,34,34
54,Placebo,61.62790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),F,,An03_03_Sex_Summ_ByTrt,Summary of Subjects by Treatment and Sex,1,61.6,-61.6
55,Placebo,38.37209302,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),M,,An03_03_Sex_Summ_ByTrt,Summary of Subjects by Treatment and Sex,1,38.4,-38.4
56,Xanomeline High Dose,47.61904762,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),F,,An03_03_Sex_Summ_ByTrt,Summary of Subjects by Treatment and Sex,1,47.6,-47.6
57,Xanomeline High Dose,52.38095238,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),M,,An03_03_Sex_Summ_ByTrt,Summary of Subjects by Treatment and Sex,1,52.4,-52.4
58,Xanomeline Low Dose,59.52380952,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),F,,An03_03_Sex_Summ_ByTrt,Summary of Subjects by Treatment and Sex,1,59.5,-59.5
59,Xanomeline Low Dose,40.47619048,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),M,,An03_03_Sex_Summ_ByTrt,Summary of Subjects by Treatment and Sex,1,40.5,-40.5
60,,0.140859829,Mth03_CatVar_Comp_PChiSq,Mth03_CatVar_Comp_PChiSq_1_pval,Out14-1-1,p-value,X.XXXX,,,An03_03_Sex_Comp_ByTrt,Comparison of Sex by Treatment,4,0.1409,0.1409
61,Placebo,3,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,HISPANIC OR LATINO,,An03_04_Ethnic_Summ_ByTrt,Summary of Subjects by Treatment and Ethnicity,1,3,3
62,Placebo,83,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,NOT HISPANIC OR LATINO,,An03_04_Ethnic_Summ_ByTrt,Summary of Subjects by Treatment and Ethnicity,1,83,83
63,Xanomeline High Dose,3,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,HISPANIC OR LATINO,,An03_04_Ethnic_Summ_ByTrt,Summary of Subjects by Treatment and Ethnicity,1,3,3
64,Xanomeline High Dose,81,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,NOT HISPANIC OR LATINO,,An03_04_Ethnic_Summ_ByTrt,Summary of Subjects by Treatment and Ethnicity,1,81,81
65,Xanomeline Low Dose,6,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,HISPANIC OR LATINO,,An03_04_Ethnic_Summ_ByTrt,Summary of Subjects by Treatment and Ethnicity,1,6,6
66,Xanomeline Low Dose,78,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,NOT HISPANIC OR LATINO,,An03_04_Ethnic_Summ_ByTrt,Summary of Subjects by Treatment and Ethnicity,1,78,78
67,Placebo,3.488372093,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),HISPANIC OR LATINO,,An03_04_Ethnic_Summ_ByTrt,Summary of Subjects by Treatment and Ethnicity,1,3.5,-3.5
68,Placebo,96.51162791,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),NOT HISPANIC OR LATINO,,An03_04_Ethnic_Summ_ByTrt,Summary of Subjects by Treatment and Ethnicity,1,96.5,-96.5
69,Xanomeline High Dose,3.571428571,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),HISPANIC OR LATINO,,An03_04_Ethnic_Summ_ByTrt,Summary of Subjects by Treatment and Ethnicity,1,3.6,-3.6
70,Xanomeline High Dose,96.42857143,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),NOT HISPANIC OR LATINO,,An03_04_Ethnic_Summ_ByTrt,Summary of Subjects by Treatment and Ethnicity,1,96.4,-96.4
71,Xanomeline Low Dose,7.142857143,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),HISPANIC OR LATINO,,An03_04_Ethnic_Summ_ByTrt,Summary of Subjects by Treatment and Ethnicity,1,7.1,-7.1
72,Xanomeline Low Dose,92.85714286,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),NOT HISPANIC OR LATINO,,An03_04_Ethnic_Summ_ByTrt,Summary of Subjects by Treatment and Ethnicity,1,92.9,-92.9
73,,0.442311944,Mth03_CatVar_Comp_PChiSq,Mth03_CatVar_Comp_PChiSq_1_pval,Out14-1-1,p-value,X.XXXX,,,An03_04_Ethnic_Comp_ByTrt,Comparison of Ethnicity by Treatment,4,0.4423,0.4423
74,Placebo,8,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,BLACK OR AFRICAN AMERICAN,,An03_05_Race_Summ_ByTrt,Summary of Subjects by Treatment and Race,1,8,8
75,Placebo,78,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,WHITE,,An03_05_Race_Summ_ByTrt,Summary of Subjects by Treatment and Race,1,78,78
76,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,AMERICAN INDIAN OR ALASKA NATIVE,,An03_05_Race_Summ_ByTrt,Summary of Subjects by Treatment and Race,1,1,1
77,Xanomeline High Dose,9,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,BLACK OR AFRICAN AMERICAN,,An03_05_Race_Summ_ByTrt,Summary of Subjects by Treatment and Race,1,9,9
78,Xanomeline High Dose,74,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,WHITE,,An03_05_Race_Summ_ByTrt,Summary of Subjects by Treatment and Race,1,74,74
79,Xanomeline Low Dose,6,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,BLACK OR AFRICAN AMERICAN,,An03_05_Race_Summ_ByTrt,Summary of Subjects by Treatment and Race,1,6,6
80,Xanomeline Low Dose,78,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-1-1,n,XXX,WHITE,,An03_05_Race_Summ_ByTrt,Summary of Subjects by Treatment and Race,1,78,78
81,Placebo,9.302325581,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),BLACK OR AFRICAN AMERICAN,,An03_05_Race_Summ_ByTrt,Summary of Subjects by Treatment and Race,1,9.3,-9.3
82,Placebo,90.69767442,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),WHITE,,An03_05_Race_Summ_ByTrt,Summary of Subjects by Treatment and Race,1,90.7,-90.7
83,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),AMERICAN INDIAN OR ALASKA NATIVE,,An03_05_Race_Summ_ByTrt,Summary of Subjects by Treatment and Race,1,1.2,-1.2
84,Xanomeline High Dose,10.71428571,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),BLACK OR AFRICAN AMERICAN,,An03_05_Race_Summ_ByTrt,Summary of Subjects by Treatment and Race,1,10.7,-10.7
85,Xanomeline High Dose,88.0952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),WHITE,,An03_05_Race_Summ_ByTrt,Summary of Subjects by Treatment and Race,1,88.1,-88.1
86,Xanomeline Low Dose,7.142857143,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),BLACK OR AFRICAN AMERICAN,,An03_05_Race_Summ_ByTrt,Summary of Subjects by Treatment and Race,1,7.1,-7.1
87,Xanomeline Low Dose,92.85714286,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-1-1,%,( XX.X),WHITE,,An03_05_Race_Summ_ByTrt,Summary of Subjects by Treatment and Race,1,92.9,-92.9
88,,0.604030437,Mth03_CatVar_Comp_PChiSq,Mth03_CatVar_Comp_PChiSq_1_pval,Out14-1-1,p-value,X.XXXX,,,An03_05_Race_Comp_ByTrt,Comparison of Race by Treatment,4,0.604,0.604
89,Placebo,86,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-1-1,n,XX,,,An03_06_Height_Summ_ByTrt,Summary of Height by Treatment,0,86,86
90,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-1-1,n,XX,,,An03_06_Height_Summ_ByTrt,Summary of Height by Treatment,0,84,84
91,Xanomeline Low Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-1-1,n,XX,,,An03_06_Height_Summ_ByTrt,Summary of Height by Treatment,0,84,84
92,Placebo,162.5732558,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-1-1,Mean,XX.X,,,An03_06_Height_Summ_ByTrt,Summary of Height by Treatment,1,162.6,162.6
93,Xanomeline High Dose,165.8202381,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-1-1,Mean,XX.X,,,An03_06_Height_Summ_ByTrt,Summary of Height by Treatment,1,165.8,165.8
94,Xanomeline Low Dose,163.4333333,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-1-1,Mean,XX.X,,,An03_06_Height_Summ_ByTrt,Summary of Height by Treatment,1,163.4,163.4
95,Placebo,11.52236112,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-1-1,SD,(XX.XX),,,An03_06_Height_Summ_ByTrt,Summary of Height by Treatment,2,11.52,-11.52
96,Xanomeline High Dose,10.13135155,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-1-1,SD,(XX.XX),,,An03_06_Height_Summ_ByTrt,Summary of Height by Treatment,2,10.13,-10.13
97,Xanomeline Low Dose,10.41924,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-1-1,SD,(XX.XX),,,An03_06_Height_Summ_ByTrt,Summary of Height by Treatment,2,10.42,-10.42
98,Placebo,162.6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-1-1,Median,XX.X,,,An03_06_Height_Summ_ByTrt,Summary of Height by Treatment,1,162.6,162.6
99,Xanomeline High Dose,165.1,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-1-1,Median,XX.X,,,An03_06_Height_Summ_ByTrt,Summary of Height by Treatment,1,165.1,165.1
100,Xanomeline Low Dose,162.6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-1-1,Median,XX.X,,,An03_06_Height_Summ_ByTrt,Summary of Height by Treatment,1,162.6,162.6
101,Placebo,154,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-1-1,Q1,XX.X,,,An03_06_Height_Summ_ByTrt,Summary of Height by Treatment,1,154,154
102,Xanomeline High Dose,157.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-1-1,Q1,XX.X,,,An03_06_Height_Summ_ByTrt,Summary of Height by Treatment,1,157.5,157.5
103,Xanomeline Low Dose,157.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-1-1,Q1,XX.X,,,An03_06_Height_Summ_ByTrt,Summary of Height by Treatment,1,157.5,157.5
104,Placebo,171.175,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-1-1,Q3,XX.X,,,An03_06_Height_Summ_ByTrt,Summary of Height by Treatment,1,171.2,171.2
105,Xanomeline High Dose,172.775,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-1-1,Q3,XX.X,,,An03_06_Height_Summ_ByTrt,Summary of Height by Treatment,1,172.8,172.8
106,Xanomeline Low Dose,170.2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-1-1,Q3,XX.X,,,An03_06_Height_Summ_ByTrt,Summary of Height by Treatment,1,170.2,170.2
107,Placebo,137.2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-1-1,Min,XX,,,An03_06_Height_Summ_ByTrt,Summary of Height by Treatment,0,137,137
108,Xanomeline High Dose,146.1,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-1-1,Min,XX,,,An03_06_Height_Summ_ByTrt,Summary of Height by Treatment,0,146,146
109,Xanomeline Low Dose,135.9,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-1-1,Min,XX,,,An03_06_Height_Summ_ByTrt,Summary of Height by Treatment,0,136,136
110,Placebo,185.4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-1-1,Max,XX,,,An03_06_Height_Summ_ByTrt,Summary of Height by Treatment,0,185,185
111,Xanomeline High Dose,190.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-1-1,Max,XX,,,An03_06_Height_Summ_ByTrt,Summary of Height by Treatment,0,190,190
112,Xanomeline Low Dose,195.6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-1-1,Max,XX,,,An03_06_Height_Summ_ByTrt,Summary of Height by Treatment,0,196,196
113,,0.126217917,Mth04_ContVar_Comp_Anova,Mth04_ContVar_Comp_Anova_1_pval,Out14-1-1,p-value,X.XXXX,,,An03_06_Height_Comp_ByTrt,Comparison of Height by Treatment,4,0.1262,0.1262
114,Placebo,86,Mth01_CatVar_Count_ByGrp,Mth01_CatVar_Count_ByGrp_1_n,Out14-3-1-1,n,(N=XX),,,An01_05_SAF_Summ_ByTrt,Summary of Subjects by Treatment,0,86,(N=86)
115,Xanomeline High Dose,84,Mth01_CatVar_Count_ByGrp,Mth01_CatVar_Count_ByGrp_1_n,Out14-3-1-1,n,(N=XX),,,An01_05_SAF_Summ_ByTrt,Summary of Subjects by Treatment,0,84,(N=84)
116,Xanomeline Low Dose,84,Mth01_CatVar_Count_ByGrp,Mth01_CatVar_Count_ByGrp_1_n,Out14-3-1-1,n,(N=XX),,,An01_05_SAF_Summ_ByTrt,Summary of Subjects by Treatment,0,84,(N=84)
117,Placebo,65,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-1-1,n,XXX,,,An07_01_TEAE_Summ_ByTrt,"Summary of Subjects with At Least One TEAE, by Treatment",1,65,65
118,Xanomeline High Dose,76,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-1-1,n,XXX,,,An07_01_TEAE_Summ_ByTrt,"Summary of Subjects with At Least One TEAE, by Treatment",1,76,76
119,Xanomeline Low Dose,77,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-1-1,n,XXX,,,An07_01_TEAE_Summ_ByTrt,"Summary of Subjects with At Least One TEAE, by Treatment",1,77,77
120,Placebo,75.58139535,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-1-1,%,( XX.X),,,An07_01_TEAE_Summ_ByTrt,"Summary of Subjects with At Least One TEAE, by Treatment",1,75.6,-75.6
121,Xanomeline High Dose,90.47619048,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-1-1,%,( XX.X),,,An07_01_TEAE_Summ_ByTrt,"Summary of Subjects with At Least One TEAE, by Treatment",1,90.5,-90.5
122,Xanomeline Low Dose,91.66666667,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-1-1,%,( XX.X),,,An07_01_TEAE_Summ_ByTrt,"Summary of Subjects with At Least One TEAE, by Treatment",1,91.7,-91.7
123,Placebo,43,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-1-1,n,XXX,,,An07_02_RelTEAE_Summ_ByTrt,"Summary of Subjects with At Least One Related TEAE, by Treatment",1,43,43
124,Xanomeline High Dose,70,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-1-1,n,XXX,,,An07_02_RelTEAE_Summ_ByTrt,"Summary of Subjects with At Least One Related TEAE, by Treatment",1,70,70
125,Xanomeline Low Dose,72,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-1-1,n,XXX,,,An07_02_RelTEAE_Summ_ByTrt,"Summary of Subjects with At Least One Related TEAE, by Treatment",1,72,72
126,Placebo,50,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-1-1,%,( XX.X),,,An07_02_RelTEAE_Summ_ByTrt,"Summary of Subjects with At Least One Related TEAE, by Treatment",1,50,-50
127,Xanomeline High Dose,83.33333333,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-1-1,%,( XX.X),,,An07_02_RelTEAE_Summ_ByTrt,"Summary of Subjects with At Least One Related TEAE, by Treatment",1,83.3,-83.3
128,Xanomeline Low Dose,85.71428571,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-1-1,%,( XX.X),,,An07_02_RelTEAE_Summ_ByTrt,"Summary of Subjects with At Least One Related TEAE, by Treatment",1,85.7,-85.7
129,Xanomeline High Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-1-1,n,XXX,,,An07_03_SerTEAE_Summ_ByTrt,"Summary of Subjects with At Least One Serious TEAE, by Treatment",1,2,2
130,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-1-1,n,XXX,,,An07_03_SerTEAE_Summ_ByTrt,"Summary of Subjects with At Least One Serious TEAE, by Treatment",1,1,1
131,Xanomeline High Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-1-1,%,( XX.X),,,An07_03_SerTEAE_Summ_ByTrt,"Summary of Subjects with At Least One Serious TEAE, by Treatment",1,2.4,-2.4
132,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-1-1,%,( XX.X),,,An07_03_SerTEAE_Summ_ByTrt,"Summary of Subjects with At Least One Serious TEAE, by Treatment",1,1.2,-1.2
133,Placebo,43,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-1-1,n,XXX,,,An07_04_RelSerTEAE_Summ_ByTrt,"Summary of Subjects with At Least One Related Serious TEAE, by Treatment",1,43,43
134,Xanomeline High Dose,70,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-1-1,n,XXX,,,An07_04_RelSerTEAE_Summ_ByTrt,"Summary of Subjects with At Least One Related Serious TEAE, by Treatment",1,70,70
135,Xanomeline Low Dose,72,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-1-1,n,XXX,,,An07_04_RelSerTEAE_Summ_ByTrt,"Summary of Subjects with At Least One Related Serious TEAE, by Treatment",1,72,72
136,Placebo,50,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-1-1,%,( XX.X),,,An07_04_RelSerTEAE_Summ_ByTrt,"Summary of Subjects with At Least One Related Serious TEAE, by Treatment",1,50,-50
137,Xanomeline High Dose,83.33333333,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-1-1,%,( XX.X),,,An07_04_RelSerTEAE_Summ_ByTrt,"Summary of Subjects with At Least One Related Serious TEAE, by Treatment",1,83.3,-83.3
138,Xanomeline Low Dose,85.71428571,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-1-1,%,( XX.X),,,An07_04_RelSerTEAE_Summ_ByTrt,"Summary of Subjects with At Least One Related Serious TEAE, by Treatment",1,85.7,-85.7
139,Placebo,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-1-1,n,XXX,,,An07_05_TEAELd2Dth_Summ_ByTrt,"Summary of Subjects with At Least One TEAE Leading to Death, by Treatment",1,2,2
140,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-1-1,n,XXX,,,An07_05_TEAELd2Dth_Summ_ByTrt,"Summary of Subjects with At Least One TEAE Leading to Death, by Treatment",1,1,1
141,Placebo,2.325581395,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-1-1,%,( XX.X),,,An07_05_TEAELd2Dth_Summ_ByTrt,"Summary of Subjects with At Least One TEAE Leading to Death, by Treatment",1,2.3,-2.3
142,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-1-1,%,( XX.X),,,An07_05_TEAELd2Dth_Summ_ByTrt,"Summary of Subjects with At Least One TEAE Leading to Death, by Treatment",1,1.2,-1.2
143,Placebo,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-1-1,n,XXX,,,An07_06_RelTEAELd2Dth_Summ_ByTrt,"Summary of Subjects with At Least One Related TEAE Leading to Death, by Treatment",1,2,2
144,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-1-1,n,XXX,,,An07_06_RelTEAELd2Dth_Summ_ByTrt,"Summary of Subjects with At Least One Related TEAE Leading to Death, by Treatment",1,1,1
145,Placebo,2.325581395,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-1-1,%,( XX.X),,,An07_06_RelTEAELd2Dth_Summ_ByTrt,"Summary of Subjects with At Least One Related TEAE Leading to Death, by Treatment",1,2.3,-2.3
146,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-1-1,%,( XX.X),,,An07_06_RelTEAELd2Dth_Summ_ByTrt,"Summary of Subjects with At Least One Related TEAE Leading to Death, by Treatment",1,1.2,-1.2
147,Placebo,86,Mth01_CatVar_Count_ByGrp,Mth01_CatVar_Count_ByGrp_1_n,Out14-3-2-1,n,(N=XX),,,An01_05_SAF_Summ_ByTrt,Summary of Subjects by Treatment,0,86,(N=86)
148,Xanomeline High Dose,84,Mth01_CatVar_Count_ByGrp,Mth01_CatVar_Count_ByGrp_1_n,Out14-3-2-1,n,(N=XX),,,An01_05_SAF_Summ_ByTrt,Summary of Subjects by Treatment,0,84,(N=84)
149,Xanomeline Low Dose,84,Mth01_CatVar_Count_ByGrp,Mth01_CatVar_Count_ByGrp_1_n,Out14-3-2-1,n,(N=XX),,,An01_05_SAF_Summ_ByTrt,Summary of Subjects by Treatment,0,84,(N=84)
150,Placebo,65,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,,,An07_01_TEAE_Summ_ByTrt,"Summary of Subjects with At Least One TEAE, by Treatment",1,65,65
151,Xanomeline High Dose,76,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,,,An07_01_TEAE_Summ_ByTrt,"Summary of Subjects with At Least One TEAE, by Treatment",1,76,76
152,Xanomeline Low Dose,77,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,,,An07_01_TEAE_Summ_ByTrt,"Summary of Subjects with At Least One TEAE, by Treatment",1,77,77
153,Placebo,75.58139535,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),,,An07_01_TEAE_Summ_ByTrt,"Summary of Subjects with At Least One TEAE, by Treatment",1,75.6,-75.6
154,Xanomeline High Dose,90.47619048,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),,,An07_01_TEAE_Summ_ByTrt,"Summary of Subjects with At Least One TEAE, by Treatment",1,90.5,-90.5
155,Xanomeline Low Dose,91.66666667,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),,,An07_01_TEAE_Summ_ByTrt,"Summary of Subjects with At Least One TEAE, by Treatment",1,91.7,-91.7
156,,0.006533129,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,,,An07_01_TEAE_Comp_ByTrt_PlacLow,Comparison of Subjects with TEAEs by Treatment - Placebo vs Low Dose,4,0.0065,0.0065
157,,0.013637692,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,,,An07_01_TEAE_Comp_ByTrt_PlacHigh,Comparison of Subjects with TEAEs by Treatment - Placebo vs High Dose,4,0.0136,0.0136
158,Placebo,12,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,12,12
159,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,EAR AND LABYRINTH DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,1,1
160,Placebo,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,EYE DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,2,2
161,Placebo,17,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,17,17
162,Placebo,21,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,21,21
163,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,HEPATOBILIARY DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,1,1
164,Placebo,16,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,16,16
165,Placebo,4,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,4,4
166,Placebo,10,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INVESTIGATIONS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,10,10
167,Placebo,6,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,METABOLISM AND NUTRITION DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,6,6
168,Placebo,4,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,4,4
169,Placebo,8,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,8,8
170,Placebo,10,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,PSYCHIATRIC DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,10,10
171,Placebo,4,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,RENAL AND URINARY DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,4,4
172,Placebo,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,2,2
173,Placebo,8,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,8,8
174,Placebo,20,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,20,20
175,Placebo,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SURGICAL AND MEDICAL PROCEDURES,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,2,2
176,Placebo,3,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,VASCULAR DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,3,3
177,Xanomeline High Dose,15,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,15,15
178,Xanomeline High Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,2,2
179,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,EAR AND LABYRINTH DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,1,1
180,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,EYE DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,1,1
181,Xanomeline High Dose,20,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,20,20
182,Xanomeline High Dose,40,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,40,40
183,Xanomeline High Dose,13,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,13,13
184,Xanomeline High Dose,5,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,5,5
185,Xanomeline High Dose,6,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INVESTIGATIONS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,6,6
186,Xanomeline High Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,METABOLISM AND NUTRITION DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,2,2
187,Xanomeline High Dose,7,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,7,7
188,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,1,1
189,Xanomeline High Dose,25,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,25,25
190,Xanomeline High Dose,8,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,PSYCHIATRIC DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,8,8
191,Xanomeline High Dose,3,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,RENAL AND URINARY DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,3,3
192,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,1,1
193,Xanomeline High Dose,10,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,10,10
194,Xanomeline High Dose,40,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,40,40
195,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SOCIAL CIRCUMSTANCES,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,1,1
196,Xanomeline High Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SURGICAL AND MEDICAL PROCEDURES,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,2,2
197,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,VASCULAR DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,1,1
198,Xanomeline Low Dose,13,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,13,13
199,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,1,1
200,Xanomeline Low Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,EAR AND LABYRINTH DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,2,2
201,Xanomeline Low Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,EYE DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,2,2
202,Xanomeline Low Dose,14,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,14,14
203,Xanomeline Low Dose,47,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,47,47
204,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,IMMUNE SYSTEM DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,1,1
205,Xanomeline Low Dose,9,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,9,9
206,Xanomeline Low Dose,5,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,5,5
207,Xanomeline Low Dose,6,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INVESTIGATIONS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,6,6
208,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,METABOLISM AND NUTRITION DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,1,1
209,Xanomeline Low Dose,7,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,7,7
210,Xanomeline Low Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,2,2
211,Xanomeline Low Dose,20,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,20,20
212,Xanomeline Low Dose,10,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,PSYCHIATRIC DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,10,10
213,Xanomeline Low Dose,3,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,RENAL AND URINARY DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,3,3
214,Xanomeline Low Dose,9,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,9,9
215,Xanomeline Low Dose,39,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,39,39
216,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SURGICAL AND MEDICAL PROCEDURES,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,1,1
217,Xanomeline Low Dose,3,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,VASCULAR DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,3,3
218,Placebo,13.95348837,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,14,-14
219,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),EAR AND LABYRINTH DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,1.2,-1.2
220,Placebo,2.325581395,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),EYE DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,2.3,-2.3
221,Placebo,19.76744186,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,19.8,-19.8
222,Placebo,24.41860465,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,24.4,-24.4
223,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),HEPATOBILIARY DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,1.2,-1.2
224,Placebo,18.60465116,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,18.6,-18.6
225,Placebo,4.651162791,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,4.7,-4.7
226,Placebo,11.62790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INVESTIGATIONS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,11.6,-11.6
227,Placebo,6.976744186,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),METABOLISM AND NUTRITION DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,7,-7
228,Placebo,4.651162791,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,4.7,-4.7
229,Placebo,9.302325581,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,9.3,-9.3
230,Placebo,11.62790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),PSYCHIATRIC DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,11.6,-11.6
231,Placebo,4.651162791,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),RENAL AND URINARY DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,4.7,-4.7
232,Placebo,2.325581395,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),REPRODUCTIVE SYSTEM AND BREAST DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,2.3,-2.3
233,Placebo,9.302325581,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,9.3,-9.3
234,Placebo,23.25581395,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,23.3,-23.3
235,Placebo,2.325581395,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SURGICAL AND MEDICAL PROCEDURES,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,2.3,-2.3
236,Placebo,3.488372093,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),VASCULAR DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,3.5,-3.5
237,Xanomeline High Dose,17.85714286,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,17.9,-17.9
238,Xanomeline High Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,2.4,-2.4
239,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),EAR AND LABYRINTH DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,1.2,-1.2
240,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),EYE DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,1.2,-1.2
241,Xanomeline High Dose,23.80952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,23.8,-23.8
242,Xanomeline High Dose,47.61904762,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,47.6,-47.6
243,Xanomeline High Dose,15.47619048,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,15.5,-15.5
244,Xanomeline High Dose,5.952380952,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,6,-6
245,Xanomeline High Dose,7.142857143,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INVESTIGATIONS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,7.1,-7.1
246,Xanomeline High Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),METABOLISM AND NUTRITION DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,2.4,-2.4
247,Xanomeline High Dose,8.333333333,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,8.3,-8.3
248,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,1.2,-1.2
249,Xanomeline High Dose,29.76190476,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,29.8,-29.8
250,Xanomeline High Dose,9.523809524,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),PSYCHIATRIC DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,9.5,-9.5
251,Xanomeline High Dose,3.571428571,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),RENAL AND URINARY DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,3.6,-3.6
252,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),REPRODUCTIVE SYSTEM AND BREAST DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,1.2,-1.2
253,Xanomeline High Dose,11.9047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,11.9,-11.9
254,Xanomeline High Dose,47.61904762,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,47.6,-47.6
255,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SOCIAL CIRCUMSTANCES,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,1.2,-1.2
256,Xanomeline High Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SURGICAL AND MEDICAL PROCEDURES,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,2.4,-2.4
257,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),VASCULAR DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,1.2,-1.2
258,Xanomeline Low Dose,15.47619048,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,15.5,-15.5
259,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,1.2,-1.2
260,Xanomeline Low Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),EAR AND LABYRINTH DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,2.4,-2.4
261,Xanomeline Low Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),EYE DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,2.4,-2.4
262,Xanomeline Low Dose,16.66666667,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,16.7,-16.7
263,Xanomeline Low Dose,55.95238095,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,56,-56
264,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),IMMUNE SYSTEM DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,1.2,-1.2
265,Xanomeline Low Dose,10.71428571,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,10.7,-10.7
266,Xanomeline Low Dose,5.952380952,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,6,-6
267,Xanomeline Low Dose,7.142857143,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INVESTIGATIONS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,7.1,-7.1
268,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),METABOLISM AND NUTRITION DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,1.2,-1.2
269,Xanomeline Low Dose,8.333333333,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,8.3,-8.3
270,Xanomeline Low Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,2.4,-2.4
271,Xanomeline Low Dose,23.80952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,23.8,-23.8
272,Xanomeline Low Dose,11.9047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),PSYCHIATRIC DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,11.9,-11.9
273,Xanomeline Low Dose,3.571428571,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),RENAL AND URINARY DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,3.6,-3.6
274,Xanomeline Low Dose,10.71428571,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,10.7,-10.7
275,Xanomeline Low Dose,46.42857143,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,46.4,-46.4
276,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SURGICAL AND MEDICAL PROCEDURES,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,1.2,-1.2
277,Xanomeline Low Dose,3.571428571,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),VASCULAR DISORDERS,,An07_09_Soc_Summ_ByTrt,Summary of Subjects with TEAEs by Treatment and System Organ Class,1,3.6,-3.6
278,,4.02E-05,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,An07_09_Soc_Comp_ByTrt_PlacLow,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs Low Dose,4,0,0
279,,0.692428919,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacLow,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs Low Dose,4,0.6924,0.6924
280,,0.002100327,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacLow,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs Low Dose,4,0.0021,0.0021
281,,0.830838674,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacLow,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs Low Dose,4,0.8308,0.8308
282,,0.19403858,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,,An07_09_Soc_Comp_ByTrt_PlacLow,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs Low Dose,4,0.194,0.194
283,,0.802870189,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,An07_09_Soc_Comp_ByTrt_PlacLow,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs Low Dose,4,0.8029,0.8029
284,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,RENAL AND URINARY DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacLow,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs Low Dose,4,1,1
285,,0.367292639,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacLow,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs Low Dose,4,0.3673,0.3673
286,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,EYE DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacLow,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs Low Dose,4,1,1
287,,0.117417773,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,METABOLISM AND NUTRITION DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacLow,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs Low Dose,4,0.1174,0.1174
288,,0.432216315,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,,An07_09_Soc_Comp_ByTrt_PlacLow,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs Low Dose,4,0.4322,0.4322
289,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SURGICAL AND MEDICAL PROCEDURES,,An07_09_Soc_Comp_ByTrt_PlacLow,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs Low Dose,4,1,1
290,,0.744955757,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,An07_09_Soc_Comp_ByTrt_PlacLow,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs Low Dose,4,0.745,0.745
291,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,PSYCHIATRIC DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacLow,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs Low Dose,4,1,1
292,,0.012983563,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacLow,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs Low Dose,4,0.013,0.013
293,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,VASCULAR DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacLow,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs Low Dose,4,1,1
294,,0.618343195,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,EAR AND LABYRINTH DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacLow,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs Low Dose,4,0.6183,0.6183
295,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,HEPATOBILIARY DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacLow,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs Low Dose,4,1,1
296,,0.242673164,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",,An07_09_Soc_Comp_ByTrt_PlacLow,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs Low Dose,4,0.2427,0.2427
297,,0.497111034,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacLow,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs Low Dose,4,0.4971,0.4971
298,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",,An07_09_Soc_Comp_ByTrt_PlacLow,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs Low Dose,4,0.4941,0.4941
299,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,IMMUNE SYSTEM DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacLow,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs Low Dose,4,0.4941,0.4941
300,,0.002273872,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,An07_09_Soc_Comp_ByTrt_PlacHigh,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs High Dose,4,0.0023,0.0023
301,,0.579522946,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacHigh,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs High Dose,4,0.5795,0.5795
302,,0.001250942,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacHigh,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs High Dose,4,0.0013,0.0013
303,,0.533664723,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacHigh,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs High Dose,4,0.5337,0.5337
304,,0.684680585,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,,An07_09_Soc_Comp_ByTrt_PlacHigh,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs High Dose,4,0.6847,0.6847
305,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,EYE DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacHigh,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs High Dose,4,1,1
306,,0.625582203,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,An07_09_Soc_Comp_ByTrt_PlacHigh,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs High Dose,4,0.6256,0.6256
307,,0.367292639,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacHigh,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs High Dose,4,0.3673,0.3673
308,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,RENAL AND URINARY DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacHigh,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs High Dose,4,1,1
309,,0.277520375,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,METABOLISM AND NUTRITION DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacHigh,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs High Dose,4,0.2775,0.2775
310,,0.80415862,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,PSYCHIATRIC DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacHigh,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs High Dose,4,0.8042,0.8042
311,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SURGICAL AND MEDICAL PROCEDURES,,An07_09_Soc_Comp_ByTrt_PlacHigh,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs High Dose,4,1,1
312,,0.000870133,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacHigh,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs High Dose,4,9.00E-04,9.00E-04
313,,0.744955757,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,An07_09_Soc_Comp_ByTrt_PlacHigh,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs High Dose,4,0.745,0.745
314,,0.432216315,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,,An07_09_Soc_Comp_ByTrt_PlacHigh,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs High Dose,4,0.4322,0.4322
315,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacHigh,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs High Dose,4,1,1
316,,0.620628565,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,VASCULAR DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacHigh,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs High Dose,4,0.6206,0.6206
317,,0.242673164,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",,An07_09_Soc_Comp_ByTrt_PlacHigh,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs High Dose,4,0.2427,0.2427
318,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,HEPATOBILIARY DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacHigh,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs High Dose,4,1,1
319,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SOCIAL CIRCUMSTANCES,,An07_09_Soc_Comp_ByTrt_PlacHigh,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs High Dose,4,0.4941,0.4941
320,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,EAR AND LABYRINTH DISORDERS,,An07_09_Soc_Comp_ByTrt_PlacHigh,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs High Dose,4,1,1
321,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",,An07_09_Soc_Comp_ByTrt_PlacHigh,Comparison of Subjects with TEAEs by Treatment and System Organ Class - Placebo vs High Dose,4,0.4941,0.4941
322,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,ATRIAL FIBRILLATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
323,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,ATRIAL HYPERTROPHY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
324,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,ATRIOVENTRICULAR BLOCK FIRST DEGREE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
325,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,ATRIOVENTRICULAR BLOCK SECOND DEGREE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
326,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,BRADYCARDIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
327,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,BUNDLE BRANCH BLOCK LEFT,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
328,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,BUNDLE BRANCH BLOCK RIGHT,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
329,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,CARDIAC FAILURE CONGESTIVE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
330,Placebo,4,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,MYOCARDIAL INFARCTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,4,4
331,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,SINUS ARRHYTHMIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
332,Placebo,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,SINUS BRADYCARDIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
333,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,SUPRAVENTRICULAR EXTRASYSTOLES,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
334,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,TACHYCARDIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
335,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,VENTRICULAR HYPERTROPHY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
336,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,EAR AND LABYRINTH DISORDERS,EAR PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
337,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,EYE DISORDERS,CONJUNCTIVITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
338,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,EYE DISORDERS,EYE ALLERGY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
339,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,EYE DISORDERS,EYE PRURITUS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
340,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,EYE DISORDERS,EYE SWELLING,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
341,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,ABDOMINAL PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
342,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,CONSTIPATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
343,Placebo,9,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,DIARRHOEA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,9,9
344,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,DYSPEPSIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
345,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,FLATULENCE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
346,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,GASTROOESOPHAGEAL REFLUX DISEASE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
347,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,GLOSSITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
348,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,HIATUS HERNIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
349,Placebo,3,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,NAUSEA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3,3
350,Placebo,3,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,VOMITING,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3,3
351,Placebo,5,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE DERMATITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,5,5
352,Placebo,3,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE ERYTHEMA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3,3
353,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE INDURATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
354,Placebo,3,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE IRRITATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3,3
355,Placebo,6,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PRURITUS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,6,6
356,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE REACTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
357,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE VESICLES,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
358,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,ASTHENIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
359,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,CHILLS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
360,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,FATIGUE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
361,Placebo,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,OEDEMA PERIPHERAL,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
362,Placebo,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,PYREXIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
363,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,HEPATOBILIARY DISORDERS,HYPERBILIRUBINAEMIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
364,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,BRONCHITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
365,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,CERVICITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
366,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,CYSTITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
367,Placebo,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,EAR INFECTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
368,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,GASTROENTERITIS VIRAL,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
369,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,INFLUENZA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
370,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,LOCALISED INFECTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
371,Placebo,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,NASOPHARYNGITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
372,Placebo,6,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,UPPER RESPIRATORY TRACT INFECTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,6,6
373,Placebo,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,URINARY TRACT INFECTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
374,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,VAGINAL MYCOSIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
375,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",CONTUSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
376,Placebo,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",EXCORIATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
377,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",FALL,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
378,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",HIP FRACTURE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
379,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",SKIN LACERATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
380,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INVESTIGATIONS,BLOOD ALKALINE PHOSPHATASE INCREASED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
381,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INVESTIGATIONS,BLOOD CREATINE PHOSPHOKINASE INCREASED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
382,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INVESTIGATIONS,BLOOD URINE PRESENT,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
383,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INVESTIGATIONS,CYSTOSCOPY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
384,Placebo,4,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INVESTIGATIONS,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,4,4
385,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INVESTIGATIONS,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
386,Placebo,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INVESTIGATIONS,ELECTROCARDIOGRAM T WAVE INVERSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
387,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INVESTIGATIONS,HEART RATE INCREASED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
388,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INVESTIGATIONS,HEART RATE IRREGULAR,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
389,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,METABOLISM AND NUTRITION DISORDERS,DECREASED APPETITE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
390,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,METABOLISM AND NUTRITION DISORDERS,DEHYDRATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
391,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,METABOLISM AND NUTRITION DISORDERS,DIABETES MELLITUS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
392,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,METABOLISM AND NUTRITION DISORDERS,FOOD CRAVING,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
393,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,METABOLISM AND NUTRITION DISORDERS,HYPONATRAEMIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
394,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,METABOLISM AND NUTRITION DISORDERS,INCREASED APPETITE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
395,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,ARTHRALGIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
396,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,BACK PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
397,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,PAIN IN EXTREMITY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
398,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,SHOULDER PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
399,Placebo,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,DIZZINESS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
400,Placebo,3,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,HEADACHE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3,3
401,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,PARKINSON'S DISEASE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
402,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,PSYCHOMOTOR HYPERACTIVITY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
403,Placebo,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,SOMNOLENCE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
404,Placebo,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,PSYCHIATRIC DISORDERS,AGITATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
405,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,PSYCHIATRIC DISORDERS,COMPLETED SUICIDE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
406,Placebo,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,PSYCHIATRIC DISORDERS,CONFUSIONAL STATE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
407,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,PSYCHIATRIC DISORDERS,DELUSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
408,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,PSYCHIATRIC DISORDERS,DISORIENTATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
409,Placebo,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,PSYCHIATRIC DISORDERS,INSOMNIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
410,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,PSYCHIATRIC DISORDERS,IRRITABILITY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
411,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,RENAL AND URINARY DISORDERS,DYSURIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
412,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,RENAL AND URINARY DISORDERS,MICTURITION URGENCY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
413,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,RENAL AND URINARY DISORDERS,NEPHROLITHIASIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
414,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,RENAL AND URINARY DISORDERS,POLLAKIURIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
415,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,BENIGN PROSTATIC HYPERPLASIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
416,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,PELVIC PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
417,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",COUGH,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
418,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",DYSPNOEA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
419,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",EMPHYSEMA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
420,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",HAEMOPTYSIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
421,Placebo,3,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NASAL CONGESTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3,3
422,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",POSTNASAL DRIP,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
423,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",RALES,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
424,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ALOPECIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
425,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,COLD SWEAT,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
426,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,DRUG ERUPTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
427,Placebo,8,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ERYTHEMA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,8,8
428,Placebo,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,HYPERHIDROSIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
429,Placebo,8,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,PRURITUS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,8,8
430,Placebo,5,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,RASH,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,5,5
431,Placebo,3,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN IRRITATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3,3
432,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN ULCER,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
433,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SURGICAL AND MEDICAL PROCEDURES,CATARACT OPERATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
434,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SURGICAL AND MEDICAL PROCEDURES,EYE LASER SURGERY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
435,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,VASCULAR DISORDERS,HYPERTENSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
436,Placebo,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,VASCULAR DISORDERS,HYPOTENSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
437,Placebo,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,VASCULAR DISORDERS,ORTHOSTATIC HYPOTENSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
438,Xanomeline High Dose,3,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,ATRIAL FIBRILLATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3,3
439,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,ATRIAL FLUTTER,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
440,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,CARDIAC DISORDER,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
441,Xanomeline High Dose,4,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,MYOCARDIAL INFARCTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,4,4
442,Xanomeline High Dose,8,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,SINUS BRADYCARDIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,8,8
443,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,SUPRAVENTRICULAR EXTRASYSTOLES,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
444,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,VENTRICULAR EXTRASYSTOLES,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
445,Xanomeline High Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",VENTRICULAR SEPTAL DEFECT,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
446,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,EAR AND LABYRINTH DISORDERS,VERTIGO,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
447,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,EYE DISORDERS,VISION BLURRED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
448,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,ABDOMINAL DISCOMFORT,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
449,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,ABDOMINAL PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
450,Xanomeline High Dose,4,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,DIARRHOEA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,4,4
451,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL HAEMORRHAGE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
452,Xanomeline High Dose,6,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,NAUSEA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,6,6
453,Xanomeline High Dose,4,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,SALIVARY HYPERSECRETION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,4,4
454,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,STOMACH DISCOMFORT,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
455,Xanomeline High Dose,7,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,VOMITING,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,7,7
456,Xanomeline High Dose,7,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE DERMATITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,7,7
457,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE DISCHARGE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
458,Xanomeline High Dose,15,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE ERYTHEMA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,15,15
459,Xanomeline High Dose,9,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE IRRITATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,9,9
460,Xanomeline High Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
461,Xanomeline High Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PERSPIRATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
462,Xanomeline High Dose,22,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PRURITUS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,22,22
463,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE REACTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
464,Xanomeline High Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE SWELLING,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
465,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE URTICARIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
466,Xanomeline High Dose,6,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE VESICLES,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,6,6
467,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,ASTHENIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
468,Xanomeline High Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,CHEST DISCOMFORT,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
469,Xanomeline High Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,CHEST PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
470,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,CHILLS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
471,Xanomeline High Dose,5,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,FATIGUE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,5,5
472,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,FEELING ABNORMAL,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
473,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,FEELING COLD,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
474,Xanomeline High Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MALAISE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
475,Xanomeline High Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,OEDEMA PERIPHERAL,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
476,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
477,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,PYREXIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
478,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,CYSTITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
479,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,HORDEOLUM,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
480,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,INFLUENZA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
481,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,LOWER RESPIRATORY TRACT INFECTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
482,Xanomeline High Dose,6,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,NASOPHARYNGITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,6,6
483,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,RHINITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
484,Xanomeline High Dose,3,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,UPPER RESPIRATORY TRACT INFECTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3,3
485,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,URINARY TRACT INFECTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
486,Xanomeline High Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",CONTUSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
487,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",EXCORIATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
488,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",FACIAL BONES FRACTURE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
489,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",FALL,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
490,Xanomeline High Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",HIP FRACTURE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
491,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INVESTIGATIONS,BIOPSY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
492,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INVESTIGATIONS,BIOPSY PROSTATE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
493,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INVESTIGATIONS,BLOOD CHOLESTEROL INCREASED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
494,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INVESTIGATIONS,BLOOD GLUCOSE INCREASED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
495,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INVESTIGATIONS,ELECTROCARDIOGRAM T WAVE INVERSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
496,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INVESTIGATIONS,WEIGHT DECREASED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
497,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,METABOLISM AND NUTRITION DISORDERS,DECREASED APPETITE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
498,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,METABOLISM AND NUTRITION DISORDERS,INCREASED APPETITE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
499,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,ARTHRALGIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
500,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,ARTHRITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
501,Xanomeline High Dose,3,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,BACK PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3,3
502,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,FLANK PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
503,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCLE SPASMS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
504,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MYALGIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
505,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",PROSTATE CANCER,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
506,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,AMNESIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
507,Xanomeline High Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,BURNING SENSATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
508,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,COGNITIVE DISORDER,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
509,Xanomeline High Dose,11,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,DIZZINESS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,11,11
510,Xanomeline High Dose,5,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,HEADACHE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,5,5
511,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,HYPERSOMNIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
512,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,LETHARGY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
513,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,PARAESTHESIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
514,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,PAROSMIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
515,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
516,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,SOMNOLENCE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
517,Xanomeline High Dose,3,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,SYNCOPE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3,3
518,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,SYNCOPE VASOVAGAL,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
519,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,TRANSIENT ISCHAEMIC ATTACK,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
520,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,PSYCHIATRIC DISORDERS,AGITATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
521,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,PSYCHIATRIC DISORDERS,CONFUSIONAL STATE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
522,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,PSYCHIATRIC DISORDERS,DELIRIUM,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
523,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,PSYCHIATRIC DISORDERS,DELUSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
524,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,PSYCHIATRIC DISORDERS,HALLUCINATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
525,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,PSYCHIATRIC DISORDERS,"HALLUCINATION, VISUAL",An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
526,Xanomeline High Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,PSYCHIATRIC DISORDERS,INSOMNIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
527,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,PSYCHIATRIC DISORDERS,LIBIDO DECREASED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
528,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,PSYCHIATRIC DISORDERS,LISTLESS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
529,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,PSYCHIATRIC DISORDERS,NIGHTMARE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
530,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,RENAL AND URINARY DISORDERS,CALCULUS URETHRAL,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
531,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,RENAL AND URINARY DISORDERS,MICTURITION URGENCY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
532,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,RENAL AND URINARY DISORDERS,NEPHROLITHIASIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
533,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,BENIGN PROSTATIC HYPERPLASIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
534,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",ALLERGIC GRANULOMATOUS ANGIITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
535,Xanomeline High Dose,5,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",COUGH,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,5,5
536,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",DYSPNOEA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
537,Xanomeline High Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",EPISTAXIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
538,Xanomeline High Dose,3,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NASAL CONGESTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3,3
539,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",PHARYNGEAL ERYTHEMA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
540,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",PHARYNGOLARYNGEAL PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
541,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",PRODUCTIVE COUGH,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
542,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",RESPIRATORY TRACT CONGESTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
543,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",RHINORRHOEA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
544,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ACTINIC KERATOSIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
545,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,BLISTER,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
546,Xanomeline High Dose,14,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ERYTHEMA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,14,14
547,Xanomeline High Dose,8,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,HYPERHIDROSIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,8,8
548,Xanomeline High Dose,26,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,PRURITUS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,26,26
549,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,PRURITUS GENERALISED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
550,Xanomeline High Dose,9,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,RASH,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,9,9
551,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,RASH MACULO-PAPULAR,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
552,Xanomeline High Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,RASH PRURITIC,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
553,Xanomeline High Dose,5,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN IRRITATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,5,5
554,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN ODOUR ABNORMAL,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
555,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,URTICARIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
556,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SOCIAL CIRCUMSTANCES,ALCOHOL USE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
557,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SURGICAL AND MEDICAL PROCEDURES,ACROCHORDON EXCISION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
558,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SURGICAL AND MEDICAL PROCEDURES,SKIN LESION EXCISION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
559,Xanomeline High Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,VASCULAR DISORDERS,WOUND HAEMORRHAGE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
560,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,ATRIAL FIBRILLATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
561,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,ATRIAL FLUTTER,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
562,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,ATRIOVENTRICULAR BLOCK FIRST DEGREE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
563,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,BUNDLE BRANCH BLOCK RIGHT,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
564,Xanomeline Low Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,MYOCARDIAL INFARCTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
565,Xanomeline Low Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,PALPITATIONS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
566,Xanomeline Low Dose,7,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,SINUS BRADYCARDIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,7,7
567,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,SUPRAVENTRICULAR EXTRASYSTOLES,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
568,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,SUPRAVENTRICULAR TACHYCARDIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
569,Xanomeline Low Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,VENTRICULAR EXTRASYSTOLES,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
570,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,CARDIAC DISORDERS,WOLFF-PARKINSON-WHITE SYNDROME,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
571,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",VENTRICULAR SEPTAL DEFECT,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
572,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,EAR AND LABYRINTH DISORDERS,CERUMEN IMPACTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
573,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,EAR AND LABYRINTH DISORDERS,VERTIGO,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
574,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,EYE DISORDERS,CONJUNCTIVAL HAEMORRHAGE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
575,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,EYE DISORDERS,VISION BLURRED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
576,Xanomeline Low Dose,3,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,ABDOMINAL PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3,3
577,Xanomeline Low Dose,4,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,DIARRHOEA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,4,4
578,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,DYSPEPSIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
579,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,DYSPHAGIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
580,Xanomeline Low Dose,3,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,NAUSEA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3,3
581,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,RECTAL HAEMORRHAGE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
582,Xanomeline Low Dose,3,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GASTROINTESTINAL DISORDERS,VOMITING,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3,3
583,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE BLEEDING,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
584,Xanomeline Low Dose,9,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE DERMATITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,9,9
585,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE DESQUAMATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
586,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE DISCOLOURATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
587,Xanomeline Low Dose,12,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE ERYTHEMA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,12,12
588,Xanomeline Low Dose,9,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE IRRITATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,9,9
589,Xanomeline Low Dose,22,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PRURITUS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,22,22
590,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE SWELLING,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
591,Xanomeline Low Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE URTICARIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
592,Xanomeline Low Dose,4,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE VESICLES,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,4,4
593,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE WARMTH,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
594,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,CHILLS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
595,Xanomeline Low Dose,5,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,FATIGUE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,5,5
596,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,INFLAMMATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
597,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MALAISE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
598,Xanomeline Low Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,OEDEMA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
599,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,OEDEMA PERIPHERAL,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
600,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
601,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SECRETION DISCHARGE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
602,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SUDDEN DEATH,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
603,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SWELLING,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
604,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,ULCER,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
605,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,IMMUNE SYSTEM DISORDERS,HYPERSENSITIVITY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
606,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,CELLULITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
607,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,INFLUENZA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
608,Xanomeline Low Dose,4,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,NASOPHARYNGITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,4,4
609,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,PNEUMONIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
610,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,UPPER RESPIRATORY TRACT INFECTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
611,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INFECTIONS AND INFESTATIONS,VIRAL INFECTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
612,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",CONTUSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
613,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",EXCORIATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
614,Xanomeline Low Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",FALL,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
615,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",JOINT DISLOCATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
616,Xanomeline Low Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",SKIN LACERATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
617,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",WOUND,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
618,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INVESTIGATIONS,BLOOD GLUCOSE INCREASED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
619,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INVESTIGATIONS,BODY TEMPERATURE INCREASED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
620,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INVESTIGATIONS,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
621,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INVESTIGATIONS,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
622,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INVESTIGATIONS,ELECTROCARDIOGRAM T WAVE INVERSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
623,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,INVESTIGATIONS,NASAL MUCOSA BIOPSY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
624,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,METABOLISM AND NUTRITION DISORDERS,FOOD CRAVING,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
625,Xanomeline Low Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,ARTHRALGIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
626,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,BACK PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
627,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCLE SPASMS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
628,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULAR WEAKNESS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
629,Xanomeline Low Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,SHOULDER PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
630,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",COLON CANCER,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
631,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",MALIGNANT FIBROUS HISTIOCYTOMA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
632,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,BALANCE DISORDER,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
633,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,COMPLEX PARTIAL SEIZURES,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
634,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,COORDINATION ABNORMAL,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
635,Xanomeline Low Dose,8,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,DIZZINESS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,8,8
636,Xanomeline Low Dose,3,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,HEADACHE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3,3
637,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,HEMIANOPIA HOMONYMOUS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
638,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,LETHARGY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
639,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,PARAESTHESIA ORAL,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
640,Xanomeline Low Dose,3,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,SOMNOLENCE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3,3
641,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,STUPOR,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
642,Xanomeline Low Dose,4,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,SYNCOPE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,4,4
643,Xanomeline Low Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,NERVOUS SYSTEM DISORDERS,TRANSIENT ISCHAEMIC ATTACK,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
644,Xanomeline Low Dose,2,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,PSYCHIATRIC DISORDERS,AGITATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2,2
645,Xanomeline Low Dose,3,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,PSYCHIATRIC DISORDERS,ANXIETY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3,3
646,Xanomeline Low Dose,3,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,PSYCHIATRIC DISORDERS,CONFUSIONAL STATE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3,3
647,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,PSYCHIATRIC DISORDERS,DEPRESSED MOOD,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
648,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,PSYCHIATRIC DISORDERS,IRRITABILITY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
649,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,PSYCHIATRIC DISORDERS,RESTLESSNESS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
650,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,RENAL AND URINARY DISORDERS,DYSURIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
651,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,RENAL AND URINARY DISORDERS,INCONTINENCE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
652,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,RENAL AND URINARY DISORDERS,MICTURITION URGENCY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
653,Xanomeline Low Dose,5,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",COUGH,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,5,5
654,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",DYSPHONIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
655,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",DYSPNOEA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
656,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",EPISTAXIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
657,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NASAL CONGESTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
658,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",PHARYNGOLARYNGEAL PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
659,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",RHINORRHOEA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
660,Xanomeline Low Dose,5,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,BLISTER,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,5,5
661,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,DERMATITIS CONTACT,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
662,Xanomeline Low Dose,14,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ERYTHEMA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,14,14
663,Xanomeline Low Dose,4,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,HYPERHIDROSIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,4,4
664,Xanomeline Low Dose,21,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,PRURITUS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,21,21
665,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,PRURITUS GENERALISED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
666,Xanomeline Low Dose,13,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,RASH,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,13,13
667,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,RASH ERYTHEMATOUS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
668,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,RASH PRURITIC,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
669,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN EXFOLIATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
670,Xanomeline Low Dose,6,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN IRRITATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,6,6
671,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,URTICARIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
672,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,SURGICAL AND MEDICAL PROCEDURES,CATARACT OPERATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
673,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,VASCULAR DISORDERS,HOT FLUSH,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
674,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,VASCULAR DISORDERS,HYPERTENSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
675,Xanomeline Low Dose,1,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_1_n,Out14-3-2-1,n,XXX,VASCULAR DISORDERS,HYPOTENSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1,1
676,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,ATRIAL FIBRILLATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
677,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,ATRIAL HYPERTROPHY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
678,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,ATRIOVENTRICULAR BLOCK FIRST DEGREE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
679,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,ATRIOVENTRICULAR BLOCK SECOND DEGREE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
680,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,BRADYCARDIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
681,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,BUNDLE BRANCH BLOCK LEFT,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
682,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,BUNDLE BRANCH BLOCK RIGHT,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
683,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,CARDIAC FAILURE CONGESTIVE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
684,Placebo,4.651162791,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,MYOCARDIAL INFARCTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,4.7,-4.7
685,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,SINUS ARRHYTHMIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
686,Placebo,2.325581395,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,SINUS BRADYCARDIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.3,-2.3
687,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,SUPRAVENTRICULAR EXTRASYSTOLES,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
688,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,TACHYCARDIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
689,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,VENTRICULAR HYPERTROPHY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
690,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),EAR AND LABYRINTH DISORDERS,EAR PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
691,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),EYE DISORDERS,CONJUNCTIVITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
692,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),EYE DISORDERS,EYE ALLERGY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
693,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),EYE DISORDERS,EYE PRURITUS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
694,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),EYE DISORDERS,EYE SWELLING,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
695,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,ABDOMINAL PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
696,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,CONSTIPATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
697,Placebo,10.46511628,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,DIARRHOEA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,10.5,-10.5
698,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,DYSPEPSIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
699,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,FLATULENCE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
700,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,GASTROOESOPHAGEAL REFLUX DISEASE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
701,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,GLOSSITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
702,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,HIATUS HERNIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
703,Placebo,3.488372093,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,NAUSEA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3.5,-3.5
704,Placebo,3.488372093,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,VOMITING,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3.5,-3.5
705,Placebo,5.813953488,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE DERMATITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,5.8,-5.8
706,Placebo,3.488372093,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE ERYTHEMA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3.5,-3.5
707,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE INDURATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
708,Placebo,3.488372093,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE IRRITATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3.5,-3.5
709,Placebo,6.976744186,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PRURITUS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,7,-7
710,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE REACTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
711,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE VESICLES,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
712,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,ASTHENIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
713,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,CHILLS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
714,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,FATIGUE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
715,Placebo,2.325581395,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,OEDEMA PERIPHERAL,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.3,-2.3
716,Placebo,2.325581395,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,PYREXIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.3,-2.3
717,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),HEPATOBILIARY DISORDERS,HYPERBILIRUBINAEMIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
718,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,BRONCHITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
719,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,CERVICITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
720,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,CYSTITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
721,Placebo,2.325581395,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,EAR INFECTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.3,-2.3
722,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,GASTROENTERITIS VIRAL,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
723,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,INFLUENZA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
724,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,LOCALISED INFECTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
725,Placebo,2.325581395,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,NASOPHARYNGITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.3,-2.3
726,Placebo,6.976744186,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,UPPER RESPIRATORY TRACT INFECTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,7,-7
727,Placebo,2.325581395,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,URINARY TRACT INFECTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.3,-2.3
728,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,VAGINAL MYCOSIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
729,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",CONTUSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
730,Placebo,2.325581395,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",EXCORIATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.3,-2.3
731,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",FALL,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
732,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",HIP FRACTURE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
733,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",SKIN LACERATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
734,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INVESTIGATIONS,BLOOD ALKALINE PHOSPHATASE INCREASED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
735,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INVESTIGATIONS,BLOOD CREATINE PHOSPHOKINASE INCREASED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
736,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INVESTIGATIONS,BLOOD URINE PRESENT,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
737,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INVESTIGATIONS,CYSTOSCOPY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
738,Placebo,4.651162791,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INVESTIGATIONS,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,4.7,-4.7
739,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INVESTIGATIONS,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
740,Placebo,2.325581395,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INVESTIGATIONS,ELECTROCARDIOGRAM T WAVE INVERSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.3,-2.3
741,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INVESTIGATIONS,HEART RATE INCREASED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
742,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INVESTIGATIONS,HEART RATE IRREGULAR,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
743,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),METABOLISM AND NUTRITION DISORDERS,DECREASED APPETITE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
744,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),METABOLISM AND NUTRITION DISORDERS,DEHYDRATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
745,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),METABOLISM AND NUTRITION DISORDERS,DIABETES MELLITUS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
746,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),METABOLISM AND NUTRITION DISORDERS,FOOD CRAVING,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
747,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),METABOLISM AND NUTRITION DISORDERS,HYPONATRAEMIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
748,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),METABOLISM AND NUTRITION DISORDERS,INCREASED APPETITE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
749,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,ARTHRALGIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
750,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,BACK PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
751,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,PAIN IN EXTREMITY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
752,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,SHOULDER PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
753,Placebo,2.325581395,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,DIZZINESS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.3,-2.3
754,Placebo,3.488372093,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,HEADACHE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3.5,-3.5
755,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,PARKINSON'S DISEASE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
756,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,PSYCHOMOTOR HYPERACTIVITY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
757,Placebo,2.325581395,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,SOMNOLENCE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.3,-2.3
758,Placebo,2.325581395,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),PSYCHIATRIC DISORDERS,AGITATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.3,-2.3
759,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),PSYCHIATRIC DISORDERS,COMPLETED SUICIDE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
760,Placebo,2.325581395,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),PSYCHIATRIC DISORDERS,CONFUSIONAL STATE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.3,-2.3
761,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),PSYCHIATRIC DISORDERS,DELUSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
762,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),PSYCHIATRIC DISORDERS,DISORIENTATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
763,Placebo,2.325581395,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),PSYCHIATRIC DISORDERS,INSOMNIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.3,-2.3
764,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),PSYCHIATRIC DISORDERS,IRRITABILITY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
765,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),RENAL AND URINARY DISORDERS,DYSURIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
766,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),RENAL AND URINARY DISORDERS,MICTURITION URGENCY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
767,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),RENAL AND URINARY DISORDERS,NEPHROLITHIASIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
768,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),RENAL AND URINARY DISORDERS,POLLAKIURIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
769,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),REPRODUCTIVE SYSTEM AND BREAST DISORDERS,BENIGN PROSTATIC HYPERPLASIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
770,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),REPRODUCTIVE SYSTEM AND BREAST DISORDERS,PELVIC PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
771,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",COUGH,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
772,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",DYSPNOEA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
773,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",EMPHYSEMA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
774,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",HAEMOPTYSIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
775,Placebo,3.488372093,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NASAL CONGESTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3.5,-3.5
776,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",POSTNASAL DRIP,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
777,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",RALES,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
778,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ALOPECIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
779,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,COLD SWEAT,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
780,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,DRUG ERUPTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
781,Placebo,9.302325581,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ERYTHEMA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,9.3,-9.3
782,Placebo,2.325581395,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,HYPERHIDROSIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.3,-2.3
783,Placebo,9.302325581,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,PRURITUS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,9.3,-9.3
784,Placebo,5.813953488,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,RASH,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,5.8,-5.8
785,Placebo,3.488372093,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN IRRITATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3.5,-3.5
786,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN ULCER,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
787,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SURGICAL AND MEDICAL PROCEDURES,CATARACT OPERATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
788,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SURGICAL AND MEDICAL PROCEDURES,EYE LASER SURGERY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
789,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),VASCULAR DISORDERS,HYPERTENSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
790,Placebo,2.325581395,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),VASCULAR DISORDERS,HYPOTENSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.3,-2.3
791,Placebo,1.162790698,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),VASCULAR DISORDERS,ORTHOSTATIC HYPOTENSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
792,Xanomeline High Dose,3.571428571,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,ATRIAL FIBRILLATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3.6,-3.6
793,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,ATRIAL FLUTTER,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
794,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,CARDIAC DISORDER,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
795,Xanomeline High Dose,4.761904762,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,MYOCARDIAL INFARCTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,4.8,-4.8
796,Xanomeline High Dose,9.523809524,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,SINUS BRADYCARDIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,9.5,-9.5
797,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,SUPRAVENTRICULAR EXTRASYSTOLES,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
798,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,VENTRICULAR EXTRASYSTOLES,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
799,Xanomeline High Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",VENTRICULAR SEPTAL DEFECT,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.4,-2.4
800,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),EAR AND LABYRINTH DISORDERS,VERTIGO,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
801,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),EYE DISORDERS,VISION BLURRED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
802,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,ABDOMINAL DISCOMFORT,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
803,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,ABDOMINAL PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
804,Xanomeline High Dose,4.761904762,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,DIARRHOEA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,4.8,-4.8
805,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,GASTROINTESTINAL HAEMORRHAGE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
806,Xanomeline High Dose,7.142857143,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,NAUSEA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,7.1,-7.1
807,Xanomeline High Dose,4.761904762,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,SALIVARY HYPERSECRETION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,4.8,-4.8
808,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,STOMACH DISCOMFORT,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
809,Xanomeline High Dose,8.333333333,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,VOMITING,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,8.3,-8.3
810,Xanomeline High Dose,8.333333333,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE DERMATITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,8.3,-8.3
811,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE DISCHARGE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
812,Xanomeline High Dose,17.85714286,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE ERYTHEMA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,17.9,-17.9
813,Xanomeline High Dose,10.71428571,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE IRRITATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,10.7,-10.7
814,Xanomeline High Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.4,-2.4
815,Xanomeline High Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PERSPIRATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.4,-2.4
816,Xanomeline High Dose,26.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PRURITUS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,26.2,-26.2
817,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE REACTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
818,Xanomeline High Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE SWELLING,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.4,-2.4
819,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE URTICARIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
820,Xanomeline High Dose,7.142857143,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE VESICLES,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,7.1,-7.1
821,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,ASTHENIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
822,Xanomeline High Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,CHEST DISCOMFORT,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.4,-2.4
823,Xanomeline High Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,CHEST PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.4,-2.4
824,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,CHILLS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
825,Xanomeline High Dose,5.952380952,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,FATIGUE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,6,-6
826,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,FEELING ABNORMAL,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
827,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,FEELING COLD,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
828,Xanomeline High Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MALAISE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.4,-2.4
829,Xanomeline High Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,OEDEMA PERIPHERAL,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.4,-2.4
830,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
831,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,PYREXIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
832,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,CYSTITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
833,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,HORDEOLUM,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
834,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,INFLUENZA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
835,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,LOWER RESPIRATORY TRACT INFECTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
836,Xanomeline High Dose,7.142857143,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,NASOPHARYNGITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,7.1,-7.1
837,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,RHINITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
838,Xanomeline High Dose,3.571428571,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,UPPER RESPIRATORY TRACT INFECTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3.6,-3.6
839,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,URINARY TRACT INFECTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
840,Xanomeline High Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",CONTUSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.4,-2.4
841,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",EXCORIATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
842,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",FACIAL BONES FRACTURE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
843,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",FALL,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
844,Xanomeline High Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",HIP FRACTURE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.4,-2.4
845,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INVESTIGATIONS,BIOPSY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
846,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INVESTIGATIONS,BIOPSY PROSTATE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
847,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INVESTIGATIONS,BLOOD CHOLESTEROL INCREASED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
848,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INVESTIGATIONS,BLOOD GLUCOSE INCREASED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
849,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INVESTIGATIONS,ELECTROCARDIOGRAM T WAVE INVERSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
850,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INVESTIGATIONS,WEIGHT DECREASED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
851,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),METABOLISM AND NUTRITION DISORDERS,DECREASED APPETITE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
852,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),METABOLISM AND NUTRITION DISORDERS,INCREASED APPETITE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
853,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,ARTHRALGIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
854,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,ARTHRITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
855,Xanomeline High Dose,3.571428571,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,BACK PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3.6,-3.6
856,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,FLANK PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
857,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCLE SPASMS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
858,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MYALGIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
859,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",PROSTATE CANCER,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
860,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,AMNESIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
861,Xanomeline High Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,BURNING SENSATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.4,-2.4
862,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,COGNITIVE DISORDER,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
863,Xanomeline High Dose,13.0952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,DIZZINESS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,13.1,-13.1
864,Xanomeline High Dose,5.952380952,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,HEADACHE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,6,-6
865,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,HYPERSOMNIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
866,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,LETHARGY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
867,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,PARAESTHESIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
868,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,PAROSMIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
869,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
870,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,SOMNOLENCE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
871,Xanomeline High Dose,3.571428571,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,SYNCOPE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3.6,-3.6
872,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,SYNCOPE VASOVAGAL,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
873,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,TRANSIENT ISCHAEMIC ATTACK,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
874,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),PSYCHIATRIC DISORDERS,AGITATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
875,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),PSYCHIATRIC DISORDERS,CONFUSIONAL STATE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
876,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),PSYCHIATRIC DISORDERS,DELIRIUM,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
877,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),PSYCHIATRIC DISORDERS,DELUSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
878,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),PSYCHIATRIC DISORDERS,HALLUCINATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
879,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),PSYCHIATRIC DISORDERS,"HALLUCINATION, VISUAL",An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
880,Xanomeline High Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),PSYCHIATRIC DISORDERS,INSOMNIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.4,-2.4
881,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),PSYCHIATRIC DISORDERS,LIBIDO DECREASED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
882,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),PSYCHIATRIC DISORDERS,LISTLESS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
883,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),PSYCHIATRIC DISORDERS,NIGHTMARE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
884,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),RENAL AND URINARY DISORDERS,CALCULUS URETHRAL,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
885,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),RENAL AND URINARY DISORDERS,MICTURITION URGENCY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
886,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),RENAL AND URINARY DISORDERS,NEPHROLITHIASIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
887,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),REPRODUCTIVE SYSTEM AND BREAST DISORDERS,BENIGN PROSTATIC HYPERPLASIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
888,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",ALLERGIC GRANULOMATOUS ANGIITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
889,Xanomeline High Dose,5.952380952,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",COUGH,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,6,-6
890,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",DYSPNOEA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
891,Xanomeline High Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",EPISTAXIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.4,-2.4
892,Xanomeline High Dose,3.571428571,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NASAL CONGESTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3.6,-3.6
893,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",PHARYNGEAL ERYTHEMA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
894,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",PHARYNGOLARYNGEAL PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
895,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",PRODUCTIVE COUGH,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
896,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",RESPIRATORY TRACT CONGESTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
897,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",RHINORRHOEA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
898,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ACTINIC KERATOSIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
899,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,BLISTER,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
900,Xanomeline High Dose,16.66666667,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ERYTHEMA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,16.7,-16.7
901,Xanomeline High Dose,9.523809524,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,HYPERHIDROSIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,9.5,-9.5
902,Xanomeline High Dose,30.95238095,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,PRURITUS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,31,-31
903,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,PRURITUS GENERALISED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
904,Xanomeline High Dose,10.71428571,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,RASH,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,10.7,-10.7
905,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,RASH MACULO-PAPULAR,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
906,Xanomeline High Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,RASH PRURITIC,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.4,-2.4
907,Xanomeline High Dose,5.952380952,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN IRRITATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,6,-6
908,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN ODOUR ABNORMAL,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
909,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,URTICARIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
910,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SOCIAL CIRCUMSTANCES,ALCOHOL USE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
911,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SURGICAL AND MEDICAL PROCEDURES,ACROCHORDON EXCISION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
912,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SURGICAL AND MEDICAL PROCEDURES,SKIN LESION EXCISION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
913,Xanomeline High Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),VASCULAR DISORDERS,WOUND HAEMORRHAGE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
914,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,ATRIAL FIBRILLATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
915,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,ATRIAL FLUTTER,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
916,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,ATRIOVENTRICULAR BLOCK FIRST DEGREE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
917,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,BUNDLE BRANCH BLOCK RIGHT,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
918,Xanomeline Low Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,MYOCARDIAL INFARCTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.4,-2.4
919,Xanomeline Low Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,PALPITATIONS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.4,-2.4
920,Xanomeline Low Dose,8.333333333,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,SINUS BRADYCARDIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,8.3,-8.3
921,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,SUPRAVENTRICULAR EXTRASYSTOLES,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
922,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,SUPRAVENTRICULAR TACHYCARDIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
923,Xanomeline Low Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,VENTRICULAR EXTRASYSTOLES,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.4,-2.4
924,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),CARDIAC DISORDERS,WOLFF-PARKINSON-WHITE SYNDROME,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
925,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",VENTRICULAR SEPTAL DEFECT,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
926,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),EAR AND LABYRINTH DISORDERS,CERUMEN IMPACTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
927,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),EAR AND LABYRINTH DISORDERS,VERTIGO,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
928,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),EYE DISORDERS,CONJUNCTIVAL HAEMORRHAGE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
929,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),EYE DISORDERS,VISION BLURRED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
930,Xanomeline Low Dose,3.571428571,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,ABDOMINAL PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3.6,-3.6
931,Xanomeline Low Dose,4.761904762,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,DIARRHOEA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,4.8,-4.8
932,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,DYSPEPSIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
933,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,DYSPHAGIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
934,Xanomeline Low Dose,3.571428571,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,NAUSEA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3.6,-3.6
935,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,RECTAL HAEMORRHAGE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
936,Xanomeline Low Dose,3.571428571,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GASTROINTESTINAL DISORDERS,VOMITING,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3.6,-3.6
937,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE BLEEDING,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
938,Xanomeline Low Dose,10.71428571,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE DERMATITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,10.7,-10.7
939,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE DESQUAMATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
940,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE DISCOLOURATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
941,Xanomeline Low Dose,14.28571429,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE ERYTHEMA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,14.3,-14.3
942,Xanomeline Low Dose,10.71428571,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE IRRITATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,10.7,-10.7
943,Xanomeline Low Dose,26.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PRURITUS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,26.2,-26.2
944,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE SWELLING,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
945,Xanomeline Low Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE URTICARIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.4,-2.4
946,Xanomeline Low Dose,4.761904762,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE VESICLES,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,4.8,-4.8
947,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE WARMTH,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
948,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,CHILLS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
949,Xanomeline Low Dose,5.952380952,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,FATIGUE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,6,-6
950,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,INFLAMMATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
951,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MALAISE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
952,Xanomeline Low Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,OEDEMA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.4,-2.4
953,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,OEDEMA PERIPHERAL,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
954,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
955,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SECRETION DISCHARGE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
956,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SUDDEN DEATH,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
957,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SWELLING,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
958,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,ULCER,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
959,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),IMMUNE SYSTEM DISORDERS,HYPERSENSITIVITY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
960,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,CELLULITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
961,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,INFLUENZA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
962,Xanomeline Low Dose,4.761904762,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,NASOPHARYNGITIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,4.8,-4.8
963,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,PNEUMONIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
964,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,UPPER RESPIRATORY TRACT INFECTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
965,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INFECTIONS AND INFESTATIONS,VIRAL INFECTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
966,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",CONTUSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
967,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",EXCORIATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
968,Xanomeline Low Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",FALL,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.4,-2.4
969,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",JOINT DISLOCATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
970,Xanomeline Low Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",SKIN LACERATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.4,-2.4
971,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",WOUND,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
972,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INVESTIGATIONS,BLOOD GLUCOSE INCREASED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
973,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INVESTIGATIONS,BODY TEMPERATURE INCREASED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
974,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INVESTIGATIONS,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
975,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INVESTIGATIONS,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
976,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INVESTIGATIONS,ELECTROCARDIOGRAM T WAVE INVERSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
977,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),INVESTIGATIONS,NASAL MUCOSA BIOPSY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
978,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),METABOLISM AND NUTRITION DISORDERS,FOOD CRAVING,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
979,Xanomeline Low Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,ARTHRALGIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.4,-2.4
980,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,BACK PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
981,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCLE SPASMS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
982,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULAR WEAKNESS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
983,Xanomeline Low Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,SHOULDER PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.4,-2.4
984,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",COLON CANCER,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
985,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",MALIGNANT FIBROUS HISTIOCYTOMA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
986,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,BALANCE DISORDER,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
987,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,COMPLEX PARTIAL SEIZURES,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
988,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,COORDINATION ABNORMAL,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
989,Xanomeline Low Dose,9.523809524,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,DIZZINESS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,9.5,-9.5
990,Xanomeline Low Dose,3.571428571,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,HEADACHE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3.6,-3.6
991,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,HEMIANOPIA HOMONYMOUS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
992,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,LETHARGY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
993,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,PARAESTHESIA ORAL,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
994,Xanomeline Low Dose,3.571428571,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,SOMNOLENCE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3.6,-3.6
995,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,STUPOR,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
996,Xanomeline Low Dose,4.761904762,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,SYNCOPE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,4.8,-4.8
997,Xanomeline Low Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),NERVOUS SYSTEM DISORDERS,TRANSIENT ISCHAEMIC ATTACK,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.4,-2.4
998,Xanomeline Low Dose,2.380952381,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),PSYCHIATRIC DISORDERS,AGITATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,2.4,-2.4
999,Xanomeline Low Dose,3.571428571,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),PSYCHIATRIC DISORDERS,ANXIETY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3.6,-3.6
1000,Xanomeline Low Dose,3.571428571,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),PSYCHIATRIC DISORDERS,CONFUSIONAL STATE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,3.6,-3.6
1001,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),PSYCHIATRIC DISORDERS,DEPRESSED MOOD,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
1002,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),PSYCHIATRIC DISORDERS,IRRITABILITY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
1003,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),PSYCHIATRIC DISORDERS,RESTLESSNESS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
1004,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),RENAL AND URINARY DISORDERS,DYSURIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
1005,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),RENAL AND URINARY DISORDERS,INCONTINENCE,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
1006,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),RENAL AND URINARY DISORDERS,MICTURITION URGENCY,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
1007,Xanomeline Low Dose,5.952380952,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",COUGH,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,6,-6
1008,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",DYSPHONIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
1009,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",DYSPNOEA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
1010,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",EPISTAXIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
1011,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NASAL CONGESTION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
1012,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",PHARYNGOLARYNGEAL PAIN,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
1013,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",RHINORRHOEA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
1014,Xanomeline Low Dose,5.952380952,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,BLISTER,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,6,-6
1015,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,DERMATITIS CONTACT,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
1016,Xanomeline Low Dose,16.66666667,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ERYTHEMA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,16.7,-16.7
1017,Xanomeline Low Dose,4.761904762,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,HYPERHIDROSIS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,4.8,-4.8
1018,Xanomeline Low Dose,25,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,PRURITUS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,25,-25
1019,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,PRURITUS GENERALISED,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
1020,Xanomeline Low Dose,15.47619048,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,RASH,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,15.5,-15.5
1021,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,RASH ERYTHEMATOUS,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
1022,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,RASH PRURITIC,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
1023,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN EXFOLIATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
1024,Xanomeline Low Dose,7.142857143,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN IRRITATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,7.1,-7.1
1025,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SKIN AND SUBCUTANEOUS TISSUE DISORDERS,URTICARIA,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
1026,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),SURGICAL AND MEDICAL PROCEDURES,CATARACT OPERATION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
1027,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),VASCULAR DISORDERS,HOT FLUSH,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
1028,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),VASCULAR DISORDERS,HYPERTENSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
1029,Xanomeline Low Dose,1.19047619,Mth01_CatVar_Summ_ByGrp,Mth01_CatVar_Summ_ByGrp_2_pct,Out14-3-2-1,%,( XX.X),VASCULAR DISORDERS,HYPOTENSION,An07_10_SocPt_Summ_ByTrt,"Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term",1,1.2,-1.2
1030,,0.015166741,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE ERYTHEMA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.0152,0.0152
1031,,0.000811758,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PRURITUS,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,8.00E-04,8.00E-04
1032,,0.248207446,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,DIARRHOEA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.2482,0.2482
1033,,0.175425361,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ERYTHEMA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.1754,0.1754
1034,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,ATRIOVENTRICULAR BLOCK SECOND DEGREE,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1035,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,HIATUS HERNIA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1036,,0.117417773,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,UPPER RESPIRATORY TRACT INFECTION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.1174,0.1174
1037,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,BUNDLE BRANCH BLOCK LEFT,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1038,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,PRURITUS GENERALISED,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1039,,0.207738369,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE VESICLES,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.2077,0.2077
1040,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",PHARYNGOLARYNGEAL PAIN,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1041,,0.620628565,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NASAL CONGESTION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.6206,0.6206
1042,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,RENAL AND URINARY DISORDERS,MICTURITION URGENCY,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1043,,0.618343195,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,ARTHRALGIA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.6183,0.6183
1044,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,CELLULITIS,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1045,,0.078319063,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE IRRITATION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.0783,0.0783
1046,,0.115173955,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,FATIGUE,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.1152,0.1152
1047,,0.276671967,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE DERMATITIS,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.2767,0.2767
1048,,0.497111034,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,URINARY TRACT INFECTION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4971,0.4971
1049,,0.497111034,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,PYREXIA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4971,0.4971
1050,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,EYE DISORDERS,EYE SWELLING,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1051,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,EYE DISORDERS,EYE ALLERGY,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1052,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,EYE DISORDERS,EYE PRURITUS,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1053,,0.007841386,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,PRURITUS,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.0078,0.0078
1054,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,METABOLISM AND NUTRITION DISORDERS,INCREASED APPETITE,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1055,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,URTICARIA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1056,,0.242673164,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE URTICARIA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.2427,0.2427
1057,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,NASAL MUCOSA BIOPSY,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1058,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SECRETION DISCHARGE,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1059,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,PNEUMONIA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1060,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULAR WEAKNESS,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1061,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SURGICAL AND MEDICAL PROCEDURES,EYE LASER SURGERY,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1062,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",JOINT DISLOCATION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1063,,0.618343195,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,SHOULDER PAIN,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.6183,0.6183
1064,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,RENAL AND URINARY DISORDERS,INCONTINENCE,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1065,,0.618343195,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",SKIN LACERATION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.6183,0.6183
1066,,0.680048188,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,PSYCHIATRIC DISORDERS,CONFUSIONAL STATE,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.68,0.68
1067,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",DYSPNOEA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1068,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SUDDEN DEATH,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1069,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,RASH ERYTHEMATOUS,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1070,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,PSYCHIATRIC DISORDERS,DEPRESSED MOOD,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1071,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",DYSPHONIA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1072,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,NAUSEA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1073,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,BACK PAIN,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1074,,0.440569104,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,HYPERHIDROSIS,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4406,0.4406
1075,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,RECTAL HAEMORRHAGE,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1076,,0.326102611,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN IRRITATION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.3261,0.3261
1077,,0.497111034,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,PSYCHIATRIC DISORDERS,INSOMNIA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4971,0.4971
1078,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,CHILLS,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1079,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SURGICAL AND MEDICAL PROCEDURES,CATARACT OPERATION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1080,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,OEDEMA PERIPHERAL,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1081,,0.680048188,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,SOMNOLENCE,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.68,0.68
1082,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,PSYCHIATRIC DISORDERS,DISORIENTATION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1083,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,METABOLISM AND NUTRITION DISORDERS,DECREASED APPETITE,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1084,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,VASCULAR DISORDERS,HYPOTENSION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1085,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,TACHYCARDIA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1086,,0.68198729,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,MYOCARDIAL INFARCTION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.682,0.682
1087,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MALAISE,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1088,,0.048021071,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,RASH,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.048,0.048
1089,,0.055618623,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,DIZZINESS,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.0556,0.0556
1090,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,CYSTITIS,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1091,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,VOMITING,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1092,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",EXCORIATION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1093,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",CONTUSION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1094,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,EAR AND LABYRINTH DISORDERS,VERTIGO,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1095,,0.242673164,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,PALPITATIONS,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.2427,0.2427
1096,,0.367714276,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.3677,0.3677
1097,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,WOLFF-PARKINSON-WHITE SYNDROME,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1098,,0.242673164,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,OEDEMA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.2427,0.2427
1099,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,INFLUENZA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1100,,0.440569104,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,NASOPHARYNGITIS,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4406,0.4406
1101,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,BLOOD GLUCOSE INCREASED,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1102,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,VIRAL INFECTION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1103,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,RENAL AND URINARY DISORDERS,POLLAKIURIA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1104,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,FLATULENCE,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1105,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,PARKINSON'S DISEASE,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1106,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,PSYCHIATRIC DISORDERS,COMPLETED SUICIDE,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1107,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,HEPATOBILIARY DISORDERS,HYPERBILIRUBINAEMIA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1108,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,DYSPEPSIA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1109,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,VENTRICULAR HYPERTROPHY,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1110,,0.364667115,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,ABDOMINAL PAIN,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.3647,0.3647
1111,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",COLON CANCER,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1112,,0.118447616,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,PSYCHIATRIC DISORDERS,ANXIETY,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.1184,0.1184
1113,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,PSYCHIATRIC DISORDERS,IRRITABILITY,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1114,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,SINUS ARRHYTHMIA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1115,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,BLOOD CREATINE PHOSPHOKINASE INCREASED,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1116,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",POSTNASAL DRIP,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1117,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,EYE DISORDERS,CONJUNCTIVITIS,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1118,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,HEADACHE,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1119,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,STUPOR,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1120,,0.242673164,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,TRANSIENT ISCHAEMIC ATTACK,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.2427,0.2427
1121,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,EYE DISORDERS,VISION BLURRED,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1122,,0.097122039,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,SINUS BRADYCARDIA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.0971,0.0971
1123,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,HEART RATE IRREGULAR,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1124,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,PSYCHIATRIC DISORDERS,AGITATION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1125,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,HEART RATE INCREASED,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1126,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCLE SPASMS,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1127,,0.242673164,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,VENTRICULAR EXTRASYSTOLES,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.2427,0.2427
1128,,0.115173955,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",COUGH,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.1152,0.1152
1129,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,VASCULAR DISORDERS,HOT FLUSH,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1130,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,CONSTIPATION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1131,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,ATRIAL HYPERTROPHY,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1132,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,PAIN IN EXTREMITY,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1133,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE SWELLING,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1134,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",EPISTAXIS,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1135,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE WARMTH,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1136,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,ELECTROCARDIOGRAM T WAVE INVERSION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1137,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,LOCALISED INFECTION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1138,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,BLOOD URINE PRESENT,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1139,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,CYSTOSCOPY,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1140,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,BENIGN PROSTATIC HYPERPLASIA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1141,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,METABOLISM AND NUTRITION DISORDERS,DEHYDRATION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1142,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,VASCULAR DISORDERS,ORTHOSTATIC HYPOTENSION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1143,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,HEMIANOPIA HOMONYMOUS,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1144,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,METABOLISM AND NUTRITION DISORDERS,DIABETES MELLITUS,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1145,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,DRUG ERUPTION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1146,,0.05745064,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,SYNCOPE,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.0575,0.0575
1147,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE BLEEDING,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1148,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,BLOOD ALKALINE PHOSPHATASE INCREASED,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1149,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",HAEMOPTYSIS,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1150,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",RALES,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1151,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN EXFOLIATION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1152,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE INDURATION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1153,,0.618343195,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",FALL,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.6183,0.6183
1154,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,COMPLEX PARTIAL SEIZURES,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1155,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,ATRIOVENTRICULAR BLOCK FIRST DEGREE,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1156,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,COLD SWEAT,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1157,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,ATRIAL FIBRILLATION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1158,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,CARDIAC FAILURE CONGESTIVE,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1159,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,METABOLISM AND NUTRITION DISORDERS,HYPONATRAEMIA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1160,,0.027687055,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,BLISTER,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.0277,0.0277
1161,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE DESQUAMATION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1162,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",HIP FRACTURE,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1163,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,PSYCHIATRIC DISORDERS,DELUSION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1164,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,PSYCHOMOTOR HYPERACTIVITY,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1165,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,SUPRAVENTRICULAR TACHYCARDIA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1166,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1167,,0.497111034,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,EAR INFECTION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4971,0.4971
1168,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,GLOSSITIS,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1169,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,PARAESTHESIA ORAL,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1170,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,SUPRAVENTRICULAR EXTRASYSTOLES,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1171,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,RASH PRURITIC,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1172,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,EYE DISORDERS,CONJUNCTIVAL HAEMORRHAGE,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1173,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,EAR AND LABYRINTH DISORDERS,CERUMEN IMPACTION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1174,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,RENAL AND URINARY DISORDERS,DYSURIA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1175,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,ASTHENIA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1176,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,PELVIC PAIN,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1177,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,GASTROENTERITIS VIRAL,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1178,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,GASTROOESOPHAGEAL REFLUX DISEASE,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1179,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,VAGINAL MYCOSIS,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1180,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,CERVICITIS,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1181,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,BUNDLE BRANCH BLOCK RIGHT,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1182,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,BRONCHITIS,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1183,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,EAR AND LABYRINTH DISORDERS,EAR PAIN,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1184,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,DERMATITIS CONTACT,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1185,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,RENAL AND URINARY DISORDERS,NEPHROLITHIASIS,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1186,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",EMPHYSEMA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1187,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,PSYCHIATRIC DISORDERS,RESTLESSNESS,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1188,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,LETHARGY,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1189,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,ATRIAL FLUTTER,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1190,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",VENTRICULAR SEPTAL DEFECT,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1191,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",MALIGNANT FIBROUS HISTIOCYTOMA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1192,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,SWELLING,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1193,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,IMMUNE SYSTEM DISORDERS,HYPERSENSITIVITY,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1194,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,ULCER,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1195,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",RHINORRHOEA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1196,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",WOUND,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1197,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ALOPECIA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1198,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,PAIN,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1199,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,INFLAMMATION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1200,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,BRADYCARDIA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1201,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,METABOLISM AND NUTRITION DISORDERS,FOOD CRAVING,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1202,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,BODY TEMPERATURE INCREASED,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1203,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,VASCULAR DISORDERS,HYPERTENSION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1204,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,BALANCE DISORDER,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1205,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,COORDINATION ABNORMAL,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1206,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE DISCOLOURATION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1207,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,DYSPHAGIA,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,0.4941,0.4941
1208,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN ULCER,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1209,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE REACTION,An07_10_SocPt_Comp_ByTrt_PlacLow,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs Low Dose",4,1,1
1210,,0.002480318,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE ERYTHEMA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.0025,0.0025
1211,,0.000811758,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PRURITUS,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,8.00E-04,8.00E-04
1212,,0.248207446,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,DIARRHOEA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.2482,0.2482
1213,,0.175425361,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ERYTHEMA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.1754,0.1754
1214,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,ATRIOVENTRICULAR BLOCK SECOND DEGREE,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1215,,0.115173955,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,FATIGUE,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.1152,0.1152
1216,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,HIATUS HERNIA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1217,,0.496132106,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,UPPER RESPIRATORY TRACT INFECTION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4961,0.4961
1218,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,BUNDLE BRANCH BLOCK LEFT,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1219,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,URINARY TRACT INFECTION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1220,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,PYREXIA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1221,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,EYE DISORDERS,EYE SWELLING,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1222,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,EYE DISORDERS,EYE ALLERGY,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1223,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,EYE DISORDERS,EYE PRURITUS,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1224,,0.000480743,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,PRURITUS,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,5.00E-04,5.00E-04
1225,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NASAL CONGESTION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1226,,0.078319063,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE IRRITATION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.0783,0.0783
1227,,0.242673164,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PAIN,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.2427,0.2427
1228,,0.062444235,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE VESICLES,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.0624,0.0624
1229,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,LOWER RESPIRATORY TRACT INFECTION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1230,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,FLANK PAIN,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1231,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,RENAL AND URINARY DISORDERS,CALCULUS URETHRAL,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1232,,0.242673164,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",EPISTAXIS,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.2427,0.2427
1233,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ACTINIC KERATOSIS,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1234,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,METABOLISM AND NUTRITION DISORDERS,INCREASED APPETITE,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1235,,0.208498294,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,VOMITING,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.2085,0.2085
1236,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,RENAL AND URINARY DISORDERS,MICTURITION URGENCY,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1237,,0.165549732,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,NASOPHARYNGITIS,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.1655,0.1655
1238,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,PSYCHIATRIC DISORDERS,AGITATION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1239,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SURGICAL AND MEDICAL PROCEDURES,EYE LASER SURGERY,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1240,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN ODOUR ABNORMAL,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1241,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,HORDEOLUM,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1242,,0.326102611,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,NAUSEA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.3261,0.3261
1243,,0.05745064,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,SALIVARY HYPERSECRETION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.0575,0.0575
1244,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,PAROSMIA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1245,,0.115173955,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",COUGH,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.1152,0.1152
1246,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",RHINORRHOEA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1247,,0.242673164,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE PERSPIRATION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.2427,0.2427
1248,,0.055618623,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,HYPERHIDROSIS,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.0556,0.0556
1249,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,STOMACH DISCOMFORT,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1250,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,PAIN,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1251,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",PHARYNGOLARYNGEAL PAIN,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1252,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",PRODUCTIVE COUGH,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1253,,0.242673164,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,MALAISE,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.2427,0.2427
1254,,0.009253649,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,DIZZINESS,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.0093,0.0093
1255,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MYALGIA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1256,,0.618343195,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",CONTUSION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.6183,0.6183
1257,,0.493367398,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,HEADACHE,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4934,0.4934
1258,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",RESPIRATORY TRACT CONGESTION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1259,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,RHINITIS,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1260,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,FEELING ABNORMAL,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1261,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,PSYCHIATRIC DISORDERS,LISTLESS,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1262,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,PSYCHIATRIC DISORDERS,LIBIDO DECREASED,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1263,,0.364667115,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,BACK PAIN,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.3647,0.3647
1264,,0.242673164,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,CHEST DISCOMFORT,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.2427,0.2427
1265,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,PARAESTHESIA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1266,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,PSYCHIATRIC DISORDERS,INSOMNIA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1267,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,BIOPSY PROSTATE,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1268,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,BENIGN PROSTATIC HYPERPLASIA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1269,,0.563332113,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE DERMATITIS,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.5633,0.5633
1270,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SURGICAL AND MEDICAL PROCEDURES,CATARACT OPERATION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1271,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,OEDEMA PERIPHERAL,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1272,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,PSYCHIATRIC DISORDERS,DISORIENTATION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1273,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,METABOLISM AND NUTRITION DISORDERS,DECREASED APPETITE,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1274,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,ARTHRITIS,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1275,,0.497111034,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,VASCULAR DISORDERS,HYPOTENSION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4971,0.4971
1276,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,TACHYCARDIA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1277,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,MYOCARDIAL INFARCTION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1278,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,WEIGHT DECREASED,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1279,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,TRANSIENT ISCHAEMIC ATTACK,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1280,,0.055618623,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,SINUS BRADYCARDIA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.0556,0.0556
1281,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,CYSTITIS,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1282,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",EXCORIATION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1283,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",SKIN LACERATION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1284,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,ARTHRALGIA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1285,,0.242673164,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",VENTRICULAR SEPTAL DEFECT,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.2427,0.2427
1286,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,INFLUENZA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1287,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,CARDIAC DISORDER,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1288,,0.276671967,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,RASH,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.2767,0.2767
1289,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,ABDOMINAL DISCOMFORT,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1290,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,CHILLS,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1291,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,BLOOD GLUCOSE INCREASED,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1292,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",DYSPNOEA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1293,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,ATRIAL FLUTTER,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1294,,0.364667115,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,ATRIAL FIBRILLATION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.3647,0.3647
1295,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,BLISTER,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1296,,0.242673164,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,BURNING SENSATION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.2427,0.2427
1297,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,RENAL AND URINARY DISORDERS,POLLAKIURIA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1298,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,FLATULENCE,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1299,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,PARKINSON'S DISEASE,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1300,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,PSYCHIATRIC DISORDERS,COMPLETED SUICIDE,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1301,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,HEPATOBILIARY DISORDERS,HYPERBILIRUBINAEMIA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1302,,0.242673164,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,RASH PRURITIC,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.2427,0.2427
1303,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,VASCULAR DISORDERS,WOUND HAEMORRHAGE,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1304,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,VENTRICULAR HYPERTROPHY,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1305,,0.120679212,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.1207,0.1207
1306,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,PSYCHIATRIC DISORDERS,IRRITABILITY,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1307,,0.118447616,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,SYNCOPE,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.1184,0.1184
1308,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,SINUS ARRHYTHMIA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1309,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,BLOOD CREATINE PHOSPHOKINASE INCREASED,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1310,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",POSTNASAL DRIP,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1311,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,EYE DISORDERS,CONJUNCTIVITIS,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1312,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,HEART RATE IRREGULAR,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1313,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SOCIAL CIRCUMSTANCES,ALCOHOL USE,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1314,,0.242673164,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE SWELLING,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.2427,0.2427
1315,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,HEART RATE INCREASED,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1316,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,ABDOMINAL PAIN,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1317,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,CONSTIPATION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1318,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,ATRIAL HYPERTROPHY,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1319,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,PAIN IN EXTREMITY,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1320,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCLE SPASMS,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1321,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",PHARYNGEAL ERYTHEMA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1322,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SURGICAL AND MEDICAL PROCEDURES,ACROCHORDON EXCISION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1323,,0.493367398,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN IRRITATION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4934,0.4934
1324,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE DISCHARGE,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1325,,0.618343195,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",HIP FRACTURE,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.6183,0.6183
1326,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SURGICAL AND MEDICAL PROCEDURES,SKIN LESION EXCISION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1327,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,LOCALISED INFECTION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1328,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,BLOOD URINE PRESENT,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1329,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,CYSTOSCOPY,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1330,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,METABOLISM AND NUTRITION DISORDERS,DEHYDRATION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1331,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,VASCULAR DISORDERS,ORTHOSTATIC HYPOTENSION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1332,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,METABOLISM AND NUTRITION DISORDERS,DIABETES MELLITUS,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1333,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,DRUG ERUPTION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1334,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,PSYCHIATRIC DISORDERS,NIGHTMARE,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1335,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,RASH MACULO-PAPULAR,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1336,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,BIOPSY,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1337,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",ALLERGIC GRANULOMATOUS ANGIITIS,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1338,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,FEELING COLD,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1339,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,BLOOD ALKALINE PHOSPHATASE INCREASED,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1340,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,RENAL AND URINARY DISORDERS,NEPHROLITHIASIS,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1341,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",FALL,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1342,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",FACIAL BONES FRACTURE,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1343,,0.242673164,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,CHEST PAIN,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.2427,0.2427
1344,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",HAEMOPTYSIS,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1345,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",RALES,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1346,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE INDURATION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1347,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,SUPRAVENTRICULAR EXTRASYSTOLES,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1348,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL HAEMORRHAGE,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1349,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,EAR AND LABYRINTH DISORDERS,VERTIGO,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1350,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,SYNCOPE VASOVAGAL,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1351,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,ATRIOVENTRICULAR BLOCK FIRST DEGREE,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1352,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,COLD SWEAT,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1353,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,CARDIAC FAILURE CONGESTIVE,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1354,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,METABOLISM AND NUTRITION DISORDERS,HYPONATRAEMIA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1355,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,SOMNOLENCE,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1356,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,PSYCHIATRIC DISORDERS,DELUSION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1357,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,PSYCHOMOTOR HYPERACTIVITY,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1358,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE URTICARIA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1359,,0.497111034,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,EAR INFECTION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4971,0.4971
1360,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,GLOSSITIS,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1361,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,ASTHENIA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1362,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,PSYCHIATRIC DISORDERS,DELIRIUM,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1363,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,RENAL AND URINARY DISORDERS,DYSURIA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1364,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,DYSPEPSIA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1365,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,PELVIC PAIN,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1366,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,GASTROENTERITIS VIRAL,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1367,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GASTROINTESTINAL DISORDERS,GASTROOESOPHAGEAL REFLUX DISEASE,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1368,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,VAGINAL MYCOSIS,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1369,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,CERVICITIS,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1370,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,SHOULDER PAIN,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1371,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,BUNDLE BRANCH BLOCK RIGHT,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1372,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,ELECTROCARDIOGRAM T WAVE INVERSION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1373,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INFECTIONS AND INFESTATIONS,BRONCHITIS,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1374,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,EAR AND LABYRINTH DISORDERS,EAR PAIN,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1375,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,APPLICATION SITE REACTION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1376,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",EMPHYSEMA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1377,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1378,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,PSYCHIATRIC DISORDERS,CONFUSIONAL STATE,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1379,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,HYPERSOMNIA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1380,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,PSYCHIATRIC DISORDERS,HALLUCINATION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1381,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",PROSTATE CANCER,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1382,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,INVESTIGATIONS,BLOOD CHOLESTEROL INCREASED,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1383,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,COGNITIVE DISORDER,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1384,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,URTICARIA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1385,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,EYE DISORDERS,VISION BLURRED,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1386,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,PRURITUS GENERALISED,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1387,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,VENTRICULAR EXTRASYSTOLES,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1388,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,ALOPECIA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1389,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,CARDIAC DISORDERS,BRADYCARDIA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1390,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,METABOLISM AND NUTRITION DISORDERS,FOOD CRAVING,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1391,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN ULCER,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1392,,1,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,VASCULAR DISORDERS,HYPERTENSION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,1,1
1393,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1394,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,PSYCHIATRIC DISORDERS,"HALLUCINATION, VISUAL",An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1395,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,AMNESIA,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1396,,0.494117647,Mth05_CatVar_Comp_FishEx,Mth03_CatVar_Comp_FishEx_1_pval,Out14-3-2-1,p-value,X.XXXX,NERVOUS SYSTEM DISORDERS,LETHARGY,An07_10_SocPt_Comp_ByTrt_PlacHigh,"Comparison of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term - Placebo vs High Dose",4,0.4941,0.4941
1397,Placebo,86,Mth01_CatVar_Count_ByGrp,Mth01_CatVar_Count_ByGrp_1_n,Out14-3-3-1a,n,(N=XX),,,An01_05_SAF_Summ_ByTrt,Summary of Subjects by Treatment,0,86,(N=86)
1398,Xanomeline High Dose,84,Mth01_CatVar_Count_ByGrp,Mth01_CatVar_Count_ByGrp_1_n,Out14-3-3-1a,n,(N=XX),,,An01_05_SAF_Summ_ByTrt,Summary of Subjects by Treatment,0,84,(N=84)
1399,Xanomeline Low Dose,84,Mth01_CatVar_Count_ByGrp,Mth01_CatVar_Count_ByGrp_1_n,Out14-3-3-1a,n,(N=XX),,,An01_05_SAF_Summ_ByTrt,Summary of Subjects by Treatment,0,84,(N=84)
1400,Placebo,255,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,255,255
1401,Placebo,246,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,246,246
1402,Placebo,207,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,207,207
1403,Placebo,204,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,204,204
1404,Placebo,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,252,252
1405,Placebo,198,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,198,198
1406,Placebo,177,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,177,177
1407,Placebo,174,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,174,174
1408,Placebo,246,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,246,246
1409,Placebo,228,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,228,228
1410,Placebo,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,219,219
1411,Placebo,255,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,255,255
1412,Placebo,246,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,246,246
1413,Placebo,207,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,207,207
1414,Placebo,204,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,204,204
1415,Placebo,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,252,252
1416,Placebo,198,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,198,198
1417,Placebo,177,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,177,177
1418,Placebo,174,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,174,174
1419,Placebo,246,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,246,246
1420,Placebo,228,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,228,228
1421,Placebo,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,219,219
1422,Placebo,255,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,255,255
1423,Placebo,246,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,246,246
1424,Placebo,207,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,207,207
1425,Placebo,204,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,204,204
1426,Placebo,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,252,252
1427,Placebo,198,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,198,198
1428,Placebo,177,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,177,177
1429,Placebo,174,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,174,174
1430,Placebo,246,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,246,246
1431,Placebo,228,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,228,228
1432,Placebo,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,219,219
1433,Placebo,86,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,86,86
1434,Placebo,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,82,82
1435,Placebo,69,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,69,69
1436,Placebo,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,68,68
1437,Placebo,83,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,83,83
1438,Placebo,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,64,64
1439,Placebo,57,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,57,57
1440,Placebo,58,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,58,58
1441,Placebo,81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,81,81
1442,Placebo,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,76,76
1443,Placebo,73,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,73,73
1444,Placebo,86,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,86,86
1445,Placebo,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,82,82
1446,Placebo,69,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,69,69
1447,Placebo,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,68,68
1448,Placebo,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,82,82
1449,Placebo,66,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,66,66
1450,Placebo,59,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,59,59
1451,Placebo,58,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,58,58
1452,Placebo,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,82,82
1453,Placebo,75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,75,75
1454,Placebo,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,72,72
1455,Xanomeline High Dose,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,252,252
1456,Xanomeline High Dose,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,219,219
1457,Xanomeline High Dose,150,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,150,150
1458,Xanomeline High Dose,111,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,111,111
1459,Xanomeline High Dose,243,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,243,243
1460,Xanomeline High Dose,96,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,96,96
1461,Xanomeline High Dose,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,90,90
1462,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,84,84
1463,Xanomeline High Dose,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,219,219
1464,Xanomeline High Dose,203,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,203,203
1465,Xanomeline High Dose,168,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,168,168
1466,Xanomeline High Dose,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,252,252
1467,Xanomeline High Dose,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,219,219
1468,Xanomeline High Dose,150,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,150,150
1469,Xanomeline High Dose,111,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,111,111
1470,Xanomeline High Dose,243,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,243,243
1471,Xanomeline High Dose,96,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,96,96
1472,Xanomeline High Dose,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,90,90
1473,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,84,84
1474,Xanomeline High Dose,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,219,219
1475,Xanomeline High Dose,204,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,204,204
1476,Xanomeline High Dose,168,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,168,168
1477,Xanomeline High Dose,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,252,252
1478,Xanomeline High Dose,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,219,219
1479,Xanomeline High Dose,150,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,150,150
1480,Xanomeline High Dose,111,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,111,111
1481,Xanomeline High Dose,243,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,243,243
1482,Xanomeline High Dose,96,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,96,96
1483,Xanomeline High Dose,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,90,90
1484,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,84,84
1485,Xanomeline High Dose,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,219,219
1486,Xanomeline High Dose,204,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,204,204
1487,Xanomeline High Dose,168,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,168,168
1488,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,84,84
1489,Xanomeline High Dose,73,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,73,73
1490,Xanomeline High Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
1491,Xanomeline High Dose,37,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
1492,Xanomeline High Dose,81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,81,81
1493,Xanomeline High Dose,32,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,32,32
1494,Xanomeline High Dose,29,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,29,29
1495,Xanomeline High Dose,28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,28,28
1496,Xanomeline High Dose,73,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,73,73
1497,Xanomeline High Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,68,68
1498,Xanomeline High Dose,56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,56,56
1499,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,84,84
1500,Xanomeline High Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,72,72
1501,Xanomeline High Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
1502,Xanomeline High Dose,37,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
1503,Xanomeline High Dose,81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,81,81
1504,Xanomeline High Dose,32,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,32,32
1505,Xanomeline High Dose,30,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,30,30
1506,Xanomeline High Dose,28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,28,28
1507,Xanomeline High Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,72,72
1508,Xanomeline High Dose,67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,67,67
1509,Xanomeline High Dose,56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,56,56
1510,Xanomeline Low Dose,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,252,252
1511,Xanomeline Low Dose,216,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,216,216
1512,Xanomeline Low Dose,156,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,156,156
1513,Xanomeline Low Dose,126,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,126,126
1514,Xanomeline Low Dose,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,252,252
1515,Xanomeline Low Dose,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,90,90
1516,Xanomeline Low Dose,81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,81,81
1517,Xanomeline Low Dose,75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,75,75
1518,Xanomeline Low Dose,216,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,216,216
1519,Xanomeline Low Dose,195,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,195,195
1520,Xanomeline Low Dose,180,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,180,180
1521,Xanomeline Low Dose,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,252,252
1522,Xanomeline Low Dose,216,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,216,216
1523,Xanomeline Low Dose,156,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,156,156
1524,Xanomeline Low Dose,126,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,126,126
1525,Xanomeline Low Dose,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,252,252
1526,Xanomeline Low Dose,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,90,90
1527,Xanomeline Low Dose,81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,81,81
1528,Xanomeline Low Dose,75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,75,75
1529,Xanomeline Low Dose,216,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,216,216
1530,Xanomeline Low Dose,195,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,195,195
1531,Xanomeline Low Dose,180,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,180,180
1532,Xanomeline Low Dose,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,252,252
1533,Xanomeline Low Dose,216,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,216,216
1534,Xanomeline Low Dose,156,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,156,156
1535,Xanomeline Low Dose,126,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,126,126
1536,Xanomeline Low Dose,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,252,252
1537,Xanomeline Low Dose,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,90,90
1538,Xanomeline Low Dose,81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,81,81
1539,Xanomeline Low Dose,75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,75,75
1540,Xanomeline Low Dose,216,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,216,216
1541,Xanomeline Low Dose,195,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,195,195
1542,Xanomeline Low Dose,180,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,180,180
1543,Xanomeline Low Dose,83,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,83,83
1544,Xanomeline Low Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,72,72
1545,Xanomeline Low Dose,52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,52,52
1546,Xanomeline Low Dose,41,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,41,41
1547,Xanomeline Low Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,84,84
1548,Xanomeline Low Dose,30,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,30,30
1549,Xanomeline Low Dose,26,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,26,26
1550,Xanomeline Low Dose,24,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,24,24
1551,Xanomeline Low Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,72,72
1552,Xanomeline Low Dose,65,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,65,65
1553,Xanomeline Low Dose,59,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,59,59
1554,Xanomeline Low Dose,83,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,83,83
1555,Xanomeline Low Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,72,72
1556,Xanomeline Low Dose,52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,52,52
1557,Xanomeline Low Dose,42,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,42,42
1558,Xanomeline Low Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,84,84
1559,Xanomeline Low Dose,31,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,31,31
1560,Xanomeline Low Dose,27,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,27,27
1561,Xanomeline Low Dose,25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,25,25
1562,Xanomeline Low Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,72,72
1563,Xanomeline Low Dose,65,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,65,65
1564,Xanomeline Low Dose,60,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,60,60
1565,Placebo,77.09411765,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,77.1,77.1
1566,Placebo,74.05691057,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.1,74.1
1567,Placebo,74.28985507,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.3,74.3
1568,Placebo,75.11764706,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.1,75.1
1569,Placebo,74.45634921,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.5,74.5
1570,Placebo,73.3989899,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.4,73.4
1571,Placebo,73.79661017,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.8,73.8
1572,Placebo,72.63218391,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72.6,72.6
1573,Placebo,75.43089431,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.4,75.4
1574,Placebo,74.48245614,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.5,74.5
1575,Placebo,75.24657534,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.2,75.2
1576,Placebo,73.52156863,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.5,73.5
1577,Placebo,73.08943089,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.1,73.1
1578,Placebo,75.04347826,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75,75
1579,Placebo,70.55392157,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.6,70.6
1580,Placebo,73.24603175,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.2,73.2
1581,Placebo,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
1582,Placebo,71.57062147,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,71.6,71.6
1583,Placebo,73.06896552,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.1,73.1
1584,Placebo,73.80894309,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.8,73.8
1585,Placebo,72.93421053,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72.9,72.9
1586,Placebo,71.82191781,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,71.8,71.8
1587,Placebo,136.8078431,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,136.8,136.8
1588,Placebo,132.3699187,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,132.4,132.4
1589,Placebo,132.705314,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,132.7,132.7
1590,Placebo,134.6029412,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,134.6,134.6
1591,Placebo,133.8134921,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,133.8,133.8
1592,Placebo,133.3282828,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,133.3,133.3
1593,Placebo,134.6779661,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,134.7,134.7
1594,Placebo,130.8850575,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130.9,130.9
1595,Placebo,133.9430894,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,133.9,133.9
1596,Placebo,133.8333333,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,133.8,133.8
1597,Placebo,136.2739726,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,136.3,136.3
1598,Placebo,36.5894186,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
1599,Placebo,36.6645122,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
1600,Placebo,36.64405797,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
1601,Placebo,36.67529412,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
1602,Placebo,36.55566265,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
1603,Placebo,36.6290625,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
1604,Placebo,36.61684211,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
1605,Placebo,36.67017241,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
1606,Placebo,36.59135802,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
1607,Placebo,36.61736842,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
1608,Placebo,36.5960274,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
1609,Placebo,62.75744186,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,62.8,62.8
1610,Placebo,63.01939024,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63,63
1611,Placebo,63.7,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.7,63.7
1612,Placebo,63.49,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.5,63.5
1613,Placebo,63.2554878,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.3,63.3
1614,Placebo,63.65787879,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.7,63.7
1615,Placebo,63.22423729,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.2,63.2
1616,Placebo,63.10155172,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.1,63.1
1617,Placebo,63.21829268,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.2,63.2
1618,Placebo,63.37866667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.4,63.4
1619,Placebo,63.17444444,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.2,63.2
1620,Xanomeline High Dose,78.26587302,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78.3,78.3
1621,Xanomeline High Dose,75.14155251,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.1,75.1
1622,Xanomeline High Dose,74.60666667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.6,74.6
1623,Xanomeline High Dose,76.02702703,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76,76
1624,Xanomeline High Dose,76.42798354,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76.4,76.4
1625,Xanomeline High Dose,74.07291667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.1,74.1
1626,Xanomeline High Dose,74.93333333,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.9,74.9
1627,Xanomeline High Dose,74.54761905,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.5,74.5
1628,Xanomeline High Dose,76.79908676,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76.8,76.8
1629,Xanomeline High Dose,75.25615764,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.3,75.3
1630,Xanomeline High Dose,77.36904762,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,77.4,77.4
1631,Xanomeline High Dose,73.00793651,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73,73
1632,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
1633,Xanomeline High Dose,73.16666667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.2,73.2
1634,Xanomeline High Dose,73.1981982,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.2,73.2
1635,Xanomeline High Dose,76.17695473,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76.2,76.2
1636,Xanomeline High Dose,76.73958333,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76.7,76.7
1637,Xanomeline High Dose,71.68888889,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,71.7,71.7
1638,Xanomeline High Dose,73.44047619,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.4,73.4
1639,Xanomeline High Dose,75.92694064,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.9,75.9
1640,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
1641,Xanomeline High Dose,74.04166667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74,74
1642,Xanomeline High Dose,138.7738095,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,138.8,138.8
1643,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
1644,Xanomeline High Dose,130.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130.3,130.3
1645,Xanomeline High Dose,133.6576577,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,133.7,133.7
1646,Xanomeline High Dose,132.3292181,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,132.3,132.3
1647,Xanomeline High Dose,127.0729167,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,127.1,127.1
1648,Xanomeline High Dose,130.6222222,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130.6,130.6
1649,Xanomeline High Dose,124.1309524,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,124.1,124.1
1650,Xanomeline High Dose,132.1872146,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,132.2,132.2
1651,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
1652,Xanomeline High Dose,135.0595238,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,135.1,135.1
1653,Xanomeline High Dose,36.56119048,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
1654,Xanomeline High Dose,36.64109589,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
1655,Xanomeline High Dose,36.6626,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
1656,Xanomeline High Dose,36.62891892,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
1657,Xanomeline High Dose,36.56962963,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
1658,Xanomeline High Dose,36.69875,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
1659,Xanomeline High Dose,36.70862069,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
1660,Xanomeline High Dose,36.77428571,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.8,36.8
1661,Xanomeline High Dose,36.64684932,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
1662,Xanomeline High Dose,36.57294118,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
1663,Xanomeline High Dose,36.60642857,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
1664,Xanomeline High Dose,69.99880952,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
1665,Xanomeline High Dose,69.31,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,69.3,69.3
1666,Xanomeline High Dose,70.8208,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.8,70.8
1667,Xanomeline High Dose,70.58378378,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.6,70.6
1668,Xanomeline High Dose,70.16938272,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.2,70.2
1669,Xanomeline High Dose,70.7640625,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.8,70.8
1670,Xanomeline High Dose,71.072,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,71.1,71.1
1671,Xanomeline High Dose,69.98464286,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
1672,Xanomeline High Dose,70.09375,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.1,70.1
1673,Xanomeline High Dose,70.46238806,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.5,70.5
1674,Xanomeline High Dose,71.10625,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,71.1,71.1
1675,Xanomeline Low Dose,76.35714286,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76.4,76.4
1676,Xanomeline Low Dose,73.81944444,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.8,73.8
1677,Xanomeline Low Dose,75.67307692,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.7,75.7
1678,Xanomeline Low Dose,75.23015873,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.2,75.2
1679,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
1680,Xanomeline Low Dose,73.66666667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.7,73.7
1681,Xanomeline Low Dose,76.20987654,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76.2,76.2
1682,Xanomeline Low Dose,72.94666667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72.9,72.9
1683,Xanomeline Low Dose,76.00462963,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76,76
1684,Xanomeline Low Dose,74.9025641,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.9,74.9
1685,Xanomeline Low Dose,75.4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.4,75.4
1686,Xanomeline Low Dose,71.49603175,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,71.5,71.5
1687,Xanomeline Low Dose,70.59722222,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.6,70.6
1688,Xanomeline Low Dose,73.08974359,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.1,73.1
1689,Xanomeline Low Dose,68.78571429,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68.8,68.8
1690,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
1691,Xanomeline Low Dose,70.13333333,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.1,70.1
1692,Xanomeline Low Dose,70.30864198,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.3,70.3
1693,Xanomeline Low Dose,70.45333333,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.5,70.5
1694,Xanomeline Low Dose,73.10648148,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.1,73.1
1695,Xanomeline Low Dose,72.00512821,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
1696,Xanomeline Low Dose,72.6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72.6,72.6
1697,Xanomeline Low Dose,136.9087302,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,136.9,136.9
1698,Xanomeline Low Dose,132.9166667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,132.9,132.9
1699,Xanomeline Low Dose,133.2051282,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,133.2,133.2
1700,Xanomeline Low Dose,132.4603175,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,132.5,132.5
1701,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
1702,Xanomeline Low Dose,128.9888889,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,129,129
1703,Xanomeline Low Dose,132.0246914,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,132,132
1704,Xanomeline Low Dose,129.3866667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,129.4,129.4
1705,Xanomeline Low Dose,135.3888889,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,135.4,135.4
1706,Xanomeline Low Dose,134.9076923,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,134.9,134.9
1707,Xanomeline Low Dose,134.9222222,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,134.9,134.9
1708,Xanomeline Low Dose,36.55554217,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
1709,Xanomeline Low Dose,36.57638889,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
1710,Xanomeline Low Dose,36.62519231,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
1711,Xanomeline Low Dose,36.55195122,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
1712,Xanomeline Low Dose,36.5222619,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.5,36.5
1713,Xanomeline Low Dose,36.67566667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
1714,Xanomeline Low Dose,36.65615385,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
1715,Xanomeline Low Dose,36.59041667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
1716,Xanomeline Low Dose,36.49625,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.5,36.5
1717,Xanomeline Low Dose,36.53046154,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.5,36.5
1718,Xanomeline Low Dose,36.58389831,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
1719,Xanomeline Low Dose,67.27421687,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,67.3,67.3
1720,Xanomeline Low Dose,66.78027778,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,66.8,66.8
1721,Xanomeline Low Dose,67.02423077,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,67,67
1722,Xanomeline Low Dose,68.09928571,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68.1,68.1
1723,Xanomeline Low Dose,67.36904762,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,67.4,67.4
1724,Xanomeline Low Dose,67.25064516,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,67.3,67.3
1725,Xanomeline Low Dose,67.4337037,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,67.4,67.4
1726,Xanomeline Low Dose,67.0516,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,67.1,67.1
1727,Xanomeline Low Dose,67.34083333,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,67.3,67.3
1728,Xanomeline Low Dose,67.18707692,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,67.2,67.2
1729,Xanomeline Low Dose,66.69433333,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,66.7,66.7
1730,Placebo,10.90974807,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.91,-10.91
1731,Placebo,11.04484426,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,11.04,-11.04
1732,Placebo,10.91952218,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.92,-10.92
1733,Placebo,11.10344918,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,11.1,-11.1
1734,Placebo,10.42379286,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.42,-10.42
1735,Placebo,10.57760295,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.58,-10.58
1736,Placebo,11.83376284,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,11.83,-11.83
1737,Placebo,10.94507036,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.95,-10.95
1738,Placebo,11.45894628,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,11.46,-11.46
1739,Placebo,10.20428558,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.2,-10.2
1740,Placebo,9.288615141,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.29,-9.29
1741,Placebo,11.89018509,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,11.89,-11.89
1742,Placebo,10.61420544,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.61,-10.61
1743,Placebo,11.58686248,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,11.59,-11.59
1744,Placebo,8.976819316,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,8.98,-8.98
1745,Placebo,10.24767898,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.25,-10.25
1746,Placebo,8.914142075,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,8.91,-8.91
1747,Placebo,9.177345883,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.18,-9.18
1748,Placebo,10.91299602,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.91,-10.91
1749,Placebo,10.73921297,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.74,-10.74
1750,Placebo,10.49271053,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.49,-10.49
1751,Placebo,9.197640003,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.2,-9.2
1752,Placebo,17.80710116,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,17.81,-17.81
1753,Placebo,18.78029117,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,18.78,-18.78
1754,Placebo,15.24477057,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,15.24,-15.24
1755,Placebo,18.54575466,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,18.55,-18.55
1756,Placebo,17.80261789,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,17.8,-17.8
1757,Placebo,20.02456127,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,20.02,-20.02
1758,Placebo,17.90420279,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,17.9,-17.9
1759,Placebo,18.40295609,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,18.4,-18.4
1760,Placebo,17.58190202,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,17.58,-17.58
1761,Placebo,18.2739393,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,18.27,-18.27
1762,Placebo,17.20219231,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,17.2,-17.2
1763,Placebo,0.393525108,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.39,-0.39
1764,Placebo,0.401866486,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.4,-0.4
1765,Placebo,0.397386013,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.4,-0.4
1766,Placebo,0.338982105,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.34,-0.34
1767,Placebo,0.443676967,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.44,-0.44
1768,Placebo,0.483334052,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.48,-0.48
1769,Placebo,0.485515771,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.49,-0.49
1770,Placebo,0.410226687,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.41,-0.41
1771,Placebo,0.512666444,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.51,-0.51
1772,Placebo,0.388900565,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.39,-0.39
1773,Placebo,0.384464778,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.38,-0.38
1774,Placebo,12.77038801,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,12.77,-12.77
1775,Placebo,12.71125091,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,12.71,-12.71
1776,Placebo,12.39652596,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,12.4,-12.4
1777,Placebo,12.5861829,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,12.59,-12.59
1778,Placebo,12.93630189,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,12.94,-12.94
1779,Placebo,12.60260285,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,12.6,-12.6
1780,Placebo,12.58336535,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,12.58,-12.58
1781,Placebo,12.64258604,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,12.64,-12.64
1782,Placebo,12.73949481,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,12.74,-12.74
1783,Placebo,12.53074083,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,12.53,-12.53
1784,Placebo,12.4457854,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,12.45,-12.45
1785,Xanomeline High Dose,10.27028874,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.27,-10.27
1786,Xanomeline High Dose,10.38139918,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.38,-10.38
1787,Xanomeline High Dose,9.212551015,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.21,-9.21
1788,Xanomeline High Dose,9.116876917,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.12,-9.12
1789,Xanomeline High Dose,10.77751902,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.78,-10.78
1790,Xanomeline High Dose,10.35500875,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.36,-10.36
1791,Xanomeline High Dose,10.23630903,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.24,-10.24
1792,Xanomeline High Dose,10.52066785,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.52,-10.52
1793,Xanomeline High Dose,9.579977164,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.58,-9.58
1794,Xanomeline High Dose,9.899664912,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.9,-9.9
1795,Xanomeline High Dose,9.284304909,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.28,-9.28
1796,Xanomeline High Dose,10.49719828,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.5,-10.5
1797,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,NA,(NA)
1798,Xanomeline High Dose,10.49155408,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.49,-10.49
1799,Xanomeline High Dose,9.802429958,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.8,-9.8
1800,Xanomeline High Dose,10.29510655,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.3,-10.3
1801,Xanomeline High Dose,11.10926099,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,11.11,-11.11
1802,Xanomeline High Dose,11.90283173,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,11.9,-11.9
1803,Xanomeline High Dose,11.18879731,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,11.19,-11.19
1804,Xanomeline High Dose,11.05549617,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,11.06,-11.06
1805,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,NA,(NA)
1806,Xanomeline High Dose,9.143142561,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.14,-9.14
1807,Xanomeline High Dose,18.73574966,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,18.74,-18.74
1808,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,NA,(NA)
1809,Xanomeline High Dose,15.57537206,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,15.58,-15.58
1810,Xanomeline High Dose,16.24779453,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,16.25,-16.25
1811,Xanomeline High Dose,16.61295703,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,16.61,-16.61
1812,Xanomeline High Dose,15.53213632,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,15.53,-15.53
1813,Xanomeline High Dose,18.5524327,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,18.55,-18.55
1814,Xanomeline High Dose,14.51445458,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.51,-14.51
1815,Xanomeline High Dose,16.43493206,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,16.43,-16.43
1816,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,NA,(NA)
1817,Xanomeline High Dose,15.88796946,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,15.89,-15.89
1818,Xanomeline High Dose,0.424177176,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.42,-0.42
1819,Xanomeline High Dose,0.385852453,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.39,-0.39
1820,Xanomeline High Dose,0.381323206,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.38,-0.38
1821,Xanomeline High Dose,0.384691679,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.38,-0.38
1822,Xanomeline High Dose,0.46947163,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.47,-0.47
1823,Xanomeline High Dose,0.535686174,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.54,-0.54
1824,Xanomeline High Dose,0.444029633,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.44,-0.44
1825,Xanomeline High Dose,0.241452834,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.24,-0.24
1826,Xanomeline High Dose,0.373139372,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.37,-0.37
1827,Xanomeline High Dose,0.422882994,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.42,-0.42
1828,Xanomeline High Dose,0.393415943,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.39,-0.39
1829,Xanomeline High Dose,14.65117244,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.65,-14.65
1830,Xanomeline High Dose,14.47951034,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.48,-14.48
1831,Xanomeline High Dose,13.8765181,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,13.88,-13.88
1832,Xanomeline High Dose,15.0459903,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,15.05,-15.05
1833,Xanomeline High Dose,14.01680878,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.02,-14.02
1834,Xanomeline High Dose,15.68580494,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,15.69,-15.69
1835,Xanomeline High Dose,15.81545499,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,15.82,-15.82
1836,Xanomeline High Dose,16.34700844,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,16.35,-16.35
1837,Xanomeline High Dose,14.34666712,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.35,-14.35
1838,Xanomeline High Dose,14.2729801,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.27,-14.27
1839,Xanomeline High Dose,13.69288754,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,13.69,-13.69
1840,Xanomeline Low Dose,10.25100464,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.25,-10.25
1841,Xanomeline Low Dose,9.125980886,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.13,-9.13
1842,Xanomeline Low Dose,10.83611849,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.84,-10.84
1843,Xanomeline Low Dose,10.12810956,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.13,-10.13
1844,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,NA,(NA)
1845,Xanomeline Low Dose,9.735836731,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.74,-9.74
1846,Xanomeline Low Dose,9.75924696,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.76,-9.76
1847,Xanomeline Low Dose,9.89115539,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.89,-9.89
1848,Xanomeline Low Dose,9.348795562,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.35,-9.35
1849,Xanomeline Low Dose,9.17840044,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.18,-9.18
1850,Xanomeline Low Dose,10.75091265,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.75,-10.75
1851,Xanomeline Low Dose,10.53527485,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.54,-10.54
1852,Xanomeline Low Dose,10.75995123,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.76,-10.76
1853,Xanomeline Low Dose,9.87494176,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.87,-9.87
1854,Xanomeline Low Dose,9.582990884,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.58,-9.58
1855,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,NA,(NA)
1856,Xanomeline Low Dose,11.42262686,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,11.42,-11.42
1857,Xanomeline Low Dose,9.902830372,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.9,-9.9
1858,Xanomeline Low Dose,8.955284312,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,8.96,-8.96
1859,Xanomeline Low Dose,10.58532352,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.59,-10.59
1860,Xanomeline Low Dose,9.187899615,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.19,-9.19
1861,Xanomeline Low Dose,11.29126819,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,11.29,-11.29
1862,Xanomeline Low Dose,17.56591466,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,17.57,-17.57
1863,Xanomeline Low Dose,18.1282896,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,18.13,-18.13
1864,Xanomeline Low Dose,16.98907351,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,16.99,-16.99
1865,Xanomeline Low Dose,14.60008263,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.6,-14.6
1866,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,NA,(NA)
1867,Xanomeline Low Dose,16.12695033,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,16.13,-16.13
1868,Xanomeline Low Dose,17.34356892,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,17.34,-17.34
1869,Xanomeline Low Dose,18.16359095,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,18.16,-18.16
1870,Xanomeline Low Dose,17.99500361,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,18,-18
1871,Xanomeline Low Dose,19.49125345,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,19.49,-19.49
1872,Xanomeline Low Dose,18.07509338,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,18.08,-18.08
1873,Xanomeline Low Dose,0.403428154,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.4,-0.4
1874,Xanomeline Low Dose,0.433047847,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.43,-0.43
1875,Xanomeline Low Dose,0.448494171,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.45,-0.45
1876,Xanomeline Low Dose,0.382192488,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.38,-0.38
1877,Xanomeline Low Dose,0.44329639,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.44,-0.44
1878,Xanomeline Low Dose,0.464555281,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.46,-0.46
1879,Xanomeline Low Dose,0.361021627,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.36,-0.36
1880,Xanomeline Low Dose,0.43997509,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.44,-0.44
1881,Xanomeline Low Dose,0.507344474,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.51,-0.51
1882,Xanomeline Low Dose,0.441292246,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.44,-0.44
1883,Xanomeline Low Dose,0.404798873,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.4,-0.4
1884,Xanomeline Low Dose,14.12506923,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.13,-14.13
1885,Xanomeline Low Dose,14.32693651,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.33,-14.33
1886,Xanomeline Low Dose,14.19595542,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.2,-14.2
1887,Xanomeline Low Dose,14.5524383,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.55,-14.55
1888,Xanomeline Low Dose,14.27130474,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.27,-14.27
1889,Xanomeline Low Dose,14.54794738,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.55,-14.55
1890,Xanomeline Low Dose,14.07154826,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.07,-14.07
1891,Xanomeline Low Dose,13.8496798,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,13.85,-13.85
1892,Xanomeline Low Dose,14.36948172,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.37,-14.37
1893,Xanomeline Low Dose,14.41713983,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.42,-14.42
1894,Xanomeline Low Dose,13.90766846,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,13.91,-13.91
1895,Placebo,78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78,78
1896,Placebo,74,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74,74
1897,Placebo,73,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73,73
1898,Placebo,76.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76.5,76.5
1899,Placebo,74,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74,74
1900,Placebo,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
1901,Placebo,74,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74,74
1902,Placebo,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
1903,Placebo,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76,76
1904,Placebo,74,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74,74
1905,Placebo,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76,76
1906,Placebo,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
1907,Placebo,74,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74,74
1908,Placebo,74,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74,74
1909,Placebo,70.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.5,70.5
1910,Placebo,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
1911,Placebo,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
1912,Placebo,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
1913,Placebo,74,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74,74
1914,Placebo,73.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.5,73.5
1915,Placebo,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
1916,Placebo,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
1917,Placebo,137,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,137,137
1918,Placebo,130,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130,130
1919,Placebo,132,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,132,132
1920,Placebo,134,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,134,134
1921,Placebo,130,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130,130
1922,Placebo,130,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130,130
1923,Placebo,131,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,131,131
1924,Placebo,130,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130,130
1925,Placebo,133.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,133.5,133.5
1926,Placebo,130,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130,130
1927,Placebo,138,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,138,138
1928,Placebo,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
1929,Placebo,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
1930,Placebo,36.72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
1931,Placebo,36.695,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
1932,Placebo,36.61,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
1933,Placebo,36.695,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
1934,Placebo,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
1935,Placebo,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
1936,Placebo,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
1937,Placebo,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
1938,Placebo,36.61,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
1939,Placebo,60.56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,60.6,60.6
1940,Placebo,63.095,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.1,63.1
1941,Placebo,63.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.5,63.5
1942,Placebo,62.595,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,62.6,62.6
1943,Placebo,62.82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,62.8,62.8
1944,Placebo,64.86,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64.9,64.9
1945,Placebo,63.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.5,63.5
1946,Placebo,62.645,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,62.6,62.6
1947,Placebo,63.05,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63,63
1948,Placebo,62.6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,62.6,62.6
1949,Placebo,61.24,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,61.2,61.2
1950,Xanomeline High Dose,79.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,79.5,79.5
1951,Xanomeline High Dose,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76,76
1952,Xanomeline High Dose,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76,76
1953,Xanomeline High Dose,78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78,78
1954,Xanomeline High Dose,77,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,77,77
1955,Xanomeline High Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
1956,Xanomeline High Dose,75.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.5,75.5
1957,Xanomeline High Dose,74,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74,74
1958,Xanomeline High Dose,78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78,78
1959,Xanomeline High Dose,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76,76
1960,Xanomeline High Dose,78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78,78
1961,Xanomeline High Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
1962,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
1963,Xanomeline High Dose,74,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74,74
1964,Xanomeline High Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
1965,Xanomeline High Dose,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76,76
1966,Xanomeline High Dose,79,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,79,79
1967,Xanomeline High Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
1968,Xanomeline High Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
1969,Xanomeline High Dose,74,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74,74
1970,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
1971,Xanomeline High Dose,72.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72.5,72.5
1972,Xanomeline High Dose,138,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,138,138
1973,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
1974,Xanomeline High Dose,130,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130,130
1975,Xanomeline High Dose,131,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,131,131
1976,Xanomeline High Dose,131,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,131,131
1977,Xanomeline High Dose,124,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,124,124
1978,Xanomeline High Dose,128,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,128,128
1979,Xanomeline High Dose,122.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,122.5,122.5
1980,Xanomeline High Dose,130,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130,130
1981,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
1982,Xanomeline High Dose,134,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,134,134
1983,Xanomeline High Dose,36.56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
1984,Xanomeline High Dose,36.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.8,36.8
1985,Xanomeline High Dose,36.83,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.8,36.8
1986,Xanomeline High Dose,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
1987,Xanomeline High Dose,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
1988,Xanomeline High Dose,36.725,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
1989,Xanomeline High Dose,36.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.8,36.8
1990,Xanomeline High Dose,36.83,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.8,36.8
1991,Xanomeline High Dose,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
1992,Xanomeline High Dose,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
1993,Xanomeline High Dose,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
1994,Xanomeline High Dose,69.175,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,69.2,69.2
1995,Xanomeline High Dose,68.04,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
1996,Xanomeline High Dose,70.99,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,71,71
1997,Xanomeline High Dose,70.31,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.3,70.3
1998,Xanomeline High Dose,70.53,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.5,70.5
1999,Xanomeline High Dose,68.945,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68.9,68.9
2000,Xanomeline High Dose,68.72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68.7,68.7
2001,Xanomeline High Dose,66.455,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,66.5,66.5
2002,Xanomeline High Dose,70.535,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.5,70.5
2003,Xanomeline High Dose,71.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,71.2,71.2
2004,Xanomeline High Dose,71.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,71.8,71.8
2005,Xanomeline Low Dose,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76,76
2006,Xanomeline Low Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
2007,Xanomeline Low Dose,75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75,75
2008,Xanomeline Low Dose,75.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.5,75.5
2009,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
2010,Xanomeline Low Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
2011,Xanomeline Low Dose,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76,76
2012,Xanomeline Low Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
2013,Xanomeline Low Dose,78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78,78
2014,Xanomeline Low Dose,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76,76
2015,Xanomeline Low Dose,74.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.5,74.5
2016,Xanomeline Low Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
2017,Xanomeline Low Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
2018,Xanomeline Low Dose,74,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74,74
2019,Xanomeline Low Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
2020,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
2021,Xanomeline Low Dose,69.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,69.5,69.5
2022,Xanomeline Low Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
2023,Xanomeline Low Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
2024,Xanomeline Low Dose,74,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74,74
2025,Xanomeline Low Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
2026,Xanomeline Low Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
2027,Xanomeline Low Dose,138,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,138,138
2028,Xanomeline Low Dose,130,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130,130
2029,Xanomeline Low Dose,131.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,131.5,131.5
2030,Xanomeline Low Dose,130,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130,130
2031,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
2032,Xanomeline Low Dose,128,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,128,128
2033,Xanomeline Low Dose,130,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130,130
2034,Xanomeline Low Dose,130,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130,130
2035,Xanomeline Low Dose,134,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,134,134
2036,Xanomeline Low Dose,131,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,131,131
2037,Xanomeline Low Dose,132,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,132,132
2038,Xanomeline Low Dose,36.61,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
2039,Xanomeline Low Dose,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
2040,Xanomeline Low Dose,36.695,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
2041,Xanomeline Low Dose,36.56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
2042,Xanomeline Low Dose,36.53,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.5,36.5
2043,Xanomeline Low Dose,36.64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
2044,Xanomeline Low Dose,36.75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.8,36.8
2045,Xanomeline Low Dose,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
2046,Xanomeline Low Dose,36.61,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
2047,Xanomeline Low Dose,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
2048,Xanomeline Low Dose,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
2049,Xanomeline Low Dose,64.86,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64.9,64.9
2050,Xanomeline Low Dose,65.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,65.9,65.9
2051,Xanomeline Low Dose,65.205,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,65.2,65.2
2052,Xanomeline Low Dose,66.68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,66.7,66.7
2053,Xanomeline Low Dose,65.775,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,65.8,65.8
2054,Xanomeline Low Dose,62.6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,62.6,62.6
2055,Xanomeline Low Dose,62.6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,62.6,62.6
2056,Xanomeline Low Dose,62.14,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,62.1,62.1
2057,Xanomeline Low Dose,66.565,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,66.6,66.6
2058,Xanomeline Low Dose,66.68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,66.7,66.7
2059,Xanomeline Low Dose,65.66,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,65.7,65.7
2060,Placebo,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
2061,Placebo,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
2062,Placebo,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
2063,Placebo,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
2064,Placebo,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
2065,Placebo,67.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,67.2,67.2
2066,Placebo,66,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,66,66
2067,Placebo,66.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,66.2,66.2
2068,Placebo,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
2069,Placebo,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
2070,Placebo,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
2071,Placebo,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64,64
2072,Placebo,65,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,65,65
2073,Placebo,67.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,67.5,67.5
2074,Placebo,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64,64
2075,Placebo,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64,64
2076,Placebo,66,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,66,66
2077,Placebo,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64,64
2078,Placebo,64.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64.2,64.2
2079,Placebo,66,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,66,66
2080,Placebo,66,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,66,66
2081,Placebo,66,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,66,66
2082,Placebo,124,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,124,124
2083,Placebo,120,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,120,120
2084,Placebo,123.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,123.5,123.5
2085,Placebo,120,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,120,120
2086,Placebo,120.75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,120.8,120.8
2087,Placebo,120,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,120,120
2088,Placebo,122,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,122,122
2089,Placebo,120,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,120,120
2090,Placebo,122.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,122.2,122.2
2091,Placebo,121.75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,121.8,121.8
2092,Placebo,128,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,128,128
2093,Placebo,36.39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
2094,Placebo,36.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
2095,Placebo,36.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
2096,Placebo,36.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
2097,Placebo,36.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.3,36.3
2098,Placebo,36.39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
2099,Placebo,36.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
2100,Placebo,36.4025,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
2101,Placebo,36.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.3,36.3
2102,Placebo,36.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.3,36.3
2103,Placebo,36.39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
2104,Placebo,53.635,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,53.6,53.6
2105,Placebo,53.805,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,53.8,53.8
2106,Placebo,54.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,54.9,54.9
2107,Placebo,54.565,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,54.6,54.6
2108,Placebo,54.0925,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,54.1,54.1
2109,Placebo,54.43,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,54.4,54.4
2110,Placebo,54.155,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,54.2,54.2
2111,Placebo,53.805,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,53.8,53.8
2112,Placebo,54.43,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,54.4,54.4
2113,Placebo,53.975,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,54,54
2114,Placebo,54.3175,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,54.3,54.3
2115,Xanomeline High Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
2116,Xanomeline High Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
2117,Xanomeline High Dose,69,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,69,69
2118,Xanomeline High Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
2119,Xanomeline High Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
2120,Xanomeline High Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
2121,Xanomeline High Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
2122,Xanomeline High Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
2123,Xanomeline High Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
2124,Xanomeline High Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
2125,Xanomeline High Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
2126,Xanomeline High Dose,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64,64
2127,Xanomeline High Dose,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64,64
2128,Xanomeline High Dose,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64,64
2129,Xanomeline High Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
2130,Xanomeline High Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
2131,Xanomeline High Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
2132,Xanomeline High Dose,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64,64
2133,Xanomeline High Dose,65.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,65.5,65.5
2134,Xanomeline High Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
2135,Xanomeline High Dose,66,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,66,66
2136,Xanomeline High Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
2137,Xanomeline High Dose,125.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,125.5,125.5
2138,Xanomeline High Dose,118,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,118,118
2139,Xanomeline High Dose,118.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,118.5,118.5
2140,Xanomeline High Dose,122.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,122.5,122.5
2141,Xanomeline High Dose,120.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,120.5,120.5
2142,Xanomeline High Dose,119.75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,119.8,119.8
2143,Xanomeline High Dose,120,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,120,120
2144,Xanomeline High Dose,112.75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,112.8,112.8
2145,Xanomeline High Dose,120,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,120,120
2146,Xanomeline High Dose,120,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,120,120
2147,Xanomeline High Dose,124,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,124,124
2148,Xanomeline High Dose,36.3175,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.3,36.3
2149,Xanomeline High Dose,36.39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
2150,Xanomeline High Dose,36.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.5,36.5
2151,Xanomeline High Dose,36.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.3,36.3
2152,Xanomeline High Dose,36.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.2,36.2
2153,Xanomeline High Dose,36.53,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.5,36.5
2154,Xanomeline High Dose,36.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
2155,Xanomeline High Dose,36.56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
2156,Xanomeline High Dose,36.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
2157,Xanomeline High Dose,36.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.3,36.3
2158,Xanomeline High Dose,36.39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
2159,Xanomeline High Dose,56.925,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,56.9,56.9
2160,Xanomeline High Dose,56.7,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,56.7,56.7
2161,Xanomeline High Dose,59.5375,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,59.5,59.5
2162,Xanomeline High Dose,55.34,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,55.3,55.3
2163,Xanomeline High Dose,57.61,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,57.6,57.6
2164,Xanomeline High Dose,55.2275,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,55.2,55.2
2165,Xanomeline High Dose,56.0175,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,56,56
2166,Xanomeline High Dose,55.6775,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,55.7,55.7
2167,Xanomeline High Dose,57.495,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,57.5,57.5
2168,Xanomeline High Dose,57.495,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,57.5,57.5
2169,Xanomeline High Dose,61.2375,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,61.2,61.2
2170,Xanomeline Low Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
2171,Xanomeline Low Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
2172,Xanomeline Low Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
2173,Xanomeline Low Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
2174,Xanomeline Low Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
2175,Xanomeline Low Dose,68.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68.2,68.2
2176,Xanomeline Low Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
2177,Xanomeline Low Dose,65,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,65,65
2178,Xanomeline Low Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
2179,Xanomeline Low Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
2180,Xanomeline Low Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
2181,Xanomeline Low Dose,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64,64
2182,Xanomeline Low Dose,63.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.5,63.5
2183,Xanomeline Low Dose,65.75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,65.8,65.8
2184,Xanomeline Low Dose,62,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,62,62
2185,Xanomeline Low Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
2186,Xanomeline Low Dose,63.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.2,63.2
2187,Xanomeline Low Dose,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64,64
2188,Xanomeline Low Dose,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64,64
2189,Xanomeline Low Dose,65.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,65.5,65.5
2190,Xanomeline Low Dose,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64,64
2191,Xanomeline Low Dose,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64,64
2192,Xanomeline Low Dose,122,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,122,122
2193,Xanomeline Low Dose,120,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,120,120
2194,Xanomeline Low Dose,120,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,120,120
2195,Xanomeline Low Dose,124,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,124,124
2196,Xanomeline Low Dose,122,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,122,122
2197,Xanomeline Low Dose,118,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,118,118
2198,Xanomeline Low Dose,122,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,122,122
2199,Xanomeline Low Dose,115.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,115.5,115.5
2200,Xanomeline Low Dose,122,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,122,122
2201,Xanomeline Low Dose,122,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,122,122
2202,Xanomeline Low Dose,126,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,126,126
2203,Xanomeline Low Dose,36.36,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
2204,Xanomeline Low Dose,36.39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
2205,Xanomeline Low Dose,36.39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
2206,Xanomeline Low Dose,36.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.3,36.3
2207,Xanomeline Low Dose,36.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.2,36.2
2208,Xanomeline Low Dose,36.345,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.3,36.3
2209,Xanomeline Low Dose,36.4175,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
2210,Xanomeline Low Dose,36.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.5,36.5
2211,Xanomeline Low Dose,36.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.2,36.2
2212,Xanomeline Low Dose,36.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.3,36.3
2213,Xanomeline Low Dose,36.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.2,36.2
2214,Xanomeline Low Dose,56.02,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,56,56
2215,Xanomeline Low Dose,55.5125,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,55.5,55.5
2216,Xanomeline Low Dose,56.0225,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,56,56
2217,Xanomeline Low Dose,56.8125,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,56.8,56.8
2218,Xanomeline Low Dose,55.79,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,55.8,55.8
2219,Xanomeline Low Dose,57.04,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,57,57
2220,Xanomeline Low Dose,56.815,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,56.8,56.8
2221,Xanomeline Low Dose,56.93,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,56.9,56.9
2222,Xanomeline Low Dose,55.5125,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,55.5,55.5
2223,Xanomeline Low Dose,54.66,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,54.7,54.7
2224,Xanomeline Low Dose,55.34,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,55.3,55.3
2225,Placebo,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,84,84
2226,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2227,Placebo,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,82,82
2228,Placebo,82.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,82.2,82.2
2229,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2230,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2231,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2232,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2233,Placebo,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,82,82
2234,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2235,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2236,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2237,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2238,Placebo,82.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,82.5,82.5
2239,Placebo,78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78,78
2240,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2241,Placebo,78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78,78
2242,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2243,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2244,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2245,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2246,Placebo,78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78,78
2247,Placebo,150,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,150,150
2248,Placebo,145,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,145,145
2249,Placebo,140,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,140,140
2250,Placebo,150,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,150,150
2251,Placebo,146.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,146.2,146.2
2252,Placebo,144,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,144,144
2253,Placebo,144,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,144,144
2254,Placebo,144,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,144,144
2255,Placebo,146,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,146,146
2256,Placebo,145,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,145,145
2257,Placebo,146,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,146,146
2258,Placebo,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2259,Placebo,36.94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2260,Placebo,36.94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2261,Placebo,36.94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2262,Placebo,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2263,Placebo,36.94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2264,Placebo,36.94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2265,Placebo,37,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,37,37
2266,Placebo,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2267,Placebo,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2268,Placebo,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2269,Placebo,74.1625,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.2,74.2
2270,Placebo,74.1625,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.2,74.2
2271,Placebo,75.3,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.3,75.3
2272,Placebo,75.4125,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.4,75.4
2273,Placebo,75.0725,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.1,75.1
2274,Placebo,74.7275,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.7,74.7
2275,Placebo,74.845,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.8,74.8
2276,Placebo,74.1625,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.2,74.2
2277,Placebo,74.7275,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.7,74.7
2278,Placebo,74.39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.4,74.4
2279,Placebo,74.0525,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.1,74.1
2280,Xanomeline High Dose,86,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,86,86
2281,Xanomeline High Dose,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,82,82
2282,Xanomeline High Dose,81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,81,81
2283,Xanomeline High Dose,81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,81,81
2284,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,84,84
2285,Xanomeline High Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2286,Xanomeline High Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2287,Xanomeline High Dose,80.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80.5,80.5
2288,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,84,84
2289,Xanomeline High Dose,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,82,82
2290,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,84,84
2291,Xanomeline High Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2292,Xanomeline High Dose,76.75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76.8,76.8
2293,Xanomeline High Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2294,Xanomeline High Dose,80.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80.5,80.5
2295,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,84,84
2296,Xanomeline High Dose,86,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,86,86
2297,Xanomeline High Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2298,Xanomeline High Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2299,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,84,84
2300,Xanomeline High Dose,80.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80.5,80.5
2301,Xanomeline High Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2302,Xanomeline High Dose,150,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,150,150
2303,Xanomeline High Dose,138,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,138,138
2304,Xanomeline High Dose,140,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,140,140
2305,Xanomeline High Dose,142,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,142,142
2306,Xanomeline High Dose,142,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,142,142
2307,Xanomeline High Dose,132,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,132,132
2308,Xanomeline High Dose,140,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,140,140
2309,Xanomeline High Dose,130.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130.2,130.2
2310,Xanomeline High Dose,142,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,142,142
2311,Xanomeline High Dose,138.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,138.5,138.5
2312,Xanomeline High Dose,144.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,144.2,144.2
2313,Xanomeline High Dose,36.94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2314,Xanomeline High Dose,36.94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2315,Xanomeline High Dose,36.94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2316,Xanomeline High Dose,36.94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2317,Xanomeline High Dose,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2318,Xanomeline High Dose,37,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,37,37
2319,Xanomeline High Dose,37,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,37,37
2320,Xanomeline High Dose,37,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,37,37
2321,Xanomeline High Dose,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2322,Xanomeline High Dose,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2323,Xanomeline High Dose,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2324,Xanomeline High Dose,80.29,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80.3,80.3
2325,Xanomeline High Dose,79.945,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,79.9,79.9
2326,Xanomeline High Dose,81.6475,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,81.6,81.6
2327,Xanomeline High Dose,81.65,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,81.7,81.7
2328,Xanomeline High Dose,79.38,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,79.4,79.4
2329,Xanomeline High Dose,81.8725,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,81.9,81.9
2330,Xanomeline High Dose,82.8975,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,82.9,82.9
2331,Xanomeline High Dose,81.99,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,82,82
2332,Xanomeline High Dose,80.5725,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80.6,80.6
2333,Xanomeline High Dose,80.285,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80.3,80.3
2334,Xanomeline High Dose,80.9075,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80.9,80.9
2335,Xanomeline Low Dose,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,82,82
2336,Xanomeline Low Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2337,Xanomeline Low Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,84,84
2338,Xanomeline Low Dose,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,82,82
2339,Xanomeline Low Dose,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,82,82
2340,Xanomeline Low Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2341,Xanomeline Low Dose,83,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,83,83
2342,Xanomeline Low Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2343,Xanomeline Low Dose,81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,81,81
2344,Xanomeline Low Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2345,Xanomeline Low Dose,82.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,82.5,82.5
2346,Xanomeline Low Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2347,Xanomeline Low Dose,78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78,78
2348,Xanomeline Low Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2349,Xanomeline Low Dose,74.75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.8,74.8
2350,Xanomeline Low Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2351,Xanomeline Low Dose,75.75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.8,75.8
2352,Xanomeline Low Dose,77,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,77,77
2353,Xanomeline Low Dose,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76,76
2354,Xanomeline Low Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2355,Xanomeline Low Dose,78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78,78
2356,Xanomeline Low Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
2357,Xanomeline Low Dose,150,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,150,150
2358,Xanomeline Low Dose,144,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,144,144
2359,Xanomeline Low Dose,144.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,144.5,144.5
2360,Xanomeline Low Dose,140,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,140,140
2361,Xanomeline Low Dose,146,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,146,146
2362,Xanomeline Low Dose,140,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,140,140
2363,Xanomeline Low Dose,140,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,140,140
2364,Xanomeline Low Dose,140,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,140,140
2365,Xanomeline Low Dose,147.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,147.2,147.2
2366,Xanomeline Low Dose,146,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,146,146
2367,Xanomeline Low Dose,144.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,144.2,144.2
2368,Xanomeline Low Dose,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2369,Xanomeline Low Dose,36.9025,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2370,Xanomeline Low Dose,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2371,Xanomeline Low Dose,36.94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2372,Xanomeline Low Dose,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2373,Xanomeline Low Dose,37,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,37,37
2374,Xanomeline Low Dose,36.94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2375,Xanomeline Low Dose,36.9025,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2376,Xanomeline Low Dose,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2377,Xanomeline Low Dose,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2378,Xanomeline Low Dose,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
2379,Xanomeline Low Dose,77.45,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,77.4,77.4
2380,Xanomeline Low Dose,78.1325,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78.1,78.1
2381,Xanomeline Low Dose,78.1325,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78.1,78.1
2382,Xanomeline Low Dose,78.1875,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78.2,78.2
2383,Xanomeline Low Dose,77.795,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,77.8,77.8
2384,Xanomeline Low Dose,77.565,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,77.6,77.6
2385,Xanomeline Low Dose,75.07,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.1,75.1
2386,Xanomeline Low Dose,73.48,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.5,73.5
2387,Xanomeline Low Dose,78.47,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78.5,78.5
2388,Xanomeline Low Dose,78.47,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78.5,78.5
2389,Xanomeline Low Dose,78.1325,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78.1,78.1
2390,Placebo,40,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,40,40
2391,Placebo,39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,39,39
2392,Placebo,49,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,49,49
2393,Placebo,49,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,49,49
2394,Placebo,45,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,45,45
2395,Placebo,48,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,48,48
2396,Placebo,44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,44,44
2397,Placebo,39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,39,39
2398,Placebo,39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,39,39
2399,Placebo,48,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,48,48
2400,Placebo,49,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,49,49
2401,Placebo,51,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,51,51
2402,Placebo,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
2403,Placebo,51,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,51,51
2404,Placebo,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
2405,Placebo,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
2406,Placebo,53,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,53,53
2407,Placebo,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
2408,Placebo,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
2409,Placebo,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
2410,Placebo,53,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,53,53
2411,Placebo,52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,52,52
2412,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,80,80
2413,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,80,80
2414,Placebo,78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,78,78
2415,Placebo,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,76,76
2416,Placebo,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,90,90
2417,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,80,80
2418,Placebo,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,90,90
2419,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,80,80
2420,Placebo,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,84,84
2421,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,80,80
2422,Placebo,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,90,90
2423,Placebo,35.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
2424,Placebo,35.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
2425,Placebo,35,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
2426,Placebo,35.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,36,36
2427,Placebo,35.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
2428,Placebo,35.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
2429,Placebo,34.72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
2430,Placebo,35.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
2431,Placebo,34.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,34,34
2432,Placebo,35.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
2433,Placebo,35.61,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,36,36
2434,Placebo,34.02,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,34,34
2435,Placebo,34.47,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,34,34
2436,Placebo,34.02,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,34,34
2437,Placebo,33.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,33,33
2438,Placebo,33.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,33,33
2439,Placebo,33.57,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,34,34
2440,Placebo,34.02,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,34,34
2441,Placebo,34.47,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,34,34
2442,Placebo,34.47,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,34,34
2443,Placebo,34.47,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,34,34
2444,Placebo,34.47,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,34,34
2445,Xanomeline High Dose,51,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,51,51
2446,Xanomeline High Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
2447,Xanomeline High Dose,54,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,54,54
2448,Xanomeline High Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
2449,Xanomeline High Dose,43,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,43,43
2450,Xanomeline High Dose,54,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,54,54
2451,Xanomeline High Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
2452,Xanomeline High Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
2453,Xanomeline High Dose,54,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,54,54
2454,Xanomeline High Dose,52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,52,52
2455,Xanomeline High Dose,54,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,54,54
2456,Xanomeline High Dose,52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,52,52
2457,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
2458,Xanomeline High Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
2459,Xanomeline High Dose,51,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,51,51
2460,Xanomeline High Dose,54,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,54,54
2461,Xanomeline High Dose,52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,52,52
2462,Xanomeline High Dose,47,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,47,47
2463,Xanomeline High Dose,53,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,53,53
2464,Xanomeline High Dose,48,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,48,48
2465,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
2466,Xanomeline High Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
2467,Xanomeline High Dose,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
2468,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
2469,Xanomeline High Dose,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
2470,Xanomeline High Dose,99,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,99,99
2471,Xanomeline High Dose,88,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,88,88
2472,Xanomeline High Dose,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
2473,Xanomeline High Dose,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,90,90
2474,Xanomeline High Dose,95,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,95,95
2475,Xanomeline High Dose,95,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,95,95
2476,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
2477,Xanomeline High Dose,91,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,91,91
2478,Xanomeline High Dose,35.61,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,36,36
2479,Xanomeline High Dose,35.72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,36,36
2480,Xanomeline High Dose,35.56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,36,36
2481,Xanomeline High Dose,35.56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,36,36
2482,Xanomeline High Dose,35.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
2483,Xanomeline High Dose,35.06,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
2484,Xanomeline High Dose,35.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,36,36
2485,Xanomeline High Dose,36.39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,36,36
2486,Xanomeline High Dose,35.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
2487,Xanomeline High Dose,35.61,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,36,36
2488,Xanomeline High Dose,35.61,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,36,36
2489,Xanomeline High Dose,41.73,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,42,42
2490,Xanomeline High Dose,42.18,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,42,42
2491,Xanomeline High Dose,48.08,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,48,48
2492,Xanomeline High Dose,48.54,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,49,49
2493,Xanomeline High Dose,42.64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,43,43
2494,Xanomeline High Dose,50.8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,51,51
2495,Xanomeline High Dose,49.9,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
2496,Xanomeline High Dose,49.9,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
2497,Xanomeline High Dose,42.18,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,42,42
2498,Xanomeline High Dose,47.17,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,47,47
2499,Xanomeline High Dose,48.08,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,48,48
2500,Xanomeline Low Dose,48,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,48,48
2501,Xanomeline Low Dose,51,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,51,51
2502,Xanomeline Low Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
2503,Xanomeline Low Dose,55,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,55,55
2504,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
2505,Xanomeline Low Dose,51,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,51,51
2506,Xanomeline Low Dose,57,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,57,57
2507,Xanomeline Low Dose,56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,56,56
2508,Xanomeline Low Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
2509,Xanomeline Low Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
2510,Xanomeline Low Dose,52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,52,52
2511,Xanomeline Low Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
2512,Xanomeline Low Dose,48,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,48,48
2513,Xanomeline Low Dose,48,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,48,48
2514,Xanomeline Low Dose,48,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,48,48
2515,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
2516,Xanomeline Low Dose,40,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,40,40
2517,Xanomeline Low Dose,52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,52,52
2518,Xanomeline Low Dose,53,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,53,53
2519,Xanomeline Low Dose,48,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,48,48
2520,Xanomeline Low Dose,52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,52,52
2521,Xanomeline Low Dose,49,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,49,49
2522,Xanomeline Low Dose,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
2523,Xanomeline Low Dose,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
2524,Xanomeline Low Dose,92,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,92,92
2525,Xanomeline Low Dose,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
2526,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
2527,Xanomeline Low Dose,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
2528,Xanomeline Low Dose,92,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,92,92
2529,Xanomeline Low Dose,99,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,99,99
2530,Xanomeline Low Dose,95,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,95,95
2531,Xanomeline Low Dose,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
2532,Xanomeline Low Dose,92,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,92,92
2533,Xanomeline Low Dose,35.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
2534,Xanomeline Low Dose,35.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
2535,Xanomeline Low Dose,35.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
2536,Xanomeline Low Dose,35.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,36,36
2537,Xanomeline Low Dose,35.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
2538,Xanomeline Low Dose,35.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
2539,Xanomeline Low Dose,35.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,36,36
2540,Xanomeline Low Dose,35.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
2541,Xanomeline Low Dose,34.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,34,34
2542,Xanomeline Low Dose,35.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
2543,Xanomeline Low Dose,35.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,36,36
2544,Xanomeline Low Dose,45.36,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,45,45
2545,Xanomeline Low Dose,41.73,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,42,42
2546,Xanomeline Low Dose,44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,44,44
2547,Xanomeline Low Dose,44.23,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,44,44
2548,Xanomeline Low Dose,44.91,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,45,45
2549,Xanomeline Low Dose,41.73,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,42,42
2550,Xanomeline Low Dose,45.54,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,46,46
2551,Xanomeline Low Dose,47.17,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,47,47
2552,Xanomeline Low Dose,44.45,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,44,44
2553,Xanomeline Low Dose,44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,44,44
2554,Xanomeline Low Dose,43.09,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,43,43
2555,Placebo,110,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,110,110
2556,Placebo,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
2557,Placebo,104,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,104,104
2558,Placebo,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
2559,Placebo,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
2560,Placebo,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
2561,Placebo,117,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,117,117
2562,Placebo,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
2563,Placebo,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
2564,Placebo,110,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,110,110
2565,Placebo,101,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,101,101
2566,Placebo,134,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,134,134
2567,Placebo,108,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,108,108
2568,Placebo,106,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,106,106
2569,Placebo,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,90,90
2570,Placebo,106,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,106,106
2571,Placebo,96,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,96,96
2572,Placebo,92,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,92,92
2573,Placebo,108,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,108,108
2574,Placebo,120,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,120,120
2575,Placebo,108,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,108,108
2576,Placebo,102,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,102,102
2577,Placebo,184,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,184,184
2578,Placebo,180,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,180,180
2579,Placebo,168,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,168,168
2580,Placebo,190,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,190,190
2581,Placebo,173,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,173,173
2582,Placebo,200,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,200,200
2583,Placebo,199,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,199,199
2584,Placebo,176,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,176,176
2585,Placebo,202,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,202,202
2586,Placebo,210,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,210,210
2587,Placebo,189,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,189,189
2588,Placebo,37.17,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
2589,Placebo,37.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,38,38
2590,Placebo,37.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
2591,Placebo,37.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
2592,Placebo,37.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,38,38
2593,Placebo,37.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,38,38
2594,Placebo,37.56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,38,38
2595,Placebo,37.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,38,38
2596,Placebo,37.56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,38,38
2597,Placebo,37.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,38,38
2598,Placebo,37.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
2599,Placebo,86.18,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,86,86
2600,Placebo,87.09,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,87,87
2601,Placebo,84.37,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,84,84
2602,Placebo,85.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,85,85
2603,Placebo,88,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,88,88
2604,Placebo,86.18,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,86,86
2605,Placebo,86.64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,87,87
2606,Placebo,87.09,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,87,87
2607,Placebo,84.37,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,84,84
2608,Placebo,84.82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,85,85
2609,Placebo,84.37,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,84,84
2610,Xanomeline High Dose,108,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,108,108
2611,Xanomeline High Dose,99,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,99,99
2612,Xanomeline High Dose,92,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,92,92
2613,Xanomeline High Dose,92,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,92,92
2614,Xanomeline High Dose,118,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,118,118
2615,Xanomeline High Dose,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
2616,Xanomeline High Dose,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
2617,Xanomeline High Dose,93,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,93,93
2618,Xanomeline High Dose,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
2619,Xanomeline High Dose,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
2620,Xanomeline High Dose,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
2621,Xanomeline High Dose,104,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,104,104
2622,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
2623,Xanomeline High Dose,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
2624,Xanomeline High Dose,96,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,96,96
2625,Xanomeline High Dose,106,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,106,106
2626,Xanomeline High Dose,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
2627,Xanomeline High Dose,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
2628,Xanomeline High Dose,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
2629,Xanomeline High Dose,114,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,114,114
2630,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
2631,Xanomeline High Dose,104,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,104,104
2632,Xanomeline High Dose,194,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,194,194
2633,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
2634,Xanomeline High Dose,177,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,177,177
2635,Xanomeline High Dose,186,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,186,186
2636,Xanomeline High Dose,191,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,191,191
2637,Xanomeline High Dose,185,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,185,185
2638,Xanomeline High Dose,198,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,198,198
2639,Xanomeline High Dose,179,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,179,179
2640,Xanomeline High Dose,181,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,181,181
2641,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
2642,Xanomeline High Dose,198,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,198,198
2643,Xanomeline High Dose,37.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
2644,Xanomeline High Dose,37.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
2645,Xanomeline High Dose,37.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
2646,Xanomeline High Dose,37.17,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
2647,Xanomeline High Dose,37.39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
2648,Xanomeline High Dose,38.06,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,38,38
2649,Xanomeline High Dose,37.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,38,38
2650,Xanomeline High Dose,37.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
2651,Xanomeline High Dose,37.39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
2652,Xanomeline High Dose,37.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
2653,Xanomeline High Dose,37.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
2654,Xanomeline High Dose,107.96,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,108,108
2655,Xanomeline High Dose,105.24,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,105,105
2656,Xanomeline High Dose,105.24,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,105,105
2657,Xanomeline High Dose,105.24,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,105,105
2658,Xanomeline High Dose,106.6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,107,107
2659,Xanomeline High Dose,105.69,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,106,106
2660,Xanomeline High Dose,105.69,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,106,106
2661,Xanomeline High Dose,105.24,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,105,105
2662,Xanomeline High Dose,105.69,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,106,106
2663,Xanomeline High Dose,104.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,105,105
2664,Xanomeline High Dose,103.42,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,103,103
2665,Xanomeline Low Dose,108,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,108,108
2666,Xanomeline Low Dose,102,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,102,102
2667,Xanomeline Low Dose,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
2668,Xanomeline Low Dose,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
2669,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
2670,Xanomeline Low Dose,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
2671,Xanomeline Low Dose,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
2672,Xanomeline Low Dose,92,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,92,92
2673,Xanomeline Low Dose,102,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,102,102
2674,Xanomeline Low Dose,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
2675,Xanomeline Low Dose,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
2676,Xanomeline Low Dose,104,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,104,104
2677,Xanomeline Low Dose,104,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,104,104
2678,Xanomeline Low Dose,94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,94,94
2679,Xanomeline Low Dose,104,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,104,104
2680,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
2681,Xanomeline Low Dose,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
2682,Xanomeline Low Dose,96,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,96,96
2683,Xanomeline Low Dose,92,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,92,92
2684,Xanomeline Low Dose,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
2685,Xanomeline Low Dose,96,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,96,96
2686,Xanomeline Low Dose,104,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,104,104
2687,Xanomeline Low Dose,186,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,186,186
2688,Xanomeline Low Dose,200,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,200,200
2689,Xanomeline Low Dose,170,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,170,170
2690,Xanomeline Low Dose,168,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,168,168
2691,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
2692,Xanomeline Low Dose,162,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,162,162
2693,Xanomeline Low Dose,173,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,173,173
2694,Xanomeline Low Dose,173,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,173,173
2695,Xanomeline Low Dose,180,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,180,180
2696,Xanomeline Low Dose,200,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,200,200
2697,Xanomeline Low Dose,200,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,200,200
2698,Xanomeline Low Dose,37.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
2699,Xanomeline Low Dose,37.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
2700,Xanomeline Low Dose,38.06,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,38,38
2701,Xanomeline Low Dose,37.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
2702,Xanomeline Low Dose,37.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,38,38
2703,Xanomeline Low Dose,37.56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,38,38
2704,Xanomeline Low Dose,37.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
2705,Xanomeline Low Dose,37.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
2706,Xanomeline Low Dose,37.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
2707,Xanomeline Low Dose,37.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
2708,Xanomeline Low Dose,37.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
2709,Xanomeline Low Dose,106.14,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,106,106
2710,Xanomeline Low Dose,104.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,105,105
2711,Xanomeline Low Dose,105.69,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,106,106
2712,Xanomeline Low Dose,106.6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,107,107
2713,Xanomeline Low Dose,104.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,105,105
2714,Xanomeline Low Dose,106.6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,107,107
2715,Xanomeline Low Dose,106.14,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,106,106
2716,Xanomeline Low Dose,104.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,105,105
2717,Xanomeline Low Dose,105.69,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,106,106
2718,Xanomeline Low Dose,106.14,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,106,106
2719,Xanomeline Low Dose,106.14,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,106,106
2720,Placebo,255,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,255,255
2721,Placebo,246,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,246,246
2722,Placebo,207,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,207,207
2723,Placebo,204,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,204,204
2724,Placebo,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,252,252
2725,Placebo,198,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,198,198
2726,Placebo,177,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,177,177
2727,Placebo,174,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,174,174
2728,Placebo,246,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,246,246
2729,Placebo,228,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,228,228
2730,Placebo,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,219,219
2731,Placebo,255,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,255,255
2732,Placebo,246,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,246,246
2733,Placebo,207,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,207,207
2734,Placebo,204,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,204,204
2735,Placebo,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,252,252
2736,Placebo,198,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,198,198
2737,Placebo,177,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,177,177
2738,Placebo,174,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,174,174
2739,Placebo,246,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,246,246
2740,Placebo,228,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,228,228
2741,Placebo,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,219,219
2742,Placebo,255,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,255,255
2743,Placebo,246,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,246,246
2744,Placebo,207,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,207,207
2745,Placebo,204,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,204,204
2746,Placebo,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,252,252
2747,Placebo,198,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,198,198
2748,Placebo,177,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,177,177
2749,Placebo,174,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,174,174
2750,Placebo,246,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,246,246
2751,Placebo,228,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,228,228
2752,Placebo,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,219,219
2753,Placebo,86,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,86,86
2754,Placebo,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,82,82
2755,Placebo,69,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,69,69
2756,Placebo,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,68,68
2757,Placebo,83,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,83,83
2758,Placebo,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,64,64
2759,Placebo,57,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,57,57
2760,Placebo,58,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,58,58
2761,Placebo,81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,81,81
2762,Placebo,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,76,76
2763,Placebo,73,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,73,73
2764,Placebo,86,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,86,86
2765,Placebo,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,82,82
2766,Placebo,69,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,69,69
2767,Placebo,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,68,68
2768,Placebo,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,82,82
2769,Placebo,66,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,66,66
2770,Placebo,59,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,59,59
2771,Placebo,58,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,58,58
2772,Placebo,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,82,82
2773,Placebo,75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,75,75
2774,Placebo,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,72,72
2775,Xanomeline High Dose,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,252,252
2776,Xanomeline High Dose,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,219,219
2777,Xanomeline High Dose,150,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,150,150
2778,Xanomeline High Dose,111,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,111,111
2779,Xanomeline High Dose,243,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,243,243
2780,Xanomeline High Dose,96,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,96,96
2781,Xanomeline High Dose,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,90,90
2782,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,84,84
2783,Xanomeline High Dose,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,219,219
2784,Xanomeline High Dose,203,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,203,203
2785,Xanomeline High Dose,168,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,168,168
2786,Xanomeline High Dose,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,252,252
2787,Xanomeline High Dose,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,219,219
2788,Xanomeline High Dose,150,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,150,150
2789,Xanomeline High Dose,111,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,111,111
2790,Xanomeline High Dose,243,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,243,243
2791,Xanomeline High Dose,96,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,96,96
2792,Xanomeline High Dose,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,90,90
2793,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,84,84
2794,Xanomeline High Dose,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,219,219
2795,Xanomeline High Dose,204,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,204,204
2796,Xanomeline High Dose,168,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,168,168
2797,Xanomeline High Dose,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,252,252
2798,Xanomeline High Dose,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,219,219
2799,Xanomeline High Dose,150,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,150,150
2800,Xanomeline High Dose,111,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,111,111
2801,Xanomeline High Dose,243,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,243,243
2802,Xanomeline High Dose,96,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,96,96
2803,Xanomeline High Dose,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,90,90
2804,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,84,84
2805,Xanomeline High Dose,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,219,219
2806,Xanomeline High Dose,204,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,204,204
2807,Xanomeline High Dose,168,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,168,168
2808,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,84,84
2809,Xanomeline High Dose,73,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,73,73
2810,Xanomeline High Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,50,50
2811,Xanomeline High Dose,37,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,37,37
2812,Xanomeline High Dose,81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,81,81
2813,Xanomeline High Dose,32,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,32,32
2814,Xanomeline High Dose,29,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,29,29
2815,Xanomeline High Dose,28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,28,28
2816,Xanomeline High Dose,73,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,73,73
2817,Xanomeline High Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,68,68
2818,Xanomeline High Dose,56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,56,56
2819,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,84,84
2820,Xanomeline High Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,72,72
2821,Xanomeline High Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,50,50
2822,Xanomeline High Dose,37,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,37,37
2823,Xanomeline High Dose,81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,81,81
2824,Xanomeline High Dose,32,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,32,32
2825,Xanomeline High Dose,30,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,30,30
2826,Xanomeline High Dose,28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,28,28
2827,Xanomeline High Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,72,72
2828,Xanomeline High Dose,67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,67,67
2829,Xanomeline High Dose,56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1a,n,XX,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,56,56
2830,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
2831,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2832,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2833,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2834,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2835,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2836,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2837,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2838,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2839,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2840,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2841,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
2842,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2843,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2844,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2845,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2846,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2847,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2848,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2849,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2850,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2851,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2852,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
2853,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2854,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2855,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2856,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2857,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2858,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2859,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2860,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2861,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2862,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2863,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
2864,Placebo,0.082317073,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
2865,Placebo,0.098115942,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
2866,Placebo,0.118088235,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
2867,Placebo,-0.025542169,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
2868,Placebo,0.06390625,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
2869,Placebo,0.077192982,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
2870,Placebo,0.132931034,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
2871,Placebo,0.013580247,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
2872,Placebo,0.0375,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
2873,Placebo,0.033424658,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
2874,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
2875,Placebo,0.038292683,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
2876,Placebo,0.524637681,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.5,0.5
2877,Placebo,0.359558824,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.4,0.4
2878,Placebo,0.09195122,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
2879,Placebo,0.133333333,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
2880,Placebo,0.147118644,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
2881,Placebo,-0.093275862,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.1,-0.1
2882,Placebo,0.237195122,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.2,0.2
2883,Placebo,0.2468,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.2,0.2
2884,Placebo,0.228055556,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.2,0.2
2885,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
2886,Xanomeline High Dose,-3.136986301,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-3.1,-3.1
2887,Xanomeline High Dose,-4.073333333,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-4.1,-4.1
2888,Xanomeline High Dose,-2.009009009,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-2,-2
2889,Xanomeline High Dose,-1.732510288,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-1.7,-1.7
2890,Xanomeline High Dose,-2.947916667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-2.9,-2.9
2891,Xanomeline High Dose,-2.2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-2.2,-2.2
2892,Xanomeline High Dose,-3.035714286,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-3,-3
2893,Xanomeline High Dose,-1.479452055,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-1.5,-1.5
2894,Xanomeline High Dose,-3.305418719,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-3.3,-3.3
2895,Xanomeline High Dose,-1.261904762,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-1.3,-1.3
2896,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
2897,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2898,Xanomeline High Dose,0.693333333,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.7,0.7
2899,Xanomeline High Dose,0.585585586,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.6,0.6
2900,Xanomeline High Dose,3.378600823,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,3.4,3.4
2901,Xanomeline High Dose,3.385416667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,3.4,3.4
2902,Xanomeline High Dose,-2.155555556,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-2.2,-2.2
2903,Xanomeline High Dose,-1.297619048,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-1.3,-1.3
2904,Xanomeline High Dose,3.360730594,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,3.4,3.4
2905,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2906,Xanomeline High Dose,1.553571429,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1.6,1.6
2907,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
2908,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2909,Xanomeline High Dose,-8.42,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8.4,-8.4
2910,Xanomeline High Dose,-4.900900901,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-4.9,-4.9
2911,Xanomeline High Dose,-6.119341564,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-6.1,-6.1
2912,Xanomeline High Dose,-10.20833333,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10.2,-10.2
2913,Xanomeline High Dose,-6.966666667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-7,-7
2914,Xanomeline High Dose,-14.44047619,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-14.4,-14.4
2915,Xanomeline High Dose,-6.251141553,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-6.3,-6.3
2916,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
2917,Xanomeline High Dose,-3.642857143,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-3.6,-3.6
2918,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
2919,Xanomeline High Dose,0.040958904,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
2920,Xanomeline High Dose,0.0496,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
2921,Xanomeline High Dose,-0.047837838,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
2922,Xanomeline High Dose,0.00962963,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
2923,Xanomeline High Dose,0.0446875,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
2924,Xanomeline High Dose,0.013793103,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
2925,Xanomeline High Dose,0.042857143,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
2926,Xanomeline High Dose,0.046712329,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
2927,Xanomeline High Dose,-0.012647059,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
2928,Xanomeline High Dose,0.021428571,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
2929,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
2930,Xanomeline High Dose,0.059027778,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
2931,Xanomeline High Dose,0.6378,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.6,0.6
2932,Xanomeline High Dose,0.830810811,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.8,0.8
2933,Xanomeline High Dose,0.534814815,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.5,0.5
2934,Xanomeline High Dose,1.0128125,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1,1
2935,Xanomeline High Dose,0.995,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1,1
2936,Xanomeline High Dose,0.672857143,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.7,0.7
2937,Xanomeline High Dose,0.842777778,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.8,0.8
2938,Xanomeline High Dose,0.718208955,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.7,0.7
2939,Xanomeline High Dose,0.804642857,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1a,Mean,XX.X,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.8,0.8
2940,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0,0
2941,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2942,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2943,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2944,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2945,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2946,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2947,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2948,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2949,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2950,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2951,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0,0
2952,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2953,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2954,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2955,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2956,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2957,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2958,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2959,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2960,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2961,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2962,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0,0
2963,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2964,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2965,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2966,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2967,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2968,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2969,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2970,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2971,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2972,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
2973,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0,0
2974,Placebo,0.363987853,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.36,-0.36
2975,Placebo,0.371706222,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.37,-0.37
2976,Placebo,0.46604483,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.47,-0.47
2977,Placebo,0.416126895,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.42,-0.42
2978,Placebo,0.466124233,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.47,-0.47
2979,Placebo,0.548337599,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.55,-0.55
2980,Placebo,0.379006127,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.38,-0.38
2981,Placebo,0.435928058,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.44,-0.44
2982,Placebo,0.402793992,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.4,-0.4
2983,Placebo,0.361966923,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.36,-0.36
2984,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0,0
2985,Placebo,1.893126492,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,1.89,-1.89
2986,Placebo,2.291145732,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,2.29,-2.29
2987,Placebo,2.336051289,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,2.34,-2.34
2988,Placebo,0.9609466,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.96,-0.96
2989,Placebo,2.163752676,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,2.16,-2.16
2990,Placebo,2.296938781,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,2.3,-2.3
2991,Placebo,2.080578857,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,2.08,-2.08
2992,Placebo,1.14197714,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,1.14,-1.14
2993,Placebo,1.569569712,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,1.57,-1.57
2994,Placebo,1.583318532,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,1.58,-1.58
2995,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0,0
2996,Xanomeline High Dose,10.50423471,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,10.5,-10.5
2997,Xanomeline High Dose,10.9078487,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,10.91,-10.91
2998,Xanomeline High Dose,10.87323277,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,10.87,-10.87
2999,Xanomeline High Dose,10.86727082,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,10.87,-10.87
3000,Xanomeline High Dose,11.0371333,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,11.04,-11.04
3001,Xanomeline High Dose,9.851937584,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,9.85,-9.85
3002,Xanomeline High Dose,9.826747895,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,9.83,-9.83
3003,Xanomeline High Dose,11.05670487,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,11.06,-11.06
3004,Xanomeline High Dose,10.07964915,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,10.08,-10.08
3005,Xanomeline High Dose,9.666435599,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,9.67,-9.67
3006,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0,0
3007,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
3008,Xanomeline High Dose,9.771858421,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,9.77,-9.77
3009,Xanomeline High Dose,12.02910748,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,12.03,-12.03
3010,Xanomeline High Dose,9.045150457,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,9.05,-9.05
3011,Xanomeline High Dose,10.522527,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,10.52,-10.52
3012,Xanomeline High Dose,11.8178223,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,11.82,-11.82
3013,Xanomeline High Dose,10.77902891,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,10.78,-10.78
3014,Xanomeline High Dose,10.32821518,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,10.33,-10.33
3015,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
3016,Xanomeline High Dose,8.781280395,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,8.78,-8.78
3017,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0,0
3018,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
3019,Xanomeline High Dose,15.34273761,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,15.34,-15.34
3020,Xanomeline High Dose,17.01227095,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,17.01,-17.01
3021,Xanomeline High Dose,15.56797134,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,15.57,-15.57
3022,Xanomeline High Dose,18.32853207,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,18.33,-18.33
3023,Xanomeline High Dose,17.7469415,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,17.75,-17.75
3024,Xanomeline High Dose,20.05675753,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,20.06,-20.06
3025,Xanomeline High Dose,15.96256906,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,15.96,-15.96
3026,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
3027,Xanomeline High Dose,15.92846498,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,15.93,-15.93
3028,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0,0
3029,Xanomeline High Dose,0.398915768,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.4,-0.4
3030,Xanomeline High Dose,0.344809678,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.34,-0.34
3031,Xanomeline High Dose,0.379986368,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.38,-0.38
3032,Xanomeline High Dose,0.405516475,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.41,-0.41
3033,Xanomeline High Dose,0.421311197,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.42,-0.42
3034,Xanomeline High Dose,0.499009117,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.5,-0.5
3035,Xanomeline High Dose,0.376709507,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.38,-0.38
3036,Xanomeline High Dose,0.332336237,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.33,-0.33
3037,Xanomeline High Dose,0.396558394,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.4,-0.4
3038,Xanomeline High Dose,0.366960134,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.37,-0.37
3039,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0,0
3040,Xanomeline High Dose,4.81890209,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,4.82,-4.82
3041,Xanomeline High Dose,4.897685538,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,4.9,-4.9
3042,Xanomeline High Dose,5.663358534,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,5.66,-5.66
3043,Xanomeline High Dose,3.975824163,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,3.98,-3.98
3044,Xanomeline High Dose,6.195530249,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,6.2,-6.2
3045,Xanomeline High Dose,6.471032935,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,6.47,-6.47
3046,Xanomeline High Dose,7.431156062,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,7.43,-7.43
3047,Xanomeline High Dose,4.139645566,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,4.14,-4.14
3048,Xanomeline High Dose,4.503905015,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,4.5,-4.5
3049,Xanomeline High Dose,4.669357738,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1a,SD,(XX.XX),WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,4.67,-4.67
3050,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3051,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3052,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3053,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3054,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3055,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3056,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3057,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3058,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3059,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3060,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3061,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3062,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3063,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3064,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3065,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3066,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3067,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3068,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3069,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3070,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3071,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3072,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3073,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3074,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3075,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3076,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3077,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3078,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3079,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3080,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3081,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3082,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3083,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3084,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3085,Placebo,0.05,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3086,Placebo,0.05,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3087,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3088,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3089,Placebo,0.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
3090,Placebo,0.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
3091,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3092,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3093,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3094,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3095,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3096,Placebo,0.23,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.2,0.2
3097,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3098,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3099,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3100,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3101,Placebo,-0.225,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
3102,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3103,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3104,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3105,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3106,Xanomeline High Dose,-2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-2,-2
3107,Xanomeline High Dose,-3.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-3.5,-3.5
3108,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3109,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3110,Xanomeline High Dose,-2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-2,-2
3111,Xanomeline High Dose,-4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-4,-4
3112,Xanomeline High Dose,-4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-4,-4
3113,Xanomeline High Dose,-1,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-1,-1
3114,Xanomeline High Dose,-2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-2,-2
3115,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3116,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3117,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3118,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3119,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3120,Xanomeline High Dose,3,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,3,3
3121,Xanomeline High Dose,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
3122,Xanomeline High Dose,-2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-2,-2
3123,Xanomeline High Dose,-2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-2,-2
3124,Xanomeline High Dose,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
3125,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3126,Xanomeline High Dose,2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,2,2
3127,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3128,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3129,Xanomeline High Dose,-9,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-9,-9
3130,Xanomeline High Dose,-5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-5,-5
3131,Xanomeline High Dose,-6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-6,-6
3132,Xanomeline High Dose,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
3133,Xanomeline High Dose,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
3134,Xanomeline High Dose,-18,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-18,-18
3135,Xanomeline High Dose,-7,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-7,-7
3136,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
3137,Xanomeline High Dose,-4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-4,-4
3138,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3139,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3140,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3141,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3142,Xanomeline High Dose,0.05,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3143,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3144,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3145,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3146,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3147,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3148,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3149,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3150,Xanomeline High Dose,-0.34,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.3,-0.3
3151,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3152,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3153,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3154,Xanomeline High Dose,0.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
3155,Xanomeline High Dose,-0.225,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
3156,Xanomeline High Dose,-0.225,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
3157,Xanomeline High Dose,0.45,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.4,0.4
3158,Xanomeline High Dose,0.45,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.5,0.5
3159,Xanomeline High Dose,0.23,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1a,Median,XX.X,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.2,0.2
3160,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3161,Placebo,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
3162,Placebo,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
3163,Placebo,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
3164,Placebo,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
3165,Placebo,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
3166,Placebo,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
3167,Placebo,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
3168,Placebo,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
3169,Placebo,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
3170,Placebo,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
3171,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3172,Placebo,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
3173,Placebo,-5.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-5.2,-5.2
3174,Placebo,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
3175,Placebo,-6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-6,-6
3176,Placebo,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
3177,Placebo,-6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-6,-6
3178,Placebo,-6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-6,-6
3179,Placebo,-4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-4,-4
3180,Placebo,-6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-6,-6
3181,Placebo,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
3182,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3183,Placebo,-17.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-17.5,-17.5
3184,Placebo,-13.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-13.2,-13.2
3185,Placebo,-14,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-14,-14
3186,Placebo,-12,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-12,-12
3187,Placebo,-15,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-15,-15
3188,Placebo,-12,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-12,-12
3189,Placebo,-19,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-19,-19
3190,Placebo,-12,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-12,-12
3191,Placebo,-11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-11,-11
3192,Placebo,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
3193,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3194,Placebo,-0.1175,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.1,-0.1
3195,Placebo,-0.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.1,-0.1
3196,Placebo,-0.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.1,-0.1
3197,Placebo,-0.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.3,-0.3
3198,Placebo,-0.2225,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
3199,Placebo,-0.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
3200,Placebo,-0.1175,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.1,-0.1
3201,Placebo,-0.17,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
3202,Placebo,-0.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
3203,Placebo,-0.17,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
3204,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3205,Placebo,-0.91,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.9,-0.9
3206,Placebo,-0.9,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.9,-0.9
3207,Placebo,-0.91,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.9,-0.9
3208,Placebo,-0.9,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.9,-0.9
3209,Placebo,-1.2475,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-1.2,-1.2
3210,Placebo,-0.91,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.9,-0.9
3211,Placebo,-1.36,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-1.4,-1.4
3212,Placebo,-0.45,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.5,-0.5
3213,Placebo,-0.455,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.5,-0.5
3214,Placebo,-0.45,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.5,-0.5
3215,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3216,Xanomeline High Dose,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
3217,Xanomeline High Dose,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
3218,Xanomeline High Dose,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
3219,Xanomeline High Dose,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
3220,Xanomeline High Dose,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
3221,Xanomeline High Dose,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
3222,Xanomeline High Dose,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
3223,Xanomeline High Dose,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
3224,Xanomeline High Dose,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
3225,Xanomeline High Dose,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
3226,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3227,Xanomeline High Dose,-7,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-7,-7
3228,Xanomeline High Dose,-6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-6,-6
3229,Xanomeline High Dose,-7,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-7,-7
3230,Xanomeline High Dose,-2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-2,-2
3231,Xanomeline High Dose,-2.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-2.2,-2.2
3232,Xanomeline High Dose,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
3233,Xanomeline High Dose,-7,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-7,-7
3234,Xanomeline High Dose,-4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-4,-4
3235,Xanomeline High Dose,-4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-4,-4
3236,Xanomeline High Dose,-4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-4,-4
3237,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3238,Xanomeline High Dose,-21.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-21.5,-21.5
3239,Xanomeline High Dose,-20,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-20,-20
3240,Xanomeline High Dose,-15.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-15.5,-15.5
3241,Xanomeline High Dose,-16,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-16,-16
3242,Xanomeline High Dose,-20,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-20,-20
3243,Xanomeline High Dose,-20,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-20,-20
3244,Xanomeline High Dose,-27,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-27,-27
3245,Xanomeline High Dose,-17,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-17,-17
3246,Xanomeline High Dose,-18,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-18,-18
3247,Xanomeline High Dose,-14,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-14,-14
3248,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3249,Xanomeline High Dose,-0.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
3250,Xanomeline High Dose,-0.17,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
3251,Xanomeline High Dose,-0.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.3,-0.3
3252,Xanomeline High Dose,-0.17,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
3253,Xanomeline High Dose,-0.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.3,-0.3
3254,Xanomeline High Dose,-0.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
3255,Xanomeline High Dose,-0.1975,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
3256,Xanomeline High Dose,-0.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.1,-0.1
3257,Xanomeline High Dose,-0.2225,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
3258,Xanomeline High Dose,-0.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
3259,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3260,Xanomeline High Dose,-1.36,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-1.4,-1.4
3261,Xanomeline High Dose,-0.79,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.8,-0.8
3262,Xanomeline High Dose,-0.91,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.9,-0.9
3263,Xanomeline High Dose,-0.45,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.4,-0.4
3264,Xanomeline High Dose,-1.4725,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-1.5,-1.5
3265,Xanomeline High Dose,-1.6975,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-1.7,-1.7
3266,Xanomeline High Dose,-2.3825,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-2.4,-2.4
3267,Xanomeline High Dose,-0.285,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.3,-0.3
3268,Xanomeline High Dose,-0.91,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.9,-0.9
3269,Xanomeline High Dose,-0.46,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1a,Q1,XX.X,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.5,-0.5
3270,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3271,Placebo,3,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,3,3
3272,Placebo,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
3273,Placebo,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
3274,Placebo,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
3275,Placebo,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
3276,Placebo,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
3277,Placebo,2.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,2.5,2.5
3278,Placebo,4.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4.5,4.5
3279,Placebo,2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,2,2
3280,Placebo,2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,2,2
3281,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3282,Placebo,6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,6,6
3283,Placebo,8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,8,8
3284,Placebo,3,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,3,3
3285,Placebo,6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,6,6
3286,Placebo,4.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4.5,4.5
3287,Placebo,6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,6,6
3288,Placebo,6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,6,6
3289,Placebo,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
3290,Placebo,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
3291,Placebo,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
3292,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3293,Placebo,7,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,7,7
3294,Placebo,8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,8,8
3295,Placebo,10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,10,10
3296,Placebo,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
3297,Placebo,6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,6,6
3298,Placebo,8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,8,8
3299,Placebo,7.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,7.5,7.5
3300,Placebo,6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,6,6
3301,Placebo,6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,6,6
3302,Placebo,8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,8,8
3303,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3304,Placebo,0.2775,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.3,0.3
3305,Placebo,0.23,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.2,0.2
3306,Placebo,0.39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.4,0.4
3307,Placebo,0.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.2,0.2
3308,Placebo,0.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.3,0.3
3309,Placebo,0.34,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.3,0.3
3310,Placebo,0.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.3,0.3
3311,Placebo,0.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.2,0.2
3312,Placebo,0.2925,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.3,0.3
3313,Placebo,0.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.2,0.2
3314,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3315,Placebo,0.9075,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.9,0.9
3316,Placebo,1.36,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1.4,1.4
3317,Placebo,1.36,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1.4,1.4
3318,Placebo,0.46,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.5,0.5
3319,Placebo,1.2475,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1.2,1.2
3320,Placebo,0.68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.7,0.7
3321,Placebo,0.9075,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.9,0.9
3322,Placebo,0.9075,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.9,0.9
3323,Placebo,1.135,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1.1,1.1
3324,Placebo,0.91,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.9,0.9
3325,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3326,Xanomeline High Dose,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
3327,Xanomeline High Dose,2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,2,2
3328,Xanomeline High Dose,2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,2,2
3329,Xanomeline High Dose,6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,6,6
3330,Xanomeline High Dose,2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,2,2
3331,Xanomeline High Dose,3.75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,3.8,3.8
3332,Xanomeline High Dose,3.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,3.2,3.2
3333,Xanomeline High Dose,5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,5,5
3334,Xanomeline High Dose,2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,2,2
3335,Xanomeline High Dose,5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,5,5
3336,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3337,Xanomeline High Dose,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
3338,Xanomeline High Dose,6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,6,6
3339,Xanomeline High Dose,8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,8,8
3340,Xanomeline High Dose,9,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,9,9
3341,Xanomeline High Dose,12,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,12,12
3342,Xanomeline High Dose,5.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,5.5,5.5
3343,Xanomeline High Dose,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
3344,Xanomeline High Dose,10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,10,10
3345,Xanomeline High Dose,8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,8,8
3346,Xanomeline High Dose,8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,8,8
3347,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3348,Xanomeline High Dose,2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,2,2
3349,Xanomeline High Dose,0.75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.8,0.8
3350,Xanomeline High Dose,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
3351,Xanomeline High Dose,3.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,3.5,3.5
3352,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3353,Xanomeline High Dose,3.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,3.5,3.5
3354,Xanomeline High Dose,-3.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-3.5,-3.5
3355,Xanomeline High Dose,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
3356,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3357,Xanomeline High Dose,6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,6,6
3358,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3359,Xanomeline High Dose,0.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.3,0.3
3360,Xanomeline High Dose,0.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.3,0.3
3361,Xanomeline High Dose,0.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
3362,Xanomeline High Dose,0.23,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.2,0.2
3363,Xanomeline High Dose,0.255,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.3,0.3
3364,Xanomeline High Dose,0.12,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
3365,Xanomeline High Dose,0.2725,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.3,0.3
3366,Xanomeline High Dose,0.23,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.2,0.2
3367,Xanomeline High Dose,0.2425,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.2,0.2
3368,Xanomeline High Dose,0.235,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.2,0.2
3369,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
3370,Xanomeline High Dose,0.46,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.5,0.5
3371,Xanomeline High Dose,1.2375,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1.2,1.2
3372,Xanomeline High Dose,0.91,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.9,0.9
3373,Xanomeline High Dose,0.9,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.9,0.9
3374,Xanomeline High Dose,1.0225,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1,1
3375,Xanomeline High Dose,1.81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1.8,1.8
3376,Xanomeline High Dose,0.965,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1,1
3377,Xanomeline High Dose,0.9675,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1,1
3378,Xanomeline High Dose,1.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1.2,1.2
3379,Xanomeline High Dose,1.36,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1a,Q3,XX.X,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1.4,1.4
3380,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
3381,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3382,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3383,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3384,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3385,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3386,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3387,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3388,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3389,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3390,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3391,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
3392,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3393,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3394,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3395,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3396,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3397,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3398,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3399,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3400,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3401,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3402,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
3403,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3404,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3405,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3406,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3407,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3408,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3409,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3410,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3411,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3412,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3413,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
3414,Placebo,-0.72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
3415,Placebo,-0.62,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
3416,Placebo,-0.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
3417,Placebo,-0.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
3418,Placebo,-1,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
3419,Placebo,-1.95,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-2,-2
3420,Placebo,-0.62,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
3421,Placebo,-1.94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-2,-2
3422,Placebo,-0.73,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
3423,Placebo,-0.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
3424,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
3425,Placebo,-4.99,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-5,-5
3426,Placebo,-4.49,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-4,-4
3427,Placebo,-4.13,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-4,-4
3428,Placebo,-1.81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-2,-2
3429,Placebo,-4.54,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-5,-5
3430,Placebo,-4.54,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-5,-5
3431,Placebo,-4.99,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-5,-5
3432,Placebo,-1.81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-2,-2
3433,Placebo,-5.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-5,-5
3434,Placebo,-4.31,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-4,-4
3435,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
3436,Xanomeline High Dose,-40,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-40,-40
3437,Xanomeline High Dose,-46,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-46,-46
3438,Xanomeline High Dose,-38,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-38,-38
3439,Xanomeline High Dose,-38,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-38,-38
3440,Xanomeline High Dose,-36,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-36,-36
3441,Xanomeline High Dose,-20,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-20,-20
3442,Xanomeline High Dose,-20,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-20,-20
3443,Xanomeline High Dose,-32,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-32,-32
3444,Xanomeline High Dose,-50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-50,-50
3445,Xanomeline High Dose,-45,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-45,-45
3446,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
3447,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3448,Xanomeline High Dose,-20,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-20,-20
3449,Xanomeline High Dose,-28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-28,-28
3450,Xanomeline High Dose,-20,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-20,-20
3451,Xanomeline High Dose,-28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-28,-28
3452,Xanomeline High Dose,-40,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-40,-40
3453,Xanomeline High Dose,-32,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-32,-32
3454,Xanomeline High Dose,-24,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-24,-24
3455,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3456,Xanomeline High Dose,-20,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-20,-20
3457,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
3458,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3459,Xanomeline High Dose,-52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-52,-52
3460,Xanomeline High Dose,-52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-52,-52
3461,Xanomeline High Dose,-52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-52,-52
3462,Xanomeline High Dose,-82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-82,-82
3463,Xanomeline High Dose,-40,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-40,-40
3464,Xanomeline High Dose,-62,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-62,-62
3465,Xanomeline High Dose,-52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-52,-52
3466,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3467,Xanomeline High Dose,-43,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-43,-43
3468,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
3469,Xanomeline High Dose,-1,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
3470,Xanomeline High Dose,-0.61,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
3471,Xanomeline High Dose,-0.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
3472,Xanomeline High Dose,-1.39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
3473,Xanomeline High Dose,-0.56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
3474,Xanomeline High Dose,-0.94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
3475,Xanomeline High Dose,-0.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
3476,Xanomeline High Dose,-1,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
3477,Xanomeline High Dose,-1.06,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
3478,Xanomeline High Dose,-0.66,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
3479,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
3480,Xanomeline High Dose,-5.9,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-6,-6
3481,Xanomeline High Dose,-5.45,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-5,-5
3482,Xanomeline High Dose,-3.18,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-3,-3
3483,Xanomeline High Dose,-5.45,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-5,-5
3484,Xanomeline High Dose,-3.62,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-4,-4
3485,Xanomeline High Dose,-4.53,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-5,-5
3486,Xanomeline High Dose,-5.9,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-6,-6
3487,Xanomeline High Dose,-2.27,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-2,-2
3488,Xanomeline High Dose,-5.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-5,-5
3489,Xanomeline High Dose,-4.54,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1a,Min,XX,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-5,-5
3490,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
3491,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3492,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3493,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3494,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3495,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3496,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3497,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3498,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3499,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3500,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3501,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
3502,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3503,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3504,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3505,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3506,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3507,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3508,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3509,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3510,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3511,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3512,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
3513,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3514,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3515,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3516,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3517,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3518,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3519,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3520,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3521,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3522,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3523,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
3524,Placebo,1.34,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
3525,Placebo,1.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
3526,Placebo,1.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
3527,Placebo,1.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
3528,Placebo,1.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
3529,Placebo,1.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
3530,Placebo,1.34,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
3531,Placebo,0.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
3532,Placebo,1.06,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
3533,Placebo,1,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
3534,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
3535,Placebo,4.99,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,5,5
3536,Placebo,11.34,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,11,11
3537,Placebo,11.34,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,11,11
3538,Placebo,2.72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,3,3
3539,Placebo,6.35,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,6,6
3540,Placebo,8.17,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,8,8
3541,Placebo,4.99,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,5,5
3542,Placebo,4.54,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,5,5
3543,Placebo,4.08,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,4,4
3544,Placebo,4.54,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,5,5
3545,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
3546,Xanomeline High Dose,22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,22,22
3547,Xanomeline High Dose,20,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,20,20
3548,Xanomeline High Dose,27,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,27,27
3549,Xanomeline High Dose,28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,28,28
3550,Xanomeline High Dose,28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,28,28
3551,Xanomeline High Dose,22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,22,22
3552,Xanomeline High Dose,20,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,20,20
3553,Xanomeline High Dose,26,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,26,26
3554,Xanomeline High Dose,20,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,20,20
3555,Xanomeline High Dose,22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,22,22
3556,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
3557,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3558,Xanomeline High Dose,28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,28,28
3559,Xanomeline High Dose,32,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,32,32
3560,Xanomeline High Dose,32,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,32,32
3561,Xanomeline High Dose,30,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,30,30
3562,Xanomeline High Dose,20,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,20,20
3563,Xanomeline High Dose,24,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,24,24
3564,Xanomeline High Dose,36,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,36,36
3565,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3566,Xanomeline High Dose,26,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,26,26
3567,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
3568,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3569,Xanomeline High Dose,35,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,35,35
3570,Xanomeline High Dose,45,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,45,45
3571,Xanomeline High Dose,40,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,40,40
3572,Xanomeline High Dose,45,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,45,45
3573,Xanomeline High Dose,42,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,42,42
3574,Xanomeline High Dose,34,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,34,34
3575,Xanomeline High Dose,40,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,40,40
3576,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
3577,Xanomeline High Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,50,50
3578,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
3579,Xanomeline High Dose,0.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
3580,Xanomeline High Dose,1.06,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
3581,Xanomeline High Dose,1.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
3582,Xanomeline High Dose,1.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
3583,Xanomeline High Dose,1.12,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
3584,Xanomeline High Dose,1.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
3585,Xanomeline High Dose,0.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
3586,Xanomeline High Dose,0.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
3587,Xanomeline High Dose,0.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
3588,Xanomeline High Dose,1,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
3589,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
3590,Xanomeline High Dose,36.97,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,37,37
3591,Xanomeline High Dose,32.66,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,33,33
3592,Xanomeline High Dose,33.12,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,33,33
3593,Xanomeline High Dose,34.48,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,34,34
3594,Xanomeline High Dose,33.12,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,33,33
3595,Xanomeline High Dose,33.34,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,33,33
3596,Xanomeline High Dose,36.97,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,37,37
3597,Xanomeline High Dose,34.02,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,34,34
3598,Xanomeline High Dose,34.93,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,35,35
3599,Xanomeline High Dose,33.12,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1a,Max,XX,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,33,33
3600,Placebo,86,Mth01_CatVar_Count_ByGrp,Mth01_CatVar_Count_ByGrp_1_n,Out14-3-3-1b,n,(N=XX),,,An01_05_SAF_Summ_ByTrt,Summary of Subjects by Treatment,0,86,(N=86)
3601,Xanomeline High Dose,84,Mth01_CatVar_Count_ByGrp,Mth01_CatVar_Count_ByGrp_1_n,Out14-3-3-1b,n,(N=XX),,,An01_05_SAF_Summ_ByTrt,Summary of Subjects by Treatment,0,84,(N=84)
3602,Xanomeline Low Dose,84,Mth01_CatVar_Count_ByGrp,Mth01_CatVar_Count_ByGrp_1_n,Out14-3-3-1b,n,(N=XX),,,An01_05_SAF_Summ_ByTrt,Summary of Subjects by Treatment,0,84,(N=84)
3603,Placebo,255,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,255,255
3604,Placebo,246,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,246,246
3605,Placebo,207,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,207,207
3606,Placebo,204,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,204,204
3607,Placebo,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,252,252
3608,Placebo,198,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,198,198
3609,Placebo,177,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,177,177
3610,Placebo,174,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,174,174
3611,Placebo,246,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,246,246
3612,Placebo,228,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,228,228
3613,Placebo,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,219,219
3614,Placebo,255,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,255,255
3615,Placebo,246,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,246,246
3616,Placebo,207,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,207,207
3617,Placebo,204,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,204,204
3618,Placebo,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,252,252
3619,Placebo,198,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,198,198
3620,Placebo,177,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,177,177
3621,Placebo,174,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,174,174
3622,Placebo,246,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,246,246
3623,Placebo,228,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,228,228
3624,Placebo,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,219,219
3625,Placebo,255,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,255,255
3626,Placebo,246,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,246,246
3627,Placebo,207,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,207,207
3628,Placebo,204,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,204,204
3629,Placebo,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,252,252
3630,Placebo,198,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,198,198
3631,Placebo,177,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,177,177
3632,Placebo,174,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,174,174
3633,Placebo,246,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,246,246
3634,Placebo,228,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,228,228
3635,Placebo,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,219,219
3636,Placebo,86,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,86,86
3637,Placebo,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,82,82
3638,Placebo,69,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,69,69
3639,Placebo,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,68,68
3640,Placebo,83,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,83,83
3641,Placebo,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,64,64
3642,Placebo,57,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,57,57
3643,Placebo,58,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,58,58
3644,Placebo,81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,81,81
3645,Placebo,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,76,76
3646,Placebo,73,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,73,73
3647,Placebo,86,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,86,86
3648,Placebo,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,82,82
3649,Placebo,69,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,69,69
3650,Placebo,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,68,68
3651,Placebo,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,82,82
3652,Placebo,66,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,66,66
3653,Placebo,59,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,59,59
3654,Placebo,58,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,58,58
3655,Placebo,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,82,82
3656,Placebo,75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,75,75
3657,Placebo,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,72,72
3658,Xanomeline High Dose,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,252,252
3659,Xanomeline High Dose,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,219,219
3660,Xanomeline High Dose,150,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,150,150
3661,Xanomeline High Dose,111,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,111,111
3662,Xanomeline High Dose,243,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,243,243
3663,Xanomeline High Dose,96,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,96,96
3664,Xanomeline High Dose,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,90,90
3665,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,84,84
3666,Xanomeline High Dose,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,219,219
3667,Xanomeline High Dose,203,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,203,203
3668,Xanomeline High Dose,168,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,168,168
3669,Xanomeline High Dose,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,252,252
3670,Xanomeline High Dose,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,219,219
3671,Xanomeline High Dose,150,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,150,150
3672,Xanomeline High Dose,111,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,111,111
3673,Xanomeline High Dose,243,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,243,243
3674,Xanomeline High Dose,96,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,96,96
3675,Xanomeline High Dose,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,90,90
3676,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,84,84
3677,Xanomeline High Dose,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,219,219
3678,Xanomeline High Dose,204,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,204,204
3679,Xanomeline High Dose,168,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,168,168
3680,Xanomeline High Dose,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,252,252
3681,Xanomeline High Dose,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,219,219
3682,Xanomeline High Dose,150,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,150,150
3683,Xanomeline High Dose,111,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,111,111
3684,Xanomeline High Dose,243,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,243,243
3685,Xanomeline High Dose,96,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,96,96
3686,Xanomeline High Dose,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,90,90
3687,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,84,84
3688,Xanomeline High Dose,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,219,219
3689,Xanomeline High Dose,204,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,204,204
3690,Xanomeline High Dose,168,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,168,168
3691,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,84,84
3692,Xanomeline High Dose,73,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,73,73
3693,Xanomeline High Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
3694,Xanomeline High Dose,37,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
3695,Xanomeline High Dose,81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,81,81
3696,Xanomeline High Dose,32,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,32,32
3697,Xanomeline High Dose,29,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,29,29
3698,Xanomeline High Dose,28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,28,28
3699,Xanomeline High Dose,73,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,73,73
3700,Xanomeline High Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,68,68
3701,Xanomeline High Dose,56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,56,56
3702,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,84,84
3703,Xanomeline High Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,72,72
3704,Xanomeline High Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
3705,Xanomeline High Dose,37,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
3706,Xanomeline High Dose,81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,81,81
3707,Xanomeline High Dose,32,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,32,32
3708,Xanomeline High Dose,30,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,30,30
3709,Xanomeline High Dose,28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,28,28
3710,Xanomeline High Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,72,72
3711,Xanomeline High Dose,67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,67,67
3712,Xanomeline High Dose,56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,56,56
3713,Xanomeline Low Dose,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,252,252
3714,Xanomeline Low Dose,216,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,216,216
3715,Xanomeline Low Dose,156,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,156,156
3716,Xanomeline Low Dose,126,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,126,126
3717,Xanomeline Low Dose,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,252,252
3718,Xanomeline Low Dose,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,90,90
3719,Xanomeline Low Dose,81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,81,81
3720,Xanomeline Low Dose,75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,75,75
3721,Xanomeline Low Dose,216,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,216,216
3722,Xanomeline Low Dose,195,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,195,195
3723,Xanomeline Low Dose,180,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,180,180
3724,Xanomeline Low Dose,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,252,252
3725,Xanomeline Low Dose,216,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,216,216
3726,Xanomeline Low Dose,156,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,156,156
3727,Xanomeline Low Dose,126,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,126,126
3728,Xanomeline Low Dose,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,252,252
3729,Xanomeline Low Dose,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,90,90
3730,Xanomeline Low Dose,81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,81,81
3731,Xanomeline Low Dose,75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,75,75
3732,Xanomeline Low Dose,216,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,216,216
3733,Xanomeline Low Dose,195,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,195,195
3734,Xanomeline Low Dose,180,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,180,180
3735,Xanomeline Low Dose,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,252,252
3736,Xanomeline Low Dose,216,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,216,216
3737,Xanomeline Low Dose,156,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,156,156
3738,Xanomeline Low Dose,126,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,126,126
3739,Xanomeline Low Dose,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,252,252
3740,Xanomeline Low Dose,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,90,90
3741,Xanomeline Low Dose,81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,81,81
3742,Xanomeline Low Dose,75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,75,75
3743,Xanomeline Low Dose,216,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,216,216
3744,Xanomeline Low Dose,195,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,195,195
3745,Xanomeline Low Dose,180,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,180,180
3746,Xanomeline Low Dose,83,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,83,83
3747,Xanomeline Low Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,72,72
3748,Xanomeline Low Dose,52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,52,52
3749,Xanomeline Low Dose,41,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,41,41
3750,Xanomeline Low Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,84,84
3751,Xanomeline Low Dose,30,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,30,30
3752,Xanomeline Low Dose,26,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,26,26
3753,Xanomeline Low Dose,24,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,24,24
3754,Xanomeline Low Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,72,72
3755,Xanomeline Low Dose,65,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,65,65
3756,Xanomeline Low Dose,59,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,59,59
3757,Xanomeline Low Dose,83,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,83,83
3758,Xanomeline Low Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,72,72
3759,Xanomeline Low Dose,52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,52,52
3760,Xanomeline Low Dose,42,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,42,42
3761,Xanomeline Low Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,84,84
3762,Xanomeline Low Dose,31,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,31,31
3763,Xanomeline Low Dose,27,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,27,27
3764,Xanomeline Low Dose,25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,25,25
3765,Xanomeline Low Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,72,72
3766,Xanomeline Low Dose,65,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,65,65
3767,Xanomeline Low Dose,60,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,60,60
3768,Placebo,77.09411765,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,77.1,77.1
3769,Placebo,74.05691057,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.1,74.1
3770,Placebo,74.28985507,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.3,74.3
3771,Placebo,75.11764706,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.1,75.1
3772,Placebo,74.45634921,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.5,74.5
3773,Placebo,73.3989899,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.4,73.4
3774,Placebo,73.79661017,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.8,73.8
3775,Placebo,72.63218391,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72.6,72.6
3776,Placebo,75.43089431,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.4,75.4
3777,Placebo,74.48245614,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.5,74.5
3778,Placebo,75.24657534,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.2,75.2
3779,Placebo,73.52156863,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.5,73.5
3780,Placebo,73.08943089,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.1,73.1
3781,Placebo,75.04347826,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75,75
3782,Placebo,70.55392157,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.6,70.6
3783,Placebo,73.24603175,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.2,73.2
3784,Placebo,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
3785,Placebo,71.57062147,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,71.6,71.6
3786,Placebo,73.06896552,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.1,73.1
3787,Placebo,73.80894309,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.8,73.8
3788,Placebo,72.93421053,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72.9,72.9
3789,Placebo,71.82191781,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,71.8,71.8
3790,Placebo,136.8078431,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,136.8,136.8
3791,Placebo,132.3699187,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,132.4,132.4
3792,Placebo,132.705314,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,132.7,132.7
3793,Placebo,134.6029412,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,134.6,134.6
3794,Placebo,133.8134921,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,133.8,133.8
3795,Placebo,133.3282828,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,133.3,133.3
3796,Placebo,134.6779661,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,134.7,134.7
3797,Placebo,130.8850575,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130.9,130.9
3798,Placebo,133.9430894,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,133.9,133.9
3799,Placebo,133.8333333,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,133.8,133.8
3800,Placebo,136.2739726,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,136.3,136.3
3801,Placebo,36.5894186,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
3802,Placebo,36.6645122,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
3803,Placebo,36.64405797,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
3804,Placebo,36.67529412,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
3805,Placebo,36.55566265,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
3806,Placebo,36.6290625,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
3807,Placebo,36.61684211,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
3808,Placebo,36.67017241,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
3809,Placebo,36.59135802,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
3810,Placebo,36.61736842,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
3811,Placebo,36.5960274,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
3812,Placebo,62.75744186,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,62.8,62.8
3813,Placebo,63.01939024,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63,63
3814,Placebo,63.7,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.7,63.7
3815,Placebo,63.49,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.5,63.5
3816,Placebo,63.2554878,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.3,63.3
3817,Placebo,63.65787879,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.7,63.7
3818,Placebo,63.22423729,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.2,63.2
3819,Placebo,63.10155172,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.1,63.1
3820,Placebo,63.21829268,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.2,63.2
3821,Placebo,63.37866667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.4,63.4
3822,Placebo,63.17444444,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.2,63.2
3823,Xanomeline High Dose,78.26587302,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78.3,78.3
3824,Xanomeline High Dose,75.14155251,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.1,75.1
3825,Xanomeline High Dose,74.60666667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.6,74.6
3826,Xanomeline High Dose,76.02702703,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76,76
3827,Xanomeline High Dose,76.42798354,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76.4,76.4
3828,Xanomeline High Dose,74.07291667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.1,74.1
3829,Xanomeline High Dose,74.93333333,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.9,74.9
3830,Xanomeline High Dose,74.54761905,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.5,74.5
3831,Xanomeline High Dose,76.79908676,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76.8,76.8
3832,Xanomeline High Dose,75.25615764,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.3,75.3
3833,Xanomeline High Dose,77.36904762,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,77.4,77.4
3834,Xanomeline High Dose,73.00793651,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73,73
3835,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
3836,Xanomeline High Dose,73.16666667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.2,73.2
3837,Xanomeline High Dose,73.1981982,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.2,73.2
3838,Xanomeline High Dose,76.17695473,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76.2,76.2
3839,Xanomeline High Dose,76.73958333,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76.7,76.7
3840,Xanomeline High Dose,71.68888889,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,71.7,71.7
3841,Xanomeline High Dose,73.44047619,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.4,73.4
3842,Xanomeline High Dose,75.92694064,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.9,75.9
3843,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
3844,Xanomeline High Dose,74.04166667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74,74
3845,Xanomeline High Dose,138.7738095,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,138.8,138.8
3846,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
3847,Xanomeline High Dose,130.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130.3,130.3
3848,Xanomeline High Dose,133.6576577,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,133.7,133.7
3849,Xanomeline High Dose,132.3292181,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,132.3,132.3
3850,Xanomeline High Dose,127.0729167,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,127.1,127.1
3851,Xanomeline High Dose,130.6222222,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130.6,130.6
3852,Xanomeline High Dose,124.1309524,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,124.1,124.1
3853,Xanomeline High Dose,132.1872146,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,132.2,132.2
3854,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
3855,Xanomeline High Dose,135.0595238,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,135.1,135.1
3856,Xanomeline High Dose,36.56119048,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
3857,Xanomeline High Dose,36.64109589,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
3858,Xanomeline High Dose,36.6626,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
3859,Xanomeline High Dose,36.62891892,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
3860,Xanomeline High Dose,36.56962963,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
3861,Xanomeline High Dose,36.69875,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
3862,Xanomeline High Dose,36.70862069,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
3863,Xanomeline High Dose,36.77428571,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.8,36.8
3864,Xanomeline High Dose,36.64684932,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
3865,Xanomeline High Dose,36.57294118,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
3866,Xanomeline High Dose,36.60642857,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
3867,Xanomeline High Dose,69.99880952,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
3868,Xanomeline High Dose,69.31,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,69.3,69.3
3869,Xanomeline High Dose,70.8208,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.8,70.8
3870,Xanomeline High Dose,70.58378378,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.6,70.6
3871,Xanomeline High Dose,70.16938272,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.2,70.2
3872,Xanomeline High Dose,70.7640625,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.8,70.8
3873,Xanomeline High Dose,71.072,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,71.1,71.1
3874,Xanomeline High Dose,69.98464286,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
3875,Xanomeline High Dose,70.09375,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.1,70.1
3876,Xanomeline High Dose,70.46238806,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.5,70.5
3877,Xanomeline High Dose,71.10625,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,71.1,71.1
3878,Xanomeline Low Dose,76.35714286,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76.4,76.4
3879,Xanomeline Low Dose,73.81944444,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.8,73.8
3880,Xanomeline Low Dose,75.67307692,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.7,75.7
3881,Xanomeline Low Dose,75.23015873,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.2,75.2
3882,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
3883,Xanomeline Low Dose,73.66666667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.7,73.7
3884,Xanomeline Low Dose,76.20987654,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76.2,76.2
3885,Xanomeline Low Dose,72.94666667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72.9,72.9
3886,Xanomeline Low Dose,76.00462963,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76,76
3887,Xanomeline Low Dose,74.9025641,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.9,74.9
3888,Xanomeline Low Dose,75.4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.4,75.4
3889,Xanomeline Low Dose,71.49603175,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,71.5,71.5
3890,Xanomeline Low Dose,70.59722222,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.6,70.6
3891,Xanomeline Low Dose,73.08974359,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.1,73.1
3892,Xanomeline Low Dose,68.78571429,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68.8,68.8
3893,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
3894,Xanomeline Low Dose,70.13333333,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.1,70.1
3895,Xanomeline Low Dose,70.30864198,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.3,70.3
3896,Xanomeline Low Dose,70.45333333,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.5,70.5
3897,Xanomeline Low Dose,73.10648148,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.1,73.1
3898,Xanomeline Low Dose,72.00512821,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
3899,Xanomeline Low Dose,72.6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72.6,72.6
3900,Xanomeline Low Dose,136.9087302,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,136.9,136.9
3901,Xanomeline Low Dose,132.9166667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,132.9,132.9
3902,Xanomeline Low Dose,133.2051282,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,133.2,133.2
3903,Xanomeline Low Dose,132.4603175,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,132.5,132.5
3904,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
3905,Xanomeline Low Dose,128.9888889,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,129,129
3906,Xanomeline Low Dose,132.0246914,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,132,132
3907,Xanomeline Low Dose,129.3866667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,129.4,129.4
3908,Xanomeline Low Dose,135.3888889,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,135.4,135.4
3909,Xanomeline Low Dose,134.9076923,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,134.9,134.9
3910,Xanomeline Low Dose,134.9222222,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,134.9,134.9
3911,Xanomeline Low Dose,36.55554217,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
3912,Xanomeline Low Dose,36.57638889,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
3913,Xanomeline Low Dose,36.62519231,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
3914,Xanomeline Low Dose,36.55195122,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
3915,Xanomeline Low Dose,36.5222619,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.5,36.5
3916,Xanomeline Low Dose,36.67566667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
3917,Xanomeline Low Dose,36.65615385,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
3918,Xanomeline Low Dose,36.59041667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
3919,Xanomeline Low Dose,36.49625,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.5,36.5
3920,Xanomeline Low Dose,36.53046154,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.5,36.5
3921,Xanomeline Low Dose,36.58389831,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
3922,Xanomeline Low Dose,67.27421687,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,67.3,67.3
3923,Xanomeline Low Dose,66.78027778,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,66.8,66.8
3924,Xanomeline Low Dose,67.02423077,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,67,67
3925,Xanomeline Low Dose,68.09928571,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68.1,68.1
3926,Xanomeline Low Dose,67.36904762,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,67.4,67.4
3927,Xanomeline Low Dose,67.25064516,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,67.3,67.3
3928,Xanomeline Low Dose,67.4337037,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,67.4,67.4
3929,Xanomeline Low Dose,67.0516,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,67.1,67.1
3930,Xanomeline Low Dose,67.34083333,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,67.3,67.3
3931,Xanomeline Low Dose,67.18707692,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,67.2,67.2
3932,Xanomeline Low Dose,66.69433333,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,66.7,66.7
3933,Placebo,10.90974807,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.91,-10.91
3934,Placebo,11.04484426,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,11.04,-11.04
3935,Placebo,10.91952218,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.92,-10.92
3936,Placebo,11.10344918,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,11.1,-11.1
3937,Placebo,10.42379286,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.42,-10.42
3938,Placebo,10.57760295,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.58,-10.58
3939,Placebo,11.83376284,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,11.83,-11.83
3940,Placebo,10.94507036,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.95,-10.95
3941,Placebo,11.45894628,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,11.46,-11.46
3942,Placebo,10.20428558,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.2,-10.2
3943,Placebo,9.288615141,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.29,-9.29
3944,Placebo,11.89018509,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,11.89,-11.89
3945,Placebo,10.61420544,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.61,-10.61
3946,Placebo,11.58686248,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,11.59,-11.59
3947,Placebo,8.976819316,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,8.98,-8.98
3948,Placebo,10.24767898,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.25,-10.25
3949,Placebo,8.914142075,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,8.91,-8.91
3950,Placebo,9.177345883,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.18,-9.18
3951,Placebo,10.91299602,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.91,-10.91
3952,Placebo,10.73921297,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.74,-10.74
3953,Placebo,10.49271053,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.49,-10.49
3954,Placebo,9.197640003,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.2,-9.2
3955,Placebo,17.80710116,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,17.81,-17.81
3956,Placebo,18.78029117,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,18.78,-18.78
3957,Placebo,15.24477057,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,15.24,-15.24
3958,Placebo,18.54575466,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,18.55,-18.55
3959,Placebo,17.80261789,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,17.8,-17.8
3960,Placebo,20.02456127,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,20.02,-20.02
3961,Placebo,17.90420279,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,17.9,-17.9
3962,Placebo,18.40295609,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,18.4,-18.4
3963,Placebo,17.58190202,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,17.58,-17.58
3964,Placebo,18.2739393,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,18.27,-18.27
3965,Placebo,17.20219231,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,17.2,-17.2
3966,Placebo,0.393525108,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.39,-0.39
3967,Placebo,0.401866486,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.4,-0.4
3968,Placebo,0.397386013,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.4,-0.4
3969,Placebo,0.338982105,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.34,-0.34
3970,Placebo,0.443676967,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.44,-0.44
3971,Placebo,0.483334052,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.48,-0.48
3972,Placebo,0.485515771,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.49,-0.49
3973,Placebo,0.410226687,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.41,-0.41
3974,Placebo,0.512666444,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.51,-0.51
3975,Placebo,0.388900565,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.39,-0.39
3976,Placebo,0.384464778,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.38,-0.38
3977,Placebo,12.77038801,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,12.77,-12.77
3978,Placebo,12.71125091,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,12.71,-12.71
3979,Placebo,12.39652596,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,12.4,-12.4
3980,Placebo,12.5861829,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,12.59,-12.59
3981,Placebo,12.93630189,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,12.94,-12.94
3982,Placebo,12.60260285,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,12.6,-12.6
3983,Placebo,12.58336535,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,12.58,-12.58
3984,Placebo,12.64258604,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,12.64,-12.64
3985,Placebo,12.73949481,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,12.74,-12.74
3986,Placebo,12.53074083,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,12.53,-12.53
3987,Placebo,12.4457854,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,12.45,-12.45
3988,Xanomeline High Dose,10.27028874,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.27,-10.27
3989,Xanomeline High Dose,10.38139918,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.38,-10.38
3990,Xanomeline High Dose,9.212551015,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.21,-9.21
3991,Xanomeline High Dose,9.116876917,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.12,-9.12
3992,Xanomeline High Dose,10.77751902,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.78,-10.78
3993,Xanomeline High Dose,10.35500875,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.36,-10.36
3994,Xanomeline High Dose,10.23630903,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.24,-10.24
3995,Xanomeline High Dose,10.52066785,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.52,-10.52
3996,Xanomeline High Dose,9.579977164,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.58,-9.58
3997,Xanomeline High Dose,9.899664912,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.9,-9.9
3998,Xanomeline High Dose,9.284304909,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.28,-9.28
3999,Xanomeline High Dose,10.49719828,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.5,-10.5
4000,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,NA,(NA)
4001,Xanomeline High Dose,10.49155408,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.49,-10.49
4002,Xanomeline High Dose,9.802429958,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.8,-9.8
4003,Xanomeline High Dose,10.29510655,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.3,-10.3
4004,Xanomeline High Dose,11.10926099,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,11.11,-11.11
4005,Xanomeline High Dose,11.90283173,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,11.9,-11.9
4006,Xanomeline High Dose,11.18879731,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,11.19,-11.19
4007,Xanomeline High Dose,11.05549617,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,11.06,-11.06
4008,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,NA,(NA)
4009,Xanomeline High Dose,9.143142561,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.14,-9.14
4010,Xanomeline High Dose,18.73574966,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,18.74,-18.74
4011,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,NA,(NA)
4012,Xanomeline High Dose,15.57537206,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,15.58,-15.58
4013,Xanomeline High Dose,16.24779453,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,16.25,-16.25
4014,Xanomeline High Dose,16.61295703,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,16.61,-16.61
4015,Xanomeline High Dose,15.53213632,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,15.53,-15.53
4016,Xanomeline High Dose,18.5524327,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,18.55,-18.55
4017,Xanomeline High Dose,14.51445458,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.51,-14.51
4018,Xanomeline High Dose,16.43493206,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,16.43,-16.43
4019,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,NA,(NA)
4020,Xanomeline High Dose,15.88796946,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,15.89,-15.89
4021,Xanomeline High Dose,0.424177176,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.42,-0.42
4022,Xanomeline High Dose,0.385852453,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.39,-0.39
4023,Xanomeline High Dose,0.381323206,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.38,-0.38
4024,Xanomeline High Dose,0.384691679,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.38,-0.38
4025,Xanomeline High Dose,0.46947163,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.47,-0.47
4026,Xanomeline High Dose,0.535686174,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.54,-0.54
4027,Xanomeline High Dose,0.444029633,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.44,-0.44
4028,Xanomeline High Dose,0.241452834,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.24,-0.24
4029,Xanomeline High Dose,0.373139372,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.37,-0.37
4030,Xanomeline High Dose,0.422882994,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.42,-0.42
4031,Xanomeline High Dose,0.393415943,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.39,-0.39
4032,Xanomeline High Dose,14.65117244,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.65,-14.65
4033,Xanomeline High Dose,14.47951034,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.48,-14.48
4034,Xanomeline High Dose,13.8765181,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,13.88,-13.88
4035,Xanomeline High Dose,15.0459903,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,15.05,-15.05
4036,Xanomeline High Dose,14.01680878,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.02,-14.02
4037,Xanomeline High Dose,15.68580494,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,15.69,-15.69
4038,Xanomeline High Dose,15.81545499,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,15.82,-15.82
4039,Xanomeline High Dose,16.34700844,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,16.35,-16.35
4040,Xanomeline High Dose,14.34666712,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.35,-14.35
4041,Xanomeline High Dose,14.2729801,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.27,-14.27
4042,Xanomeline High Dose,13.69288754,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,13.69,-13.69
4043,Xanomeline Low Dose,10.25100464,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.25,-10.25
4044,Xanomeline Low Dose,9.125980886,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.13,-9.13
4045,Xanomeline Low Dose,10.83611849,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.84,-10.84
4046,Xanomeline Low Dose,10.12810956,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.13,-10.13
4047,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,NA,(NA)
4048,Xanomeline Low Dose,9.735836731,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.74,-9.74
4049,Xanomeline Low Dose,9.75924696,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.76,-9.76
4050,Xanomeline Low Dose,9.89115539,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.89,-9.89
4051,Xanomeline Low Dose,9.348795562,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.35,-9.35
4052,Xanomeline Low Dose,9.17840044,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.18,-9.18
4053,Xanomeline Low Dose,10.75091265,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.75,-10.75
4054,Xanomeline Low Dose,10.53527485,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.54,-10.54
4055,Xanomeline Low Dose,10.75995123,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.76,-10.76
4056,Xanomeline Low Dose,9.87494176,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.87,-9.87
4057,Xanomeline Low Dose,9.582990884,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.58,-9.58
4058,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,NA,(NA)
4059,Xanomeline Low Dose,11.42262686,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,11.42,-11.42
4060,Xanomeline Low Dose,9.902830372,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.9,-9.9
4061,Xanomeline Low Dose,8.955284312,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,8.96,-8.96
4062,Xanomeline Low Dose,10.58532352,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,10.59,-10.59
4063,Xanomeline Low Dose,9.187899615,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,9.19,-9.19
4064,Xanomeline Low Dose,11.29126819,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,11.29,-11.29
4065,Xanomeline Low Dose,17.56591466,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,17.57,-17.57
4066,Xanomeline Low Dose,18.1282896,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,18.13,-18.13
4067,Xanomeline Low Dose,16.98907351,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,16.99,-16.99
4068,Xanomeline Low Dose,14.60008263,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.6,-14.6
4069,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,NA,(NA)
4070,Xanomeline Low Dose,16.12695033,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,16.13,-16.13
4071,Xanomeline Low Dose,17.34356892,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,17.34,-17.34
4072,Xanomeline Low Dose,18.16359095,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,18.16,-18.16
4073,Xanomeline Low Dose,17.99500361,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,18,-18
4074,Xanomeline Low Dose,19.49125345,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,19.49,-19.49
4075,Xanomeline Low Dose,18.07509338,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,18.08,-18.08
4076,Xanomeline Low Dose,0.403428154,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.4,-0.4
4077,Xanomeline Low Dose,0.433047847,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.43,-0.43
4078,Xanomeline Low Dose,0.448494171,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.45,-0.45
4079,Xanomeline Low Dose,0.382192488,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.38,-0.38
4080,Xanomeline Low Dose,0.44329639,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.44,-0.44
4081,Xanomeline Low Dose,0.464555281,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.46,-0.46
4082,Xanomeline Low Dose,0.361021627,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.36,-0.36
4083,Xanomeline Low Dose,0.43997509,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.44,-0.44
4084,Xanomeline Low Dose,0.507344474,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.51,-0.51
4085,Xanomeline Low Dose,0.441292246,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.44,-0.44
4086,Xanomeline Low Dose,0.404798873,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,0.4,-0.4
4087,Xanomeline Low Dose,14.12506923,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.13,-14.13
4088,Xanomeline Low Dose,14.32693651,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.33,-14.33
4089,Xanomeline Low Dose,14.19595542,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.2,-14.2
4090,Xanomeline Low Dose,14.5524383,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.55,-14.55
4091,Xanomeline Low Dose,14.27130474,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.27,-14.27
4092,Xanomeline Low Dose,14.54794738,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.55,-14.55
4093,Xanomeline Low Dose,14.07154826,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.07,-14.07
4094,Xanomeline Low Dose,13.8496798,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,13.85,-13.85
4095,Xanomeline Low Dose,14.36948172,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.37,-14.37
4096,Xanomeline Low Dose,14.41713983,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,14.42,-14.42
4097,Xanomeline Low Dose,13.90766846,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",2,13.91,-13.91
4098,Placebo,78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78,78
4099,Placebo,74,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74,74
4100,Placebo,73,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73,73
4101,Placebo,76.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76.5,76.5
4102,Placebo,74,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74,74
4103,Placebo,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
4104,Placebo,74,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74,74
4105,Placebo,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
4106,Placebo,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76,76
4107,Placebo,74,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74,74
4108,Placebo,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76,76
4109,Placebo,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
4110,Placebo,74,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74,74
4111,Placebo,74,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74,74
4112,Placebo,70.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.5,70.5
4113,Placebo,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
4114,Placebo,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
4115,Placebo,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
4116,Placebo,74,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74,74
4117,Placebo,73.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.5,73.5
4118,Placebo,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
4119,Placebo,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
4120,Placebo,137,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,137,137
4121,Placebo,130,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130,130
4122,Placebo,132,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,132,132
4123,Placebo,134,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,134,134
4124,Placebo,130,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130,130
4125,Placebo,130,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130,130
4126,Placebo,131,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,131,131
4127,Placebo,130,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130,130
4128,Placebo,133.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,133.5,133.5
4129,Placebo,130,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130,130
4130,Placebo,138,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,138,138
4131,Placebo,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
4132,Placebo,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
4133,Placebo,36.72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
4134,Placebo,36.695,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
4135,Placebo,36.61,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
4136,Placebo,36.695,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
4137,Placebo,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
4138,Placebo,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
4139,Placebo,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
4140,Placebo,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
4141,Placebo,36.61,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
4142,Placebo,60.56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,60.6,60.6
4143,Placebo,63.095,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.1,63.1
4144,Placebo,63.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.5,63.5
4145,Placebo,62.595,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,62.6,62.6
4146,Placebo,62.82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,62.8,62.8
4147,Placebo,64.86,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64.9,64.9
4148,Placebo,63.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.5,63.5
4149,Placebo,62.645,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,62.6,62.6
4150,Placebo,63.05,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63,63
4151,Placebo,62.6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,62.6,62.6
4152,Placebo,61.24,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,61.2,61.2
4153,Xanomeline High Dose,79.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,79.5,79.5
4154,Xanomeline High Dose,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76,76
4155,Xanomeline High Dose,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76,76
4156,Xanomeline High Dose,78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78,78
4157,Xanomeline High Dose,77,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,77,77
4158,Xanomeline High Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
4159,Xanomeline High Dose,75.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.5,75.5
4160,Xanomeline High Dose,74,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74,74
4161,Xanomeline High Dose,78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78,78
4162,Xanomeline High Dose,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76,76
4163,Xanomeline High Dose,78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78,78
4164,Xanomeline High Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
4165,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
4166,Xanomeline High Dose,74,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74,74
4167,Xanomeline High Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
4168,Xanomeline High Dose,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76,76
4169,Xanomeline High Dose,79,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,79,79
4170,Xanomeline High Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
4171,Xanomeline High Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
4172,Xanomeline High Dose,74,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74,74
4173,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
4174,Xanomeline High Dose,72.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72.5,72.5
4175,Xanomeline High Dose,138,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,138,138
4176,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
4177,Xanomeline High Dose,130,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130,130
4178,Xanomeline High Dose,131,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,131,131
4179,Xanomeline High Dose,131,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,131,131
4180,Xanomeline High Dose,124,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,124,124
4181,Xanomeline High Dose,128,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,128,128
4182,Xanomeline High Dose,122.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,122.5,122.5
4183,Xanomeline High Dose,130,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130,130
4184,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
4185,Xanomeline High Dose,134,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,134,134
4186,Xanomeline High Dose,36.56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
4187,Xanomeline High Dose,36.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.8,36.8
4188,Xanomeline High Dose,36.83,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.8,36.8
4189,Xanomeline High Dose,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
4190,Xanomeline High Dose,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
4191,Xanomeline High Dose,36.725,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
4192,Xanomeline High Dose,36.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.8,36.8
4193,Xanomeline High Dose,36.83,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.8,36.8
4194,Xanomeline High Dose,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
4195,Xanomeline High Dose,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
4196,Xanomeline High Dose,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
4197,Xanomeline High Dose,69.175,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,69.2,69.2
4198,Xanomeline High Dose,68.04,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
4199,Xanomeline High Dose,70.99,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,71,71
4200,Xanomeline High Dose,70.31,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.3,70.3
4201,Xanomeline High Dose,70.53,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.5,70.5
4202,Xanomeline High Dose,68.945,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68.9,68.9
4203,Xanomeline High Dose,68.72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68.7,68.7
4204,Xanomeline High Dose,66.455,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,66.5,66.5
4205,Xanomeline High Dose,70.535,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70.5,70.5
4206,Xanomeline High Dose,71.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,71.2,71.2
4207,Xanomeline High Dose,71.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,71.8,71.8
4208,Xanomeline Low Dose,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76,76
4209,Xanomeline Low Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
4210,Xanomeline Low Dose,75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75,75
4211,Xanomeline Low Dose,75.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.5,75.5
4212,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
4213,Xanomeline Low Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
4214,Xanomeline Low Dose,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76,76
4215,Xanomeline Low Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
4216,Xanomeline Low Dose,78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78,78
4217,Xanomeline Low Dose,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76,76
4218,Xanomeline Low Dose,74.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.5,74.5
4219,Xanomeline Low Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
4220,Xanomeline Low Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
4221,Xanomeline Low Dose,74,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74,74
4222,Xanomeline Low Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
4223,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
4224,Xanomeline Low Dose,69.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,69.5,69.5
4225,Xanomeline Low Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
4226,Xanomeline Low Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
4227,Xanomeline Low Dose,74,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74,74
4228,Xanomeline Low Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
4229,Xanomeline Low Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
4230,Xanomeline Low Dose,138,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,138,138
4231,Xanomeline Low Dose,130,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130,130
4232,Xanomeline Low Dose,131.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,131.5,131.5
4233,Xanomeline Low Dose,130,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130,130
4234,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,NA,NA
4235,Xanomeline Low Dose,128,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,128,128
4236,Xanomeline Low Dose,130,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130,130
4237,Xanomeline Low Dose,130,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130,130
4238,Xanomeline Low Dose,134,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,134,134
4239,Xanomeline Low Dose,131,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,131,131
4240,Xanomeline Low Dose,132,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,132,132
4241,Xanomeline Low Dose,36.61,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
4242,Xanomeline Low Dose,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
4243,Xanomeline Low Dose,36.695,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
4244,Xanomeline Low Dose,36.56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
4245,Xanomeline Low Dose,36.53,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.5,36.5
4246,Xanomeline Low Dose,36.64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
4247,Xanomeline Low Dose,36.75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.8,36.8
4248,Xanomeline Low Dose,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
4249,Xanomeline Low Dose,36.61,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
4250,Xanomeline Low Dose,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
4251,Xanomeline Low Dose,36.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.7,36.7
4252,Xanomeline Low Dose,64.86,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64.9,64.9
4253,Xanomeline Low Dose,65.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,65.9,65.9
4254,Xanomeline Low Dose,65.205,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,65.2,65.2
4255,Xanomeline Low Dose,66.68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,66.7,66.7
4256,Xanomeline Low Dose,65.775,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,65.8,65.8
4257,Xanomeline Low Dose,62.6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,62.6,62.6
4258,Xanomeline Low Dose,62.6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,62.6,62.6
4259,Xanomeline Low Dose,62.14,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,62.1,62.1
4260,Xanomeline Low Dose,66.565,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,66.6,66.6
4261,Xanomeline Low Dose,66.68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,66.7,66.7
4262,Xanomeline Low Dose,65.66,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,65.7,65.7
4263,Placebo,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
4264,Placebo,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
4265,Placebo,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
4266,Placebo,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
4267,Placebo,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
4268,Placebo,67.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,67.2,67.2
4269,Placebo,66,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,66,66
4270,Placebo,66.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,66.2,66.2
4271,Placebo,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
4272,Placebo,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
4273,Placebo,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
4274,Placebo,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64,64
4275,Placebo,65,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,65,65
4276,Placebo,67.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,67.5,67.5
4277,Placebo,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64,64
4278,Placebo,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64,64
4279,Placebo,66,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,66,66
4280,Placebo,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64,64
4281,Placebo,64.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64.2,64.2
4282,Placebo,66,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,66,66
4283,Placebo,66,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,66,66
4284,Placebo,66,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,66,66
4285,Placebo,124,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,124,124
4286,Placebo,120,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,120,120
4287,Placebo,123.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,123.5,123.5
4288,Placebo,120,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,120,120
4289,Placebo,120.75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,120.8,120.8
4290,Placebo,120,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,120,120
4291,Placebo,122,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,122,122
4292,Placebo,120,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,120,120
4293,Placebo,122.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,122.2,122.2
4294,Placebo,121.75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,121.8,121.8
4295,Placebo,128,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,128,128
4296,Placebo,36.39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
4297,Placebo,36.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
4298,Placebo,36.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
4299,Placebo,36.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
4300,Placebo,36.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.3,36.3
4301,Placebo,36.39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
4302,Placebo,36.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
4303,Placebo,36.4025,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
4304,Placebo,36.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.3,36.3
4305,Placebo,36.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.3,36.3
4306,Placebo,36.39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
4307,Placebo,53.635,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,53.6,53.6
4308,Placebo,53.805,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,53.8,53.8
4309,Placebo,54.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,54.9,54.9
4310,Placebo,54.565,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,54.6,54.6
4311,Placebo,54.0925,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,54.1,54.1
4312,Placebo,54.43,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,54.4,54.4
4313,Placebo,54.155,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,54.2,54.2
4314,Placebo,53.805,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,53.8,53.8
4315,Placebo,54.43,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,54.4,54.4
4316,Placebo,53.975,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,54,54
4317,Placebo,54.3175,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,54.3,54.3
4318,Xanomeline High Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
4319,Xanomeline High Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
4320,Xanomeline High Dose,69,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,69,69
4321,Xanomeline High Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
4322,Xanomeline High Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
4323,Xanomeline High Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
4324,Xanomeline High Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
4325,Xanomeline High Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
4326,Xanomeline High Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
4327,Xanomeline High Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
4328,Xanomeline High Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,72,72
4329,Xanomeline High Dose,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64,64
4330,Xanomeline High Dose,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64,64
4331,Xanomeline High Dose,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64,64
4332,Xanomeline High Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
4333,Xanomeline High Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
4334,Xanomeline High Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
4335,Xanomeline High Dose,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64,64
4336,Xanomeline High Dose,65.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,65.5,65.5
4337,Xanomeline High Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
4338,Xanomeline High Dose,66,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,66,66
4339,Xanomeline High Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
4340,Xanomeline High Dose,125.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,125.5,125.5
4341,Xanomeline High Dose,118,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,118,118
4342,Xanomeline High Dose,118.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,118.5,118.5
4343,Xanomeline High Dose,122.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,122.5,122.5
4344,Xanomeline High Dose,120.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,120.5,120.5
4345,Xanomeline High Dose,119.75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,119.8,119.8
4346,Xanomeline High Dose,120,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,120,120
4347,Xanomeline High Dose,112.75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,112.8,112.8
4348,Xanomeline High Dose,120,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,120,120
4349,Xanomeline High Dose,120,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,120,120
4350,Xanomeline High Dose,124,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,124,124
4351,Xanomeline High Dose,36.3175,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.3,36.3
4352,Xanomeline High Dose,36.39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
4353,Xanomeline High Dose,36.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.5,36.5
4354,Xanomeline High Dose,36.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.3,36.3
4355,Xanomeline High Dose,36.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.2,36.2
4356,Xanomeline High Dose,36.53,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.5,36.5
4357,Xanomeline High Dose,36.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
4358,Xanomeline High Dose,36.56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.6,36.6
4359,Xanomeline High Dose,36.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
4360,Xanomeline High Dose,36.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.3,36.3
4361,Xanomeline High Dose,36.39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
4362,Xanomeline High Dose,56.925,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,56.9,56.9
4363,Xanomeline High Dose,56.7,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,56.7,56.7
4364,Xanomeline High Dose,59.5375,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,59.5,59.5
4365,Xanomeline High Dose,55.34,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,55.3,55.3
4366,Xanomeline High Dose,57.61,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,57.6,57.6
4367,Xanomeline High Dose,55.2275,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,55.2,55.2
4368,Xanomeline High Dose,56.0175,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,56,56
4369,Xanomeline High Dose,55.6775,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,55.7,55.7
4370,Xanomeline High Dose,57.495,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,57.5,57.5
4371,Xanomeline High Dose,57.495,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,57.5,57.5
4372,Xanomeline High Dose,61.2375,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,61.2,61.2
4373,Xanomeline Low Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
4374,Xanomeline Low Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
4375,Xanomeline Low Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
4376,Xanomeline Low Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
4377,Xanomeline Low Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
4378,Xanomeline Low Dose,68.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68.2,68.2
4379,Xanomeline Low Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
4380,Xanomeline Low Dose,65,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,65,65
4381,Xanomeline Low Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
4382,Xanomeline Low Dose,70,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,70,70
4383,Xanomeline Low Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
4384,Xanomeline Low Dose,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64,64
4385,Xanomeline Low Dose,63.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.5,63.5
4386,Xanomeline Low Dose,65.75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,65.8,65.8
4387,Xanomeline Low Dose,62,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,62,62
4388,Xanomeline Low Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,68,68
4389,Xanomeline Low Dose,63.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,63.2,63.2
4390,Xanomeline Low Dose,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64,64
4391,Xanomeline Low Dose,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64,64
4392,Xanomeline Low Dose,65.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,65.5,65.5
4393,Xanomeline Low Dose,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64,64
4394,Xanomeline Low Dose,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,64,64
4395,Xanomeline Low Dose,122,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,122,122
4396,Xanomeline Low Dose,120,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,120,120
4397,Xanomeline Low Dose,120,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,120,120
4398,Xanomeline Low Dose,124,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,124,124
4399,Xanomeline Low Dose,122,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,122,122
4400,Xanomeline Low Dose,118,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,118,118
4401,Xanomeline Low Dose,122,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,122,122
4402,Xanomeline Low Dose,115.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,115.5,115.5
4403,Xanomeline Low Dose,122,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,122,122
4404,Xanomeline Low Dose,122,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,122,122
4405,Xanomeline Low Dose,126,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,126,126
4406,Xanomeline Low Dose,36.36,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
4407,Xanomeline Low Dose,36.39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
4408,Xanomeline Low Dose,36.39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
4409,Xanomeline Low Dose,36.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.3,36.3
4410,Xanomeline Low Dose,36.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.2,36.2
4411,Xanomeline Low Dose,36.345,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.3,36.3
4412,Xanomeline Low Dose,36.4175,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.4,36.4
4413,Xanomeline Low Dose,36.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.5,36.5
4414,Xanomeline Low Dose,36.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.2,36.2
4415,Xanomeline Low Dose,36.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.3,36.3
4416,Xanomeline Low Dose,36.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.2,36.2
4417,Xanomeline Low Dose,56.02,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,56,56
4418,Xanomeline Low Dose,55.5125,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,55.5,55.5
4419,Xanomeline Low Dose,56.0225,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,56,56
4420,Xanomeline Low Dose,56.8125,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,56.8,56.8
4421,Xanomeline Low Dose,55.79,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,55.8,55.8
4422,Xanomeline Low Dose,57.04,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,57,57
4423,Xanomeline Low Dose,56.815,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,56.8,56.8
4424,Xanomeline Low Dose,56.93,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,56.9,56.9
4425,Xanomeline Low Dose,55.5125,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,55.5,55.5
4426,Xanomeline Low Dose,54.66,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,54.7,54.7
4427,Xanomeline Low Dose,55.34,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,55.3,55.3
4428,Placebo,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,84,84
4429,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4430,Placebo,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,82,82
4431,Placebo,82.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,82.2,82.2
4432,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4433,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4434,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4435,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4436,Placebo,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,82,82
4437,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4438,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4439,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4440,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4441,Placebo,82.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,82.5,82.5
4442,Placebo,78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78,78
4443,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4444,Placebo,78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78,78
4445,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4446,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4447,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4448,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4449,Placebo,78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78,78
4450,Placebo,150,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,150,150
4451,Placebo,145,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,145,145
4452,Placebo,140,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,140,140
4453,Placebo,150,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,150,150
4454,Placebo,146.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,146.2,146.2
4455,Placebo,144,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,144,144
4456,Placebo,144,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,144,144
4457,Placebo,144,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,144,144
4458,Placebo,146,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,146,146
4459,Placebo,145,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,145,145
4460,Placebo,146,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,146,146
4461,Placebo,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4462,Placebo,36.94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4463,Placebo,36.94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4464,Placebo,36.94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4465,Placebo,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4466,Placebo,36.94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4467,Placebo,36.94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4468,Placebo,37,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,37,37
4469,Placebo,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4470,Placebo,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4471,Placebo,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4472,Placebo,74.1625,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.2,74.2
4473,Placebo,74.1625,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.2,74.2
4474,Placebo,75.3,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.3,75.3
4475,Placebo,75.4125,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.4,75.4
4476,Placebo,75.0725,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.1,75.1
4477,Placebo,74.7275,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.7,74.7
4478,Placebo,74.845,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.8,74.8
4479,Placebo,74.1625,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.2,74.2
4480,Placebo,74.7275,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.7,74.7
4481,Placebo,74.39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.4,74.4
4482,Placebo,74.0525,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.1,74.1
4483,Xanomeline High Dose,86,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,86,86
4484,Xanomeline High Dose,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,82,82
4485,Xanomeline High Dose,81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,81,81
4486,Xanomeline High Dose,81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,81,81
4487,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,84,84
4488,Xanomeline High Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4489,Xanomeline High Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4490,Xanomeline High Dose,80.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80.5,80.5
4491,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,84,84
4492,Xanomeline High Dose,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,82,82
4493,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,84,84
4494,Xanomeline High Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4495,Xanomeline High Dose,76.75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76.8,76.8
4496,Xanomeline High Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4497,Xanomeline High Dose,80.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80.5,80.5
4498,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,84,84
4499,Xanomeline High Dose,86,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,86,86
4500,Xanomeline High Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4501,Xanomeline High Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4502,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,84,84
4503,Xanomeline High Dose,80.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80.5,80.5
4504,Xanomeline High Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4505,Xanomeline High Dose,150,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,150,150
4506,Xanomeline High Dose,138,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,138,138
4507,Xanomeline High Dose,140,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,140,140
4508,Xanomeline High Dose,142,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,142,142
4509,Xanomeline High Dose,142,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,142,142
4510,Xanomeline High Dose,132,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,132,132
4511,Xanomeline High Dose,140,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,140,140
4512,Xanomeline High Dose,130.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,130.2,130.2
4513,Xanomeline High Dose,142,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,142,142
4514,Xanomeline High Dose,138.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,138.5,138.5
4515,Xanomeline High Dose,144.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,144.2,144.2
4516,Xanomeline High Dose,36.94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4517,Xanomeline High Dose,36.94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4518,Xanomeline High Dose,36.94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4519,Xanomeline High Dose,36.94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4520,Xanomeline High Dose,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4521,Xanomeline High Dose,37,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,37,37
4522,Xanomeline High Dose,37,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,37,37
4523,Xanomeline High Dose,37,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,37,37
4524,Xanomeline High Dose,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4525,Xanomeline High Dose,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4526,Xanomeline High Dose,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4527,Xanomeline High Dose,80.29,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80.3,80.3
4528,Xanomeline High Dose,79.945,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,79.9,79.9
4529,Xanomeline High Dose,81.6475,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,81.6,81.6
4530,Xanomeline High Dose,81.65,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,81.7,81.7
4531,Xanomeline High Dose,79.38,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,79.4,79.4
4532,Xanomeline High Dose,81.8725,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,81.9,81.9
4533,Xanomeline High Dose,82.8975,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,82.9,82.9
4534,Xanomeline High Dose,81.99,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,82,82
4535,Xanomeline High Dose,80.5725,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80.6,80.6
4536,Xanomeline High Dose,80.285,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80.3,80.3
4537,Xanomeline High Dose,80.9075,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80.9,80.9
4538,Xanomeline Low Dose,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,82,82
4539,Xanomeline Low Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4540,Xanomeline Low Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,84,84
4541,Xanomeline Low Dose,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,82,82
4542,Xanomeline Low Dose,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,82,82
4543,Xanomeline Low Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4544,Xanomeline Low Dose,83,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,83,83
4545,Xanomeline Low Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4546,Xanomeline Low Dose,81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,81,81
4547,Xanomeline Low Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4548,Xanomeline Low Dose,82.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,82.5,82.5
4549,Xanomeline Low Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4550,Xanomeline Low Dose,78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78,78
4551,Xanomeline Low Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4552,Xanomeline Low Dose,74.75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,74.8,74.8
4553,Xanomeline Low Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4554,Xanomeline Low Dose,75.75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.8,75.8
4555,Xanomeline Low Dose,77,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,77,77
4556,Xanomeline Low Dose,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,76,76
4557,Xanomeline Low Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4558,Xanomeline Low Dose,78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78,78
4559,Xanomeline Low Dose,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,80,80
4560,Xanomeline Low Dose,150,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,150,150
4561,Xanomeline Low Dose,144,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,144,144
4562,Xanomeline Low Dose,144.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,144.5,144.5
4563,Xanomeline Low Dose,140,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,140,140
4564,Xanomeline Low Dose,146,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,146,146
4565,Xanomeline Low Dose,140,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,140,140
4566,Xanomeline Low Dose,140,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,140,140
4567,Xanomeline Low Dose,140,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,140,140
4568,Xanomeline Low Dose,147.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,147.2,147.2
4569,Xanomeline Low Dose,146,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,146,146
4570,Xanomeline Low Dose,144.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,144.2,144.2
4571,Xanomeline Low Dose,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4572,Xanomeline Low Dose,36.9025,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4573,Xanomeline Low Dose,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4574,Xanomeline Low Dose,36.94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4575,Xanomeline Low Dose,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4576,Xanomeline Low Dose,37,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,37,37
4577,Xanomeline Low Dose,36.94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4578,Xanomeline Low Dose,36.9025,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4579,Xanomeline Low Dose,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4580,Xanomeline Low Dose,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4581,Xanomeline Low Dose,36.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,36.9,36.9
4582,Xanomeline Low Dose,77.45,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,77.4,77.4
4583,Xanomeline Low Dose,78.1325,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78.1,78.1
4584,Xanomeline Low Dose,78.1325,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78.1,78.1
4585,Xanomeline Low Dose,78.1875,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78.2,78.2
4586,Xanomeline Low Dose,77.795,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,77.8,77.8
4587,Xanomeline Low Dose,77.565,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,77.6,77.6
4588,Xanomeline Low Dose,75.07,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,75.1,75.1
4589,Xanomeline Low Dose,73.48,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,73.5,73.5
4590,Xanomeline Low Dose,78.47,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78.5,78.5
4591,Xanomeline Low Dose,78.47,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78.5,78.5
4592,Xanomeline Low Dose,78.1325,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",1,78.1,78.1
4593,Placebo,40,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,40,40
4594,Placebo,39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,39,39
4595,Placebo,49,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,49,49
4596,Placebo,49,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,49,49
4597,Placebo,45,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,45,45
4598,Placebo,48,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,48,48
4599,Placebo,44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,44,44
4600,Placebo,39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,39,39
4601,Placebo,39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,39,39
4602,Placebo,48,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,48,48
4603,Placebo,49,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,49,49
4604,Placebo,51,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,51,51
4605,Placebo,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
4606,Placebo,51,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,51,51
4607,Placebo,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
4608,Placebo,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
4609,Placebo,53,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,53,53
4610,Placebo,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
4611,Placebo,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
4612,Placebo,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
4613,Placebo,53,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,53,53
4614,Placebo,52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,52,52
4615,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,80,80
4616,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,80,80
4617,Placebo,78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,78,78
4618,Placebo,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,76,76
4619,Placebo,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,90,90
4620,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,80,80
4621,Placebo,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,90,90
4622,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,80,80
4623,Placebo,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,84,84
4624,Placebo,80,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,80,80
4625,Placebo,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,90,90
4626,Placebo,35.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
4627,Placebo,35.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
4628,Placebo,35,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
4629,Placebo,35.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,36,36
4630,Placebo,35.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
4631,Placebo,35.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
4632,Placebo,34.72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
4633,Placebo,35.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
4634,Placebo,34.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,34,34
4635,Placebo,35.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
4636,Placebo,35.61,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,36,36
4637,Placebo,34.02,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,34,34
4638,Placebo,34.47,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,34,34
4639,Placebo,34.02,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,34,34
4640,Placebo,33.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,33,33
4641,Placebo,33.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,33,33
4642,Placebo,33.57,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,34,34
4643,Placebo,34.02,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,34,34
4644,Placebo,34.47,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,34,34
4645,Placebo,34.47,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,34,34
4646,Placebo,34.47,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,34,34
4647,Placebo,34.47,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,34,34
4648,Xanomeline High Dose,51,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,51,51
4649,Xanomeline High Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
4650,Xanomeline High Dose,54,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,54,54
4651,Xanomeline High Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
4652,Xanomeline High Dose,43,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,43,43
4653,Xanomeline High Dose,54,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,54,54
4654,Xanomeline High Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
4655,Xanomeline High Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
4656,Xanomeline High Dose,54,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,54,54
4657,Xanomeline High Dose,52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,52,52
4658,Xanomeline High Dose,54,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,54,54
4659,Xanomeline High Dose,52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,52,52
4660,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
4661,Xanomeline High Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
4662,Xanomeline High Dose,51,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,51,51
4663,Xanomeline High Dose,54,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,54,54
4664,Xanomeline High Dose,52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,52,52
4665,Xanomeline High Dose,47,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,47,47
4666,Xanomeline High Dose,53,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,53,53
4667,Xanomeline High Dose,48,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,48,48
4668,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
4669,Xanomeline High Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
4670,Xanomeline High Dose,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
4671,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
4672,Xanomeline High Dose,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
4673,Xanomeline High Dose,99,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,99,99
4674,Xanomeline High Dose,88,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,88,88
4675,Xanomeline High Dose,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
4676,Xanomeline High Dose,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,90,90
4677,Xanomeline High Dose,95,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,95,95
4678,Xanomeline High Dose,95,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,95,95
4679,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
4680,Xanomeline High Dose,91,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,91,91
4681,Xanomeline High Dose,35.61,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,36,36
4682,Xanomeline High Dose,35.72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,36,36
4683,Xanomeline High Dose,35.56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,36,36
4684,Xanomeline High Dose,35.56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,36,36
4685,Xanomeline High Dose,35.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
4686,Xanomeline High Dose,35.06,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
4687,Xanomeline High Dose,35.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,36,36
4688,Xanomeline High Dose,36.39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,36,36
4689,Xanomeline High Dose,35.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
4690,Xanomeline High Dose,35.61,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,36,36
4691,Xanomeline High Dose,35.61,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,36,36
4692,Xanomeline High Dose,41.73,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,42,42
4693,Xanomeline High Dose,42.18,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,42,42
4694,Xanomeline High Dose,48.08,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,48,48
4695,Xanomeline High Dose,48.54,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,49,49
4696,Xanomeline High Dose,42.64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,43,43
4697,Xanomeline High Dose,50.8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,51,51
4698,Xanomeline High Dose,49.9,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
4699,Xanomeline High Dose,49.9,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
4700,Xanomeline High Dose,42.18,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,42,42
4701,Xanomeline High Dose,47.17,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,47,47
4702,Xanomeline High Dose,48.08,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,48,48
4703,Xanomeline Low Dose,48,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,48,48
4704,Xanomeline Low Dose,51,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,51,51
4705,Xanomeline Low Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
4706,Xanomeline Low Dose,55,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,55,55
4707,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
4708,Xanomeline Low Dose,51,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,51,51
4709,Xanomeline Low Dose,57,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,57,57
4710,Xanomeline Low Dose,56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,56,56
4711,Xanomeline Low Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
4712,Xanomeline Low Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
4713,Xanomeline Low Dose,52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,52,52
4714,Xanomeline Low Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,50,50
4715,Xanomeline Low Dose,48,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,48,48
4716,Xanomeline Low Dose,48,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,48,48
4717,Xanomeline Low Dose,48,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,48,48
4718,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
4719,Xanomeline Low Dose,40,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,40,40
4720,Xanomeline Low Dose,52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,52,52
4721,Xanomeline Low Dose,53,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,53,53
4722,Xanomeline Low Dose,48,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,48,48
4723,Xanomeline Low Dose,52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,52,52
4724,Xanomeline Low Dose,49,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,49,49
4725,Xanomeline Low Dose,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
4726,Xanomeline Low Dose,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
4727,Xanomeline Low Dose,92,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,92,92
4728,Xanomeline Low Dose,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
4729,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
4730,Xanomeline Low Dose,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
4731,Xanomeline Low Dose,92,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,92,92
4732,Xanomeline Low Dose,99,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,99,99
4733,Xanomeline Low Dose,95,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,95,95
4734,Xanomeline Low Dose,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
4735,Xanomeline Low Dose,92,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,92,92
4736,Xanomeline Low Dose,35.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
4737,Xanomeline Low Dose,35.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
4738,Xanomeline Low Dose,35.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
4739,Xanomeline Low Dose,35.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,36,36
4740,Xanomeline Low Dose,35.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
4741,Xanomeline Low Dose,35.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
4742,Xanomeline Low Dose,35.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,36,36
4743,Xanomeline Low Dose,35.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
4744,Xanomeline Low Dose,34.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,34,34
4745,Xanomeline Low Dose,35.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,35,35
4746,Xanomeline Low Dose,35.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,36,36
4747,Xanomeline Low Dose,45.36,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,45,45
4748,Xanomeline Low Dose,41.73,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,42,42
4749,Xanomeline Low Dose,44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,44,44
4750,Xanomeline Low Dose,44.23,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,44,44
4751,Xanomeline Low Dose,44.91,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,45,45
4752,Xanomeline Low Dose,41.73,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,42,42
4753,Xanomeline Low Dose,45.54,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,46,46
4754,Xanomeline Low Dose,47.17,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,47,47
4755,Xanomeline Low Dose,44.45,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,44,44
4756,Xanomeline Low Dose,44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,44,44
4757,Xanomeline Low Dose,43.09,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,43,43
4758,Placebo,110,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,110,110
4759,Placebo,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
4760,Placebo,104,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,104,104
4761,Placebo,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
4762,Placebo,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
4763,Placebo,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
4764,Placebo,117,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,117,117
4765,Placebo,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
4766,Placebo,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
4767,Placebo,110,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,110,110
4768,Placebo,101,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,101,101
4769,Placebo,134,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,134,134
4770,Placebo,108,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,108,108
4771,Placebo,106,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,106,106
4772,Placebo,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,90,90
4773,Placebo,106,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,106,106
4774,Placebo,96,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,96,96
4775,Placebo,92,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,92,92
4776,Placebo,108,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,108,108
4777,Placebo,120,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,120,120
4778,Placebo,108,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,108,108
4779,Placebo,102,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,102,102
4780,Placebo,184,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,184,184
4781,Placebo,180,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,180,180
4782,Placebo,168,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,168,168
4783,Placebo,190,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,190,190
4784,Placebo,173,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,173,173
4785,Placebo,200,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,200,200
4786,Placebo,199,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,199,199
4787,Placebo,176,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,176,176
4788,Placebo,202,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,202,202
4789,Placebo,210,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,210,210
4790,Placebo,189,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,189,189
4791,Placebo,37.17,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
4792,Placebo,37.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,38,38
4793,Placebo,37.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
4794,Placebo,37.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
4795,Placebo,37.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,38,38
4796,Placebo,37.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,38,38
4797,Placebo,37.56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,38,38
4798,Placebo,37.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,38,38
4799,Placebo,37.56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,38,38
4800,Placebo,37.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,38,38
4801,Placebo,37.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
4802,Placebo,86.18,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,86,86
4803,Placebo,87.09,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,87,87
4804,Placebo,84.37,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,84,84
4805,Placebo,85.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,85,85
4806,Placebo,88,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,88,88
4807,Placebo,86.18,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,86,86
4808,Placebo,86.64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,87,87
4809,Placebo,87.09,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,87,87
4810,Placebo,84.37,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,84,84
4811,Placebo,84.82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,85,85
4812,Placebo,84.37,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,84,84
4813,Xanomeline High Dose,108,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,108,108
4814,Xanomeline High Dose,99,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,99,99
4815,Xanomeline High Dose,92,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,92,92
4816,Xanomeline High Dose,92,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,92,92
4817,Xanomeline High Dose,118,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,118,118
4818,Xanomeline High Dose,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
4819,Xanomeline High Dose,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
4820,Xanomeline High Dose,93,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,93,93
4821,Xanomeline High Dose,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
4822,Xanomeline High Dose,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
4823,Xanomeline High Dose,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
4824,Xanomeline High Dose,104,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,104,104
4825,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
4826,Xanomeline High Dose,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
4827,Xanomeline High Dose,96,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,96,96
4828,Xanomeline High Dose,106,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,106,106
4829,Xanomeline High Dose,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
4830,Xanomeline High Dose,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
4831,Xanomeline High Dose,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
4832,Xanomeline High Dose,114,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,114,114
4833,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
4834,Xanomeline High Dose,104,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,104,104
4835,Xanomeline High Dose,194,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,194,194
4836,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
4837,Xanomeline High Dose,177,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,177,177
4838,Xanomeline High Dose,186,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,186,186
4839,Xanomeline High Dose,191,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,191,191
4840,Xanomeline High Dose,185,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,185,185
4841,Xanomeline High Dose,198,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,198,198
4842,Xanomeline High Dose,179,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,179,179
4843,Xanomeline High Dose,181,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,181,181
4844,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
4845,Xanomeline High Dose,198,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,198,198
4846,Xanomeline High Dose,37.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
4847,Xanomeline High Dose,37.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
4848,Xanomeline High Dose,37.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
4849,Xanomeline High Dose,37.17,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
4850,Xanomeline High Dose,37.39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
4851,Xanomeline High Dose,38.06,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,38,38
4852,Xanomeline High Dose,37.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,38,38
4853,Xanomeline High Dose,37.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
4854,Xanomeline High Dose,37.39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
4855,Xanomeline High Dose,37.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
4856,Xanomeline High Dose,37.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
4857,Xanomeline High Dose,107.96,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,108,108
4858,Xanomeline High Dose,105.24,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,105,105
4859,Xanomeline High Dose,105.24,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,105,105
4860,Xanomeline High Dose,105.24,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,105,105
4861,Xanomeline High Dose,106.6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,107,107
4862,Xanomeline High Dose,105.69,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,106,106
4863,Xanomeline High Dose,105.69,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,106,106
4864,Xanomeline High Dose,105.24,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,105,105
4865,Xanomeline High Dose,105.69,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,106,106
4866,Xanomeline High Dose,104.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,105,105
4867,Xanomeline High Dose,103.42,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,103,103
4868,Xanomeline Low Dose,108,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,108,108
4869,Xanomeline Low Dose,102,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,102,102
4870,Xanomeline Low Dose,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
4871,Xanomeline Low Dose,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
4872,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
4873,Xanomeline Low Dose,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
4874,Xanomeline Low Dose,98,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,98,98
4875,Xanomeline Low Dose,92,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,92,92
4876,Xanomeline Low Dose,102,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,102,102
4877,Xanomeline Low Dose,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
4878,Xanomeline Low Dose,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
4879,Xanomeline Low Dose,104,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,104,104
4880,Xanomeline Low Dose,104,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,104,104
4881,Xanomeline Low Dose,94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,94,94
4882,Xanomeline Low Dose,104,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,104,104
4883,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
4884,Xanomeline Low Dose,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
4885,Xanomeline Low Dose,96,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,96,96
4886,Xanomeline Low Dose,92,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,92,92
4887,Xanomeline Low Dose,100,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,100,100
4888,Xanomeline Low Dose,96,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,96,96
4889,Xanomeline Low Dose,104,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,104,104
4890,Xanomeline Low Dose,186,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,186,186
4891,Xanomeline Low Dose,200,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,200,200
4892,Xanomeline Low Dose,170,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,170,170
4893,Xanomeline Low Dose,168,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,168,168
4894,Xanomeline Low Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,NA,NA
4895,Xanomeline Low Dose,162,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,162,162
4896,Xanomeline Low Dose,173,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,173,173
4897,Xanomeline Low Dose,173,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,173,173
4898,Xanomeline Low Dose,180,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,180,180
4899,Xanomeline Low Dose,200,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,200,200
4900,Xanomeline Low Dose,200,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,200,200
4901,Xanomeline Low Dose,37.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
4902,Xanomeline Low Dose,37.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
4903,Xanomeline Low Dose,38.06,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,38,38
4904,Xanomeline Low Dose,37.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
4905,Xanomeline Low Dose,37.67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,38,38
4906,Xanomeline Low Dose,37.56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,38,38
4907,Xanomeline Low Dose,37.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
4908,Xanomeline Low Dose,37.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
4909,Xanomeline Low Dose,37.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
4910,Xanomeline Low Dose,37.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
4911,Xanomeline Low Dose,37.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,37,37
4912,Xanomeline Low Dose,106.14,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Baseline,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,106,106
4913,Xanomeline Low Dose,104.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,End of Treatment,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,105,105
4914,Xanomeline Low Dose,105.69,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 12,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,106,106
4915,Xanomeline Low Dose,106.6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 16,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,107,107
4916,Xanomeline Low Dose,104.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 2,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,105,105
4917,Xanomeline Low Dose,106.6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 20,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,107,107
4918,Xanomeline Low Dose,106.14,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 24,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,106,106
4919,Xanomeline Low Dose,104.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 26,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,105,105
4920,Xanomeline Low Dose,105.69,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 4,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,106,106
4921,Xanomeline Low Dose,106.14,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 6,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,106,106
4922,Xanomeline Low Dose,106.14,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 8,An08_01_Obs_Summ_ByTrt,"Summary of Observed Value by Treatment, Parameter and Visit",0,106,106
4923,Placebo,255,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,255,255
4924,Placebo,246,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,246,246
4925,Placebo,207,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,207,207
4926,Placebo,204,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,204,204
4927,Placebo,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,252,252
4928,Placebo,198,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,198,198
4929,Placebo,177,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,177,177
4930,Placebo,174,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,174,174
4931,Placebo,246,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,246,246
4932,Placebo,228,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,228,228
4933,Placebo,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,219,219
4934,Placebo,255,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,255,255
4935,Placebo,246,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,246,246
4936,Placebo,207,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,207,207
4937,Placebo,204,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,204,204
4938,Placebo,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,252,252
4939,Placebo,198,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,198,198
4940,Placebo,177,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,177,177
4941,Placebo,174,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,174,174
4942,Placebo,246,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,246,246
4943,Placebo,228,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,228,228
4944,Placebo,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,219,219
4945,Placebo,255,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,255,255
4946,Placebo,246,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,246,246
4947,Placebo,207,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,207,207
4948,Placebo,204,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,204,204
4949,Placebo,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,252,252
4950,Placebo,198,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,198,198
4951,Placebo,177,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,177,177
4952,Placebo,174,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,174,174
4953,Placebo,246,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,246,246
4954,Placebo,228,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,228,228
4955,Placebo,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,219,219
4956,Placebo,86,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,86,86
4957,Placebo,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,82,82
4958,Placebo,69,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,69,69
4959,Placebo,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,68,68
4960,Placebo,83,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,83,83
4961,Placebo,64,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,64,64
4962,Placebo,57,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,57,57
4963,Placebo,58,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,58,58
4964,Placebo,81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,81,81
4965,Placebo,76,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,76,76
4966,Placebo,73,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,73,73
4967,Placebo,86,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,86,86
4968,Placebo,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,82,82
4969,Placebo,69,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,69,69
4970,Placebo,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,68,68
4971,Placebo,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,82,82
4972,Placebo,66,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,66,66
4973,Placebo,59,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,59,59
4974,Placebo,58,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,58,58
4975,Placebo,82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,82,82
4976,Placebo,75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,75,75
4977,Placebo,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,72,72
4978,Xanomeline High Dose,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,252,252
4979,Xanomeline High Dose,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,219,219
4980,Xanomeline High Dose,150,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,150,150
4981,Xanomeline High Dose,111,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,111,111
4982,Xanomeline High Dose,243,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,243,243
4983,Xanomeline High Dose,96,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,96,96
4984,Xanomeline High Dose,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,90,90
4985,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,84,84
4986,Xanomeline High Dose,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,219,219
4987,Xanomeline High Dose,203,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,203,203
4988,Xanomeline High Dose,168,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,168,168
4989,Xanomeline High Dose,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,252,252
4990,Xanomeline High Dose,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,219,219
4991,Xanomeline High Dose,150,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,150,150
4992,Xanomeline High Dose,111,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,111,111
4993,Xanomeline High Dose,243,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,243,243
4994,Xanomeline High Dose,96,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,96,96
4995,Xanomeline High Dose,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,90,90
4996,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,84,84
4997,Xanomeline High Dose,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,219,219
4998,Xanomeline High Dose,204,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,204,204
4999,Xanomeline High Dose,168,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,168,168
5000,Xanomeline High Dose,252,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,252,252
5001,Xanomeline High Dose,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,219,219
5002,Xanomeline High Dose,150,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,150,150
5003,Xanomeline High Dose,111,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,111,111
5004,Xanomeline High Dose,243,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,243,243
5005,Xanomeline High Dose,96,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,96,96
5006,Xanomeline High Dose,90,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,90,90
5007,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,84,84
5008,Xanomeline High Dose,219,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,219,219
5009,Xanomeline High Dose,204,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,204,204
5010,Xanomeline High Dose,168,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,168,168
5011,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,84,84
5012,Xanomeline High Dose,73,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,73,73
5013,Xanomeline High Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,50,50
5014,Xanomeline High Dose,37,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,37,37
5015,Xanomeline High Dose,81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,81,81
5016,Xanomeline High Dose,32,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,32,32
5017,Xanomeline High Dose,29,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,29,29
5018,Xanomeline High Dose,28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,28,28
5019,Xanomeline High Dose,73,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,73,73
5020,Xanomeline High Dose,68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,68,68
5021,Xanomeline High Dose,56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,56,56
5022,Xanomeline High Dose,84,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,84,84
5023,Xanomeline High Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,72,72
5024,Xanomeline High Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,50,50
5025,Xanomeline High Dose,37,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,37,37
5026,Xanomeline High Dose,81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,81,81
5027,Xanomeline High Dose,32,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,32,32
5028,Xanomeline High Dose,30,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,30,30
5029,Xanomeline High Dose,28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,28,28
5030,Xanomeline High Dose,72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,72,72
5031,Xanomeline High Dose,67,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,67,67
5032,Xanomeline High Dose,56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_1_n,Out14-3-3-1b,n,XX,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,56,56
5033,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5034,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5035,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5036,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5037,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5038,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5039,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5040,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5041,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5042,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5043,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5044,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5045,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5046,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5047,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5048,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5049,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5050,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5051,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5052,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5053,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5054,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5055,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5056,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5057,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5058,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5059,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5060,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5061,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5062,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5063,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5064,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5065,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5066,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5067,Placebo,0.082317073,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
5068,Placebo,0.098115942,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
5069,Placebo,0.118088235,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
5070,Placebo,-0.025542169,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5071,Placebo,0.06390625,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
5072,Placebo,0.077192982,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
5073,Placebo,0.132931034,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
5074,Placebo,0.013580247,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5075,Placebo,0.0375,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5076,Placebo,0.033424658,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5077,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5078,Placebo,0.038292683,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5079,Placebo,0.524637681,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.5,0.5
5080,Placebo,0.359558824,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.4,0.4
5081,Placebo,0.09195122,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
5082,Placebo,0.133333333,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
5083,Placebo,0.147118644,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
5084,Placebo,-0.093275862,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.1,-0.1
5085,Placebo,0.237195122,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.2,0.2
5086,Placebo,0.2468,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.2,0.2
5087,Placebo,0.228055556,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.2,0.2
5088,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5089,Xanomeline High Dose,-3.136986301,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-3.1,-3.1
5090,Xanomeline High Dose,-4.073333333,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-4.1,-4.1
5091,Xanomeline High Dose,-2.009009009,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-2,-2
5092,Xanomeline High Dose,-1.732510288,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-1.7,-1.7
5093,Xanomeline High Dose,-2.947916667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-2.9,-2.9
5094,Xanomeline High Dose,-2.2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-2.2,-2.2
5095,Xanomeline High Dose,-3.035714286,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-3,-3
5096,Xanomeline High Dose,-1.479452055,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-1.5,-1.5
5097,Xanomeline High Dose,-3.305418719,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-3.3,-3.3
5098,Xanomeline High Dose,-1.261904762,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-1.3,-1.3
5099,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5100,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5101,Xanomeline High Dose,0.693333333,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.7,0.7
5102,Xanomeline High Dose,0.585585586,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.6,0.6
5103,Xanomeline High Dose,3.378600823,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,3.4,3.4
5104,Xanomeline High Dose,3.385416667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,3.4,3.4
5105,Xanomeline High Dose,-2.155555556,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-2.2,-2.2
5106,Xanomeline High Dose,-1.297619048,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-1.3,-1.3
5107,Xanomeline High Dose,3.360730594,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,3.4,3.4
5108,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5109,Xanomeline High Dose,1.553571429,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1.6,1.6
5110,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5111,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5112,Xanomeline High Dose,-8.42,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8.4,-8.4
5113,Xanomeline High Dose,-4.900900901,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-4.9,-4.9
5114,Xanomeline High Dose,-6.119341564,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-6.1,-6.1
5115,Xanomeline High Dose,-10.20833333,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10.2,-10.2
5116,Xanomeline High Dose,-6.966666667,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-7,-7
5117,Xanomeline High Dose,-14.44047619,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-14.4,-14.4
5118,Xanomeline High Dose,-6.251141553,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-6.3,-6.3
5119,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5120,Xanomeline High Dose,-3.642857143,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-3.6,-3.6
5121,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5122,Xanomeline High Dose,0.040958904,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5123,Xanomeline High Dose,0.0496,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5124,Xanomeline High Dose,-0.047837838,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5125,Xanomeline High Dose,0.00962963,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5126,Xanomeline High Dose,0.0446875,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5127,Xanomeline High Dose,0.013793103,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5128,Xanomeline High Dose,0.042857143,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5129,Xanomeline High Dose,0.046712329,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5130,Xanomeline High Dose,-0.012647059,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5131,Xanomeline High Dose,0.021428571,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5132,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5133,Xanomeline High Dose,0.059027778,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
5134,Xanomeline High Dose,0.6378,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.6,0.6
5135,Xanomeline High Dose,0.830810811,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.8,0.8
5136,Xanomeline High Dose,0.534814815,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.5,0.5
5137,Xanomeline High Dose,1.0128125,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1,1
5138,Xanomeline High Dose,0.995,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1,1
5139,Xanomeline High Dose,0.672857143,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.7,0.7
5140,Xanomeline High Dose,0.842777778,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.8,0.8
5141,Xanomeline High Dose,0.718208955,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.7,0.7
5142,Xanomeline High Dose,0.804642857,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_2_Mean,Out14-3-3-1b,Mean,XX.X,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.8,0.8
5143,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0,0
5144,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5145,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5146,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5147,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5148,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5149,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5150,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5151,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5152,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5153,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5154,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0,0
5155,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5156,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5157,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5158,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5159,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5160,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5161,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5162,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5163,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5164,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5165,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0,0
5166,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5167,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5168,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5169,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5170,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5171,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5172,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5173,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5174,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5175,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5176,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0,0
5177,Placebo,0.363987853,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.36,-0.36
5178,Placebo,0.371706222,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.37,-0.37
5179,Placebo,0.46604483,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.47,-0.47
5180,Placebo,0.416126895,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.42,-0.42
5181,Placebo,0.466124233,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.47,-0.47
5182,Placebo,0.548337599,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.55,-0.55
5183,Placebo,0.379006127,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.38,-0.38
5184,Placebo,0.435928058,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.44,-0.44
5185,Placebo,0.402793992,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.4,-0.4
5186,Placebo,0.361966923,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.36,-0.36
5187,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0,0
5188,Placebo,1.893126492,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,1.89,-1.89
5189,Placebo,2.291145732,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,2.29,-2.29
5190,Placebo,2.336051289,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,2.34,-2.34
5191,Placebo,0.9609466,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.96,-0.96
5192,Placebo,2.163752676,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,2.16,-2.16
5193,Placebo,2.296938781,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,2.3,-2.3
5194,Placebo,2.080578857,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,2.08,-2.08
5195,Placebo,1.14197714,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,1.14,-1.14
5196,Placebo,1.569569712,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,1.57,-1.57
5197,Placebo,1.583318532,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,1.58,-1.58
5198,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0,0
5199,Xanomeline High Dose,10.50423471,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,10.5,-10.5
5200,Xanomeline High Dose,10.9078487,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,10.91,-10.91
5201,Xanomeline High Dose,10.87323277,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,10.87,-10.87
5202,Xanomeline High Dose,10.86727082,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,10.87,-10.87
5203,Xanomeline High Dose,11.0371333,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,11.04,-11.04
5204,Xanomeline High Dose,9.851937584,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,9.85,-9.85
5205,Xanomeline High Dose,9.826747895,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,9.83,-9.83
5206,Xanomeline High Dose,11.05670487,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,11.06,-11.06
5207,Xanomeline High Dose,10.07964915,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,10.08,-10.08
5208,Xanomeline High Dose,9.666435599,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,9.67,-9.67
5209,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0,0
5210,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5211,Xanomeline High Dose,9.771858421,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,9.77,-9.77
5212,Xanomeline High Dose,12.02910748,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,12.03,-12.03
5213,Xanomeline High Dose,9.045150457,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,9.05,-9.05
5214,Xanomeline High Dose,10.522527,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,10.52,-10.52
5215,Xanomeline High Dose,11.8178223,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,11.82,-11.82
5216,Xanomeline High Dose,10.77902891,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,10.78,-10.78
5217,Xanomeline High Dose,10.32821518,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,10.33,-10.33
5218,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5219,Xanomeline High Dose,8.781280395,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,8.78,-8.78
5220,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0,0
5221,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5222,Xanomeline High Dose,15.34273761,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,15.34,-15.34
5223,Xanomeline High Dose,17.01227095,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,17.01,-17.01
5224,Xanomeline High Dose,15.56797134,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,15.57,-15.57
5225,Xanomeline High Dose,18.32853207,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,18.33,-18.33
5226,Xanomeline High Dose,17.7469415,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,17.75,-17.75
5227,Xanomeline High Dose,20.05675753,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,20.06,-20.06
5228,Xanomeline High Dose,15.96256906,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,15.96,-15.96
5229,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,NA,(NA)
5230,Xanomeline High Dose,15.92846498,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,15.93,-15.93
5231,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0,0
5232,Xanomeline High Dose,0.398915768,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.4,-0.4
5233,Xanomeline High Dose,0.344809678,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.34,-0.34
5234,Xanomeline High Dose,0.379986368,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.38,-0.38
5235,Xanomeline High Dose,0.405516475,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.41,-0.41
5236,Xanomeline High Dose,0.421311197,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.42,-0.42
5237,Xanomeline High Dose,0.499009117,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.5,-0.5
5238,Xanomeline High Dose,0.376709507,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.38,-0.38
5239,Xanomeline High Dose,0.332336237,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.33,-0.33
5240,Xanomeline High Dose,0.396558394,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.4,-0.4
5241,Xanomeline High Dose,0.366960134,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0.37,-0.37
5242,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,0,0
5243,Xanomeline High Dose,4.81890209,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,4.82,-4.82
5244,Xanomeline High Dose,4.897685538,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,4.9,-4.9
5245,Xanomeline High Dose,5.663358534,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,5.66,-5.66
5246,Xanomeline High Dose,3.975824163,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,3.98,-3.98
5247,Xanomeline High Dose,6.195530249,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,6.2,-6.2
5248,Xanomeline High Dose,6.471032935,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,6.47,-6.47
5249,Xanomeline High Dose,7.431156062,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,7.43,-7.43
5250,Xanomeline High Dose,4.139645566,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,4.14,-4.14
5251,Xanomeline High Dose,4.503905015,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,4.5,-4.5
5252,Xanomeline High Dose,4.669357738,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_3_SD,Out14-3-3-1b,SD,(XX.XX),WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",2,4.67,-4.67
5253,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5254,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5255,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5256,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5257,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5258,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5259,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5260,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5261,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5262,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5263,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5264,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5265,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5266,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5267,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5268,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5269,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5270,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5271,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5272,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5273,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5274,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5275,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5276,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5277,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5278,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5279,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5280,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5281,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5282,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5283,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5284,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5285,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5286,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5287,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5288,Placebo,0.05,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5289,Placebo,0.05,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5290,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5291,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5292,Placebo,0.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
5293,Placebo,0.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
5294,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5295,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5296,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5297,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5298,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5299,Placebo,0.23,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.2,0.2
5300,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5301,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5302,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5303,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5304,Placebo,-0.225,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
5305,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5306,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5307,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5308,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5309,Xanomeline High Dose,-2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-2,-2
5310,Xanomeline High Dose,-3.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-3.5,-3.5
5311,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5312,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5313,Xanomeline High Dose,-2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-2,-2
5314,Xanomeline High Dose,-4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-4,-4
5315,Xanomeline High Dose,-4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-4,-4
5316,Xanomeline High Dose,-1,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-1,-1
5317,Xanomeline High Dose,-2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-2,-2
5318,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5319,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5320,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5321,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5322,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5323,Xanomeline High Dose,3,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,3,3
5324,Xanomeline High Dose,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
5325,Xanomeline High Dose,-2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-2,-2
5326,Xanomeline High Dose,-2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-2,-2
5327,Xanomeline High Dose,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
5328,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5329,Xanomeline High Dose,2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,2,2
5330,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5331,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5332,Xanomeline High Dose,-9,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-9,-9
5333,Xanomeline High Dose,-5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-5,-5
5334,Xanomeline High Dose,-6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-6,-6
5335,Xanomeline High Dose,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
5336,Xanomeline High Dose,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
5337,Xanomeline High Dose,-18,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-18,-18
5338,Xanomeline High Dose,-7,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-7,-7
5339,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,NA,NA
5340,Xanomeline High Dose,-4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-4,-4
5341,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5342,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5343,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5344,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5345,Xanomeline High Dose,0.05,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5346,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5347,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5348,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5349,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5350,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5351,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5352,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5353,Xanomeline High Dose,-0.34,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.3,-0.3
5354,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5355,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5356,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5357,Xanomeline High Dose,0.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
5358,Xanomeline High Dose,-0.225,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
5359,Xanomeline High Dose,-0.225,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
5360,Xanomeline High Dose,0.45,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.4,0.4
5361,Xanomeline High Dose,0.45,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.5,0.5
5362,Xanomeline High Dose,0.23,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_4_Median,Out14-3-3-1b,Median,XX.X,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.2,0.2
5363,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5364,Placebo,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
5365,Placebo,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
5366,Placebo,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
5367,Placebo,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
5368,Placebo,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
5369,Placebo,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
5370,Placebo,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
5371,Placebo,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
5372,Placebo,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
5373,Placebo,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
5374,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5375,Placebo,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
5376,Placebo,-5.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-5.2,-5.2
5377,Placebo,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
5378,Placebo,-6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-6,-6
5379,Placebo,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
5380,Placebo,-6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-6,-6
5381,Placebo,-6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-6,-6
5382,Placebo,-4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-4,-4
5383,Placebo,-6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-6,-6
5384,Placebo,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
5385,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5386,Placebo,-17.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-17.5,-17.5
5387,Placebo,-13.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-13.2,-13.2
5388,Placebo,-14,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-14,-14
5389,Placebo,-12,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-12,-12
5390,Placebo,-15,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-15,-15
5391,Placebo,-12,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-12,-12
5392,Placebo,-19,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-19,-19
5393,Placebo,-12,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-12,-12
5394,Placebo,-11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-11,-11
5395,Placebo,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
5396,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5397,Placebo,-0.1175,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.1,-0.1
5398,Placebo,-0.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.1,-0.1
5399,Placebo,-0.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.1,-0.1
5400,Placebo,-0.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.3,-0.3
5401,Placebo,-0.2225,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
5402,Placebo,-0.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
5403,Placebo,-0.1175,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.1,-0.1
5404,Placebo,-0.17,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
5405,Placebo,-0.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
5406,Placebo,-0.17,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
5407,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5408,Placebo,-0.91,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.9,-0.9
5409,Placebo,-0.9,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.9,-0.9
5410,Placebo,-0.91,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.9,-0.9
5411,Placebo,-0.9,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.9,-0.9
5412,Placebo,-1.2475,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-1.2,-1.2
5413,Placebo,-0.91,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.9,-0.9
5414,Placebo,-1.36,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-1.4,-1.4
5415,Placebo,-0.45,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.5,-0.5
5416,Placebo,-0.455,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.5,-0.5
5417,Placebo,-0.45,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.5,-0.5
5418,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5419,Xanomeline High Dose,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
5420,Xanomeline High Dose,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
5421,Xanomeline High Dose,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
5422,Xanomeline High Dose,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
5423,Xanomeline High Dose,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
5424,Xanomeline High Dose,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
5425,Xanomeline High Dose,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
5426,Xanomeline High Dose,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
5427,Xanomeline High Dose,-10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-10,-10
5428,Xanomeline High Dose,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
5429,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5430,Xanomeline High Dose,-7,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-7,-7
5431,Xanomeline High Dose,-6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-6,-6
5432,Xanomeline High Dose,-7,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-7,-7
5433,Xanomeline High Dose,-2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-2,-2
5434,Xanomeline High Dose,-2.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-2.2,-2.2
5435,Xanomeline High Dose,-8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-8,-8
5436,Xanomeline High Dose,-7,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-7,-7
5437,Xanomeline High Dose,-4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-4,-4
5438,Xanomeline High Dose,-4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-4,-4
5439,Xanomeline High Dose,-4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-4,-4
5440,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5441,Xanomeline High Dose,-21.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-21.5,-21.5
5442,Xanomeline High Dose,-20,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-20,-20
5443,Xanomeline High Dose,-15.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-15.5,-15.5
5444,Xanomeline High Dose,-16,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-16,-16
5445,Xanomeline High Dose,-20,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-20,-20
5446,Xanomeline High Dose,-20,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-20,-20
5447,Xanomeline High Dose,-27,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-27,-27
5448,Xanomeline High Dose,-17,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-17,-17
5449,Xanomeline High Dose,-18,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-18,-18
5450,Xanomeline High Dose,-14,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-14,-14
5451,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5452,Xanomeline High Dose,-0.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
5453,Xanomeline High Dose,-0.17,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
5454,Xanomeline High Dose,-0.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.3,-0.3
5455,Xanomeline High Dose,-0.17,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
5456,Xanomeline High Dose,-0.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.3,-0.3
5457,Xanomeline High Dose,-0.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
5458,Xanomeline High Dose,-0.1975,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
5459,Xanomeline High Dose,-0.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.1,-0.1
5460,Xanomeline High Dose,-0.2225,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
5461,Xanomeline High Dose,-0.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.2,-0.2
5462,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5463,Xanomeline High Dose,-1.36,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-1.4,-1.4
5464,Xanomeline High Dose,-0.79,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.8,-0.8
5465,Xanomeline High Dose,-0.91,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.9,-0.9
5466,Xanomeline High Dose,-0.45,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.4,-0.4
5467,Xanomeline High Dose,-1.4725,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-1.5,-1.5
5468,Xanomeline High Dose,-1.6975,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-1.7,-1.7
5469,Xanomeline High Dose,-2.3825,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-2.4,-2.4
5470,Xanomeline High Dose,-0.285,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.3,-0.3
5471,Xanomeline High Dose,-0.91,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.9,-0.9
5472,Xanomeline High Dose,-0.46,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_5_Q1,Out14-3-3-1b,Q1,XX.X,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-0.5,-0.5
5473,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5474,Placebo,3,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,3,3
5475,Placebo,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
5476,Placebo,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
5477,Placebo,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
5478,Placebo,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
5479,Placebo,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
5480,Placebo,2.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,2.5,2.5
5481,Placebo,4.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4.5,4.5
5482,Placebo,2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,2,2
5483,Placebo,2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,2,2
5484,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5485,Placebo,6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,6,6
5486,Placebo,8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,8,8
5487,Placebo,3,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,3,3
5488,Placebo,6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,6,6
5489,Placebo,4.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4.5,4.5
5490,Placebo,6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,6,6
5491,Placebo,6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,6,6
5492,Placebo,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
5493,Placebo,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
5494,Placebo,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
5495,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5496,Placebo,7,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,7,7
5497,Placebo,8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,8,8
5498,Placebo,10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,10,10
5499,Placebo,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
5500,Placebo,6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,6,6
5501,Placebo,8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,8,8
5502,Placebo,7.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,7.5,7.5
5503,Placebo,6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,6,6
5504,Placebo,6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,6,6
5505,Placebo,8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,8,8
5506,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5507,Placebo,0.2775,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.3,0.3
5508,Placebo,0.23,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.2,0.2
5509,Placebo,0.39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.4,0.4
5510,Placebo,0.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.2,0.2
5511,Placebo,0.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.3,0.3
5512,Placebo,0.34,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.3,0.3
5513,Placebo,0.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.3,0.3
5514,Placebo,0.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.2,0.2
5515,Placebo,0.2925,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.3,0.3
5516,Placebo,0.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.2,0.2
5517,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5518,Placebo,0.9075,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.9,0.9
5519,Placebo,1.36,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1.4,1.4
5520,Placebo,1.36,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1.4,1.4
5521,Placebo,0.46,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.5,0.5
5522,Placebo,1.2475,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1.2,1.2
5523,Placebo,0.68,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.7,0.7
5524,Placebo,0.9075,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.9,0.9
5525,Placebo,0.9075,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.9,0.9
5526,Placebo,1.135,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1.1,1.1
5527,Placebo,0.91,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.9,0.9
5528,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5529,Xanomeline High Dose,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
5530,Xanomeline High Dose,2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,2,2
5531,Xanomeline High Dose,2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,2,2
5532,Xanomeline High Dose,6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,6,6
5533,Xanomeline High Dose,2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,2,2
5534,Xanomeline High Dose,3.75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,3.8,3.8
5535,Xanomeline High Dose,3.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,3.2,3.2
5536,Xanomeline High Dose,5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,5,5
5537,Xanomeline High Dose,2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,2,2
5538,Xanomeline High Dose,5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,5,5
5539,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5540,Xanomeline High Dose,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
5541,Xanomeline High Dose,6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,6,6
5542,Xanomeline High Dose,8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,8,8
5543,Xanomeline High Dose,9,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,9,9
5544,Xanomeline High Dose,12,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,12,12
5545,Xanomeline High Dose,5.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,5.5,5.5
5546,Xanomeline High Dose,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
5547,Xanomeline High Dose,10,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,10,10
5548,Xanomeline High Dose,8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,8,8
5549,Xanomeline High Dose,8,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,8,8
5550,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5551,Xanomeline High Dose,2,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,2,2
5552,Xanomeline High Dose,0.75,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.8,0.8
5553,Xanomeline High Dose,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
5554,Xanomeline High Dose,3.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,3.5,3.5
5555,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5556,Xanomeline High Dose,3.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,3.5,3.5
5557,Xanomeline High Dose,-3.5,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,-3.5,-3.5
5558,Xanomeline High Dose,4,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,4,4
5559,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5560,Xanomeline High Dose,6,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,6,6
5561,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5562,Xanomeline High Dose,0.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.3,0.3
5563,Xanomeline High Dose,0.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.3,0.3
5564,Xanomeline High Dose,0.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
5565,Xanomeline High Dose,0.23,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.2,0.2
5566,Xanomeline High Dose,0.255,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.3,0.3
5567,Xanomeline High Dose,0.12,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.1,0.1
5568,Xanomeline High Dose,0.2725,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.3,0.3
5569,Xanomeline High Dose,0.23,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.2,0.2
5570,Xanomeline High Dose,0.2425,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.2,0.2
5571,Xanomeline High Dose,0.235,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.2,0.2
5572,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0,0
5573,Xanomeline High Dose,0.46,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.5,0.5
5574,Xanomeline High Dose,1.2375,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1.2,1.2
5575,Xanomeline High Dose,0.91,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.9,0.9
5576,Xanomeline High Dose,0.9,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,0.9,0.9
5577,Xanomeline High Dose,1.0225,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1,1
5578,Xanomeline High Dose,1.81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1.8,1.8
5579,Xanomeline High Dose,0.965,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1,1
5580,Xanomeline High Dose,0.9675,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1,1
5581,Xanomeline High Dose,1.25,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1.2,1.2
5582,Xanomeline High Dose,1.36,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_6_Q3,Out14-3-3-1b,Q3,XX.X,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",1,1.4,1.4
5583,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
5584,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5585,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5586,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5587,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5588,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5589,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5590,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5591,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5592,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5593,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5594,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
5595,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5596,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5597,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5598,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5599,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5600,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5601,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5602,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5603,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5604,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5605,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
5606,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5607,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5608,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5609,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5610,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5611,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5612,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5613,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5614,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5615,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5616,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
5617,Placebo,-0.72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
5618,Placebo,-0.62,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
5619,Placebo,-0.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
5620,Placebo,-0.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
5621,Placebo,-1,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
5622,Placebo,-1.95,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-2,-2
5623,Placebo,-0.62,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
5624,Placebo,-1.94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-2,-2
5625,Placebo,-0.73,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
5626,Placebo,-0.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
5627,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
5628,Placebo,-4.99,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-5,-5
5629,Placebo,-4.49,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-4,-4
5630,Placebo,-4.13,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-4,-4
5631,Placebo,-1.81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-2,-2
5632,Placebo,-4.54,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-5,-5
5633,Placebo,-4.54,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-5,-5
5634,Placebo,-4.99,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-5,-5
5635,Placebo,-1.81,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-2,-2
5636,Placebo,-5.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-5,-5
5637,Placebo,-4.31,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-4,-4
5638,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
5639,Xanomeline High Dose,-40,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-40,-40
5640,Xanomeline High Dose,-46,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-46,-46
5641,Xanomeline High Dose,-38,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-38,-38
5642,Xanomeline High Dose,-38,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-38,-38
5643,Xanomeline High Dose,-36,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-36,-36
5644,Xanomeline High Dose,-20,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-20,-20
5645,Xanomeline High Dose,-20,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-20,-20
5646,Xanomeline High Dose,-32,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-32,-32
5647,Xanomeline High Dose,-50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-50,-50
5648,Xanomeline High Dose,-45,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-45,-45
5649,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
5650,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5651,Xanomeline High Dose,-20,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-20,-20
5652,Xanomeline High Dose,-28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-28,-28
5653,Xanomeline High Dose,-20,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-20,-20
5654,Xanomeline High Dose,-28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-28,-28
5655,Xanomeline High Dose,-40,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-40,-40
5656,Xanomeline High Dose,-32,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-32,-32
5657,Xanomeline High Dose,-24,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-24,-24
5658,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5659,Xanomeline High Dose,-20,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-20,-20
5660,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
5661,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5662,Xanomeline High Dose,-52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-52,-52
5663,Xanomeline High Dose,-52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-52,-52
5664,Xanomeline High Dose,-52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-52,-52
5665,Xanomeline High Dose,-82,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-82,-82
5666,Xanomeline High Dose,-40,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-40,-40
5667,Xanomeline High Dose,-62,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-62,-62
5668,Xanomeline High Dose,-52,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-52,-52
5669,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5670,Xanomeline High Dose,-43,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-43,-43
5671,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
5672,Xanomeline High Dose,-1,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
5673,Xanomeline High Dose,-0.61,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
5674,Xanomeline High Dose,-0.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
5675,Xanomeline High Dose,-1.39,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
5676,Xanomeline High Dose,-0.56,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
5677,Xanomeline High Dose,-0.94,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
5678,Xanomeline High Dose,-0.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
5679,Xanomeline High Dose,-1,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
5680,Xanomeline High Dose,-1.06,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
5681,Xanomeline High Dose,-0.66,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-1,-1
5682,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
5683,Xanomeline High Dose,-5.9,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-6,-6
5684,Xanomeline High Dose,-5.45,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-5,-5
5685,Xanomeline High Dose,-3.18,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-3,-3
5686,Xanomeline High Dose,-5.45,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-5,-5
5687,Xanomeline High Dose,-3.62,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-4,-4
5688,Xanomeline High Dose,-4.53,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-5,-5
5689,Xanomeline High Dose,-5.9,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-6,-6
5690,Xanomeline High Dose,-2.27,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-2,-2
5691,Xanomeline High Dose,-5.44,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-5,-5
5692,Xanomeline High Dose,-4.54,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_7_Min,Out14-3-3-1b,Min,XX,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,-5,-5
5693,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
5694,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5695,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5696,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5697,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5698,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5699,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5700,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5701,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5702,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5703,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5704,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
5705,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5706,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5707,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5708,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5709,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5710,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5711,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5712,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5713,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5714,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5715,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
5716,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5717,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5718,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5719,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5720,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5721,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5722,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5723,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5724,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5725,Placebo,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5726,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
5727,Placebo,1.34,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
5728,Placebo,1.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
5729,Placebo,1.33,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
5730,Placebo,1.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
5731,Placebo,1.28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
5732,Placebo,1.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
5733,Placebo,1.34,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
5734,Placebo,0.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
5735,Placebo,1.06,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
5736,Placebo,1,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
5737,Placebo,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
5738,Placebo,4.99,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,5,5
5739,Placebo,11.34,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,11,11
5740,Placebo,11.34,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,11,11
5741,Placebo,2.72,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,3,3
5742,Placebo,6.35,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,6,6
5743,Placebo,8.17,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,8,8
5744,Placebo,4.99,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,5,5
5745,Placebo,4.54,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,5,5
5746,Placebo,4.08,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,4,4
5747,Placebo,4.54,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,5,5
5748,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
5749,Xanomeline High Dose,22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,22,22
5750,Xanomeline High Dose,20,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,20,20
5751,Xanomeline High Dose,27,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,27,27
5752,Xanomeline High Dose,28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,28,28
5753,Xanomeline High Dose,28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,28,28
5754,Xanomeline High Dose,22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,22,22
5755,Xanomeline High Dose,20,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,20,20
5756,Xanomeline High Dose,26,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,26,26
5757,Xanomeline High Dose,20,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,20,20
5758,Xanomeline High Dose,22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,DIABP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,22,22
5759,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
5760,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5761,Xanomeline High Dose,28,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,28,28
5762,Xanomeline High Dose,32,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,32,32
5763,Xanomeline High Dose,32,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,32,32
5764,Xanomeline High Dose,30,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,30,30
5765,Xanomeline High Dose,20,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,20,20
5766,Xanomeline High Dose,24,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,24,24
5767,Xanomeline High Dose,36,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,36,36
5768,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5769,Xanomeline High Dose,26,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,PULSE,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,26,26
5770,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
5771,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5772,Xanomeline High Dose,35,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,35,35
5773,Xanomeline High Dose,45,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,45,45
5774,Xanomeline High Dose,40,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,40,40
5775,Xanomeline High Dose,45,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,45,45
5776,Xanomeline High Dose,42,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,42,42
5777,Xanomeline High Dose,34,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,34,34
5778,Xanomeline High Dose,40,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,40,40
5779,Xanomeline High Dose,NA,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,NA,NA
5780,Xanomeline High Dose,50,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,SYSBP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,50,50
5781,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
5782,Xanomeline High Dose,0.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
5783,Xanomeline High Dose,1.06,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
5784,Xanomeline High Dose,1.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
5785,Xanomeline High Dose,1.11,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
5786,Xanomeline High Dose,1.12,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
5787,Xanomeline High Dose,1.22,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
5788,Xanomeline High Dose,0.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
5789,Xanomeline High Dose,0.78,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
5790,Xanomeline High Dose,0.89,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
5791,Xanomeline High Dose,1,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,TEMP,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,1,1
5792,Xanomeline High Dose,0,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Baseline,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,0,0
5793,Xanomeline High Dose,36.97,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,End of Treatment,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,37,37
5794,Xanomeline High Dose,32.66,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 12,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,33,33
5795,Xanomeline High Dose,33.12,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 16,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,33,33
5796,Xanomeline High Dose,34.48,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 2,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,34,34
5797,Xanomeline High Dose,33.12,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 20,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,33,33
5798,Xanomeline High Dose,33.34,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 24,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,33,33
5799,Xanomeline High Dose,36.97,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 26,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,37,37
5800,Xanomeline High Dose,34.02,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 4,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,34,34
5801,Xanomeline High Dose,34.93,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 6,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,35,35
5802,Xanomeline High Dose,33.12,Mth02_ContVar_Summ_ByGrp,Mth02_ContVar_Summ_ByGrp_8_Max,Out14-3-3-1b,Max,XX,WEIGHT,Week 8,An08_02_ChgBl_Summ_ByTrt,"Summary of Change from Baseline by Treatment, Parameter and Visit",0,33,33
